<!DOCTYPE html>
<html class="js" lang="en"><head>
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
        <title>Targeted genome editing in acute lymphoblastic leukemia: a review | BMC Biotechnology | Full Text</title>

        

    <meta name="citation_abstract" content="Genome editing technologies offers new opportunities for tackling diseases such as acute lymphoblastic leukemia (ALL) that have been beyond the reach of previous therapies. We show how the recent availability of genome-editing tools such as CRISPR-Cas9 are an important means of advancing functional studies of ALL through the incorporation, elimination and modification of somatic mutations and fusion genes in cell lines and mouse models. These tools not only broaden the understanding of the involvement of various genetic alterations in the pathogenesis of the disease but also identify new therapeutic targets for future clinical trials. New approaches including CRISPR-Cas9 are crucial for functional studies of genetic aberrations driving cancer progression, and that may be responsible for treatment resistance and relapses. By using this approach, diseases can be more faithfully reproduced and new therapeutic targets and approaches found.">

    <meta name="description" content="Genome editing technologies offers new opportunities for tackling diseases such as acute lymphoblastic leukemia (ALL) that have been beyond the reach of previous therapies. We show how the recent availability of genome-editing tools such as CRISPR-Cas9 are an important means of advancing functional studies of ALL through the incorporation, elimination and modification of somatic mutations and fusion genes in cell lines and mouse models. These tools not only broaden the understanding of the involvement of various genetic alterations in the pathogenesis of the disease but also identify new therapeutic targets for future clinical trials. New approaches including CRISPR-Cas9 are crucial for functional studies of genetic aberrations driving cancer progression, and that may be responsible for treatment resistance and relapses. By using this approach, diseases can be more faithfully reproduced and new therapeutic targets and approaches found.">

    <meta name="journal_id" content="12896">

    <meta name="dc.title" content="Targeted genome editing in acute lymphoblastic leukemia: a review">

    <meta name="dc.source" content="BMC Biotechnology 2018 18:1">

    <meta name="dc.format" content="text/html">

    <meta name="dc.publisher" content="BioMed Central">

    <meta name="dc.date" content="2018-07-17">

    <meta name="dc.type" content="ReviewPaper">

    <meta name="dc.language" content="En">

    <meta name="dc.copyright" content="2018 The Author(s).">

    <meta name="dc.rightsAgent" content="reprints@biomedcentral.com">

    <meta name="dc.description" content="Genome editing technologies offers new opportunities for tackling diseases such as acute lymphoblastic leukemia (ALL) that have been beyond the reach of previous therapies. We show how the recent availability of genome-editing tools such as CRISPR-Cas9 are an important means of advancing functional studies of ALL through the incorporation, elimination and modification of somatic mutations and fusion genes in cell lines and mouse models. These tools not only broaden the understanding of the involvement of various genetic alterations in the pathogenesis of the disease but also identify new therapeutic targets for future clinical trials. New approaches including CRISPR-Cas9 are crucial for functional studies of genetic aberrations driving cancer progression, and that may be responsible for treatment resistance and relapses. By using this approach, diseases can be more faithfully reproduced and new therapeutic targets and approaches found.">

    <meta name="prism.issn" content="1472-6750">

    <meta name="prism.publicationName" content="BMC Biotechnology">

    <meta name="prism.publicationDate" content="2018-07-17">

    <meta name="prism.volume" content="18">

    <meta name="prism.number" content="1">

    <meta name="prism.section" content="ReviewPaper">

    <meta name="prism.startingPage" content="45">

    <meta name="prism.copyright" content="2018 The Author(s).">

    <meta name="prism.rightsAgent" content="reprints@biomedcentral.com">

    <meta name="prism.url" content="https://bmcbiotechnol.biomedcentral.com/articles/10.1186/s12896-018-0455-9">

    <meta name="prism.doi" content="doi:10.1186/s12896-018-0455-9">

    <meta name="citation_pdf_url" content="https://bmcbiotechnol.biomedcentral.com/track/pdf/10.1186/s12896-018-0455-9">

    <meta name="citation_fulltext_html_url" content="https://bmcbiotechnol.biomedcentral.com/articles/10.1186/s12896-018-0455-9">

    <meta name="citation_journal_title" content="BMC Biotechnology">

    <meta name="citation_publisher" content="BioMed Central">

    <meta name="citation_issn" content="1472-6750">

    <meta name="citation_title" content="Targeted genome editing in acute lymphoblastic leukemia: a review">

    <meta name="citation_volume" content="18">

    <meta name="citation_issue" content="1">

    <meta name="citation_publication_date" content="2018/12">

    <meta name="citation_online_date" content="2018/07/17">

    <meta name="citation_firstpage" content="45">

    <meta name="citation_article_type" content="Review">

    <meta name="citation_fulltext_world_readable" content="">

    <meta name="dc.identifier" content="doi:10.1186/s12896-018-0455-9">

    <meta name="DOI" content="10.1186/s12896-018-0455-9">

    <meta name="citation_doi" content="10.1186/s12896-018-0455-9">

    <meta name="dc.creator" content="Adrián Montaño">

    <meta name="dc.creator" content="Maribel Forero-Castro">

    <meta name="dc.creator" content="Jesús-María Hernández-Rivas">

    <meta name="dc.creator" content="Ignacio García-Tuñón">

    <meta name="dc.creator" content="Rocío Benito">

    <meta name="dc.subject" content="Applied Microbiology">

    <meta name="dc.subject" content="Biotechnology">

    <meta name="dc.subject" content="Biochemical Engineering">

    <meta name="dc.subject" content="Genetic Engineering">

    <meta name="dc.subject" content="Plant Breeding/Biotechnology">

    <meta name="dc.subject" content="Biomedical Engineering/Biotechnology">

    <meta name="citation_reference" content="citation_journal_title=J Clin Oncol; citation_title=Genetic basis of acute lymphoblastic leukemia; citation_author=I Iacobucci, CG Mullighan; citation_volume=35; citation_issue=9; citation_publication_date=2017; citation_pages=975-983; citation_doi=10.1200/JCO.2016.70.7836; citation_id=CR1">

    <meta name="citation_reference" content="citation_journal_title=Acta Nat; citation_title=TALEN and CRISPR/Cas genome editing systems: tools of discovery; citation_author=AA Nemudryi, KR Valetdinova, SP Medvedev, SM Zakian; citation_volume=6; citation_issue=3; citation_publication_date=2014; citation_pages=19-40; citation_id=CR2">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Metabolic gatekeeper function of B-lymphoid transcription factors; citation_author=LN Chan, Z Chen, D Braas, JW Lee, G Xiao, H Geng, KN Cosgun, C Hurtz, S Shojaee, V Cazzaniga; citation_volume=542; citation_issue=7642; citation_publication_date=2017; citation_pages=479-483; citation_doi=10.1038/nature21076; citation_id=CR3">

    <meta name="citation_reference" content="citation_journal_title=Nat Commun; citation_title=Site- and allele-specific polycomb dysregulation in T-cell leukaemia; citation_author=JM Navarro, A Touzart, LC Pradel, M Loosveld, M Koubi, R Fenouil, S Le Noir, MA Maqbool, E Morgado, C Gregoire; citation_volume=6; citation_publication_date=2015; citation_pages=6094; citation_doi=10.1038/ncomms7094; citation_id=CR4">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia; citation_author=S Rahman, M Magnussen, TE Leon, N Farah, Z Li, BJ Abraham, KZ Alapi, RJ Mitchell, T Naughton, AK Fielding; citation_volume=129; citation_issue=24; citation_publication_date=2017; citation_pages=3221-3226; citation_doi=10.1182/blood-2016-09-742148; citation_id=CR5">

    <meta name="citation_reference" content="citation_journal_title=Haematologica; citation_title=CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo; citation_author=J Reimer, S Knoss, M Labuhn, EM Charpentier, G Gohring, B Schlegelberger, JH Klusmann, D Heckl; citation_volume=102; citation_issue=9; citation_publication_date=2017; citation_pages=1558-1566; citation_doi=10.3324/haematol.2017.164046; citation_id=CR6">

    <meta name="citation_reference" content="citation_journal_title=BMC Cancer; citation_title=Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns; citation_author=KM Kampa-Schittenhelm, O Salitzky, F Akmut, B Illing, L Kanz, HR Salih, MM Schittenhelm; citation_volume=16; citation_publication_date=2016; citation_pages=25; citation_doi=10.1186/s12885-015-2029-8; citation_id=CR7">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK; citation_author=E Kim, C Hurtz, S Koehrer, Z Wang, S Balasubramanian, BY Chang, M Muschen, RE Davis, JA Burger; citation_volume=129; citation_issue=9; citation_publication_date=2017; citation_pages=1155-1165; citation_doi=10.1182/blood-2016-06-722900; citation_id=CR8">

    <meta name="citation_reference" content="Qasim W, Zhan H, Samarasinghe S, Adams S, Amrolia P, Stafford S, Butler K, Rivat C, Wright G, Somana K, et al. Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells. Sci Transl Med. 2017;9(374)">

    <meta name="citation_reference" content="citation_journal_title=Br J Haematol; citation_title=Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemia; citation_author=S Randhawa, BS Cho, D Ghosh, M Sivina, S Koehrer, M Muschen, A Peled, RE Davis, M Konopleva, JA Burger; citation_volume=174; citation_issue=3; citation_publication_date=2016; citation_pages=425-436; citation_doi=10.1111/bjh.14075; citation_id=CR10">

    <meta name="citation_reference" content="citation_journal_title=Trends Biotechnol; citation_title=ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering; citation_author=T Gaj, CA Gersbach, CF Barbas; citation_volume=31; citation_issue=7; citation_publication_date=2013; citation_pages=397-405; citation_doi=10.1016/j.tibtech.2013.04.004; citation_id=CR11">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Genet; citation_title=Genome editing with engineered zinc finger nucleases; citation_author=FD Urnov, EJ Rebar, MC Holmes, HS Zhang, PD Gregory; citation_volume=11; citation_issue=9; citation_publication_date=2010; citation_pages=636-646; citation_doi=10.1038/nrg2842; citation_id=CR12">

    <meta name="citation_reference" content="citation_journal_title=Genetics; citation_title=Genome engineering with zinc-finger nucleases; citation_author=D Carroll; citation_volume=188; citation_issue=4; citation_publication_date=2011; citation_pages=773-782; citation_doi=10.1534/genetics.111.131433; citation_id=CR13">

    <meta name="citation_reference" content="citation_journal_title=Annu Rev Genet; citation_title=DNA double-strand break repair: all's well that ends well; citation_author=C Wyman, R Kanaar; citation_volume=40; citation_publication_date=2006; citation_pages=363-383; citation_doi=10.1146/annurev.genet.40.110405.090451; citation_id=CR14">

    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=Knockout rats produced using designed zinc finger nucleases; citation_author=AM Geurts, GJ Cost, Y Freyvert, Z Zeitler, JC Miller, VM Choi, SS Jenkins, A Wood, X Cui, X Meng; citation_volume=325; citation_issue=5939; citation_publication_date=2009; citation_pages=433; citation_doi=10.1126/science.1172447; citation_id=CR15">

    <meta name="citation_reference" content="citation_journal_title=Nat Biotechnol; citation_title=Knockout rats generated by embryo microinjection of TALENs; citation_author=L Tesson, C Usal, S Menoret, E Leung, BJ Niles, S Remy, Y Santiago, AI Vincent, X Meng, L Zhang; citation_volume=29; citation_issue=8; citation_publication_date=2011; citation_pages=695-696; citation_doi=10.1038/nbt.1940; citation_id=CR16">

    <meta name="citation_reference" content="citation_journal_title=Nat Biotechnol; citation_title=A TALE nuclease architecture for efficient genome editing; citation_author=JC Miller, S Tan, G Qiao, KA Barlow, J Wang, DF Xia, X Meng, DE Paschon, E Leung, SJ Hinkley; citation_volume=29; citation_issue=2; citation_publication_date=2011; citation_pages=143-148; citation_doi=10.1038/nbt.1755; citation_id=CR17">

    <meta name="citation_reference" content="citation_journal_title=J Bacteriol; citation_title=Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product; citation_author=Y Ishino, H Shinagawa, K Makino, M Amemura, A Nakata; citation_volume=169; citation_issue=12; citation_publication_date=1987; citation_pages=5429-5433; citation_doi=10.1128/jb.169.12.5429-5433.1987; citation_id=CR18">

    <meta name="citation_reference" content="citation_journal_title=J Mol Evol; citation_title=Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements; citation_author=FJ Mojica, C Diez-Villasenor, J Garcia-Martinez, E Soria; citation_volume=60; citation_issue=2; citation_publication_date=2005; citation_pages=174-182; citation_doi=10.1007/s00239-004-0046-3; citation_id=CR19">

    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity; citation_author=M Jinek, K Chylinski, I Fonfara, M Hauer, JA Doudna, E Charpentier; citation_volume=337; citation_issue=6096; citation_publication_date=2012; citation_pages=816-821; citation_doi=10.1126/science.1225829; citation_id=CR20">

    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=RNA-guided human genome engineering via Cas9; citation_author=P Mali, L Yang, KM Esvelt, J Aach, M Guell, JE DiCarlo, JE Norville, GM Church; citation_volume=339; citation_issue=6121; citation_publication_date=2013; citation_pages=823-826; citation_doi=10.1126/science.1232033; citation_id=CR21">

    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=Multiplex genome engineering using CRISPR/Cas systems; citation_author=L Cong, FA Ran, D Cox, S Lin, R Barretto, N Habib, PD Hsu, X Wu, W Jiang, LA Marraffini; citation_volume=339; citation_issue=6121; citation_publication_date=2013; citation_pages=819-823; citation_doi=10.1126/science.1231143; citation_id=CR22">

    <meta name="citation_reference" content="citation_journal_title=Nat Protoc; citation_title=CRISPR interference (CRISPRi) for sequence-specific control of gene expression; citation_author=MH Larson, LA Gilbert, X Wang, WA Lim, JS Weissman, LS Qi; citation_volume=8; citation_issue=11; citation_publication_date=2013; citation_pages=2180-2196; citation_doi=10.1038/nprot.2013.132; citation_id=CR23">

    <meta name="citation_reference" content="citation_journal_title=Genetics; citation_title=Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila; citation_author=Z Yu, M Ren, Z Wang, B Zhang, YS Rong, R Jiao, G Gao; citation_volume=195; citation_issue=1; citation_publication_date=2013; citation_pages=289-291; citation_doi=10.1534/genetics.113.153825; citation_id=CR24">

    <meta name="citation_reference" content="citation_journal_title=Nat Methods; citation_title=Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination; citation_author=DJ Dickinson, JD Ward, DJ Reiner, B Goldstein; citation_volume=10; citation_issue=10; citation_publication_date=2013; citation_pages=1028-1034; citation_doi=10.1038/nmeth.2641; citation_id=CR25">

    <meta name="citation_reference" content="citation_journal_title=Cell Res; citation_title=Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos; citation_author=N Chang, C Sun, L Gao, D Zhu, X Xu, X Zhu, JW Xiong, JJ Xi; citation_volume=23; citation_issue=4; citation_publication_date=2013; citation_pages=465-472; citation_doi=10.1038/cr.2013.45; citation_id=CR26">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering; citation_author=H Wang, H Yang, CS Shivalila, MM Dawlaty, AW Cheng, F Zhang, R Jaenisch; citation_volume=153; citation_issue=4; citation_publication_date=2013; citation_pages=910-918; citation_doi=10.1016/j.cell.2013.04.025; citation_id=CR27">

    <meta name="citation_reference" content="citation_journal_title=Nat Biotechnol; citation_title=Heritable gene targeting in the mouse and rat using a CRISPR-Cas system; citation_author=D Li, Z Qiu, Y Shao, Y Chen, Y Guan, M Liu, Y Li, N Gao, L Wang, X Lu; citation_volume=31; citation_issue=8; citation_publication_date=2013; citation_pages=681-683; citation_doi=10.1038/nbt.2661; citation_id=CR28">

    <meta name="citation_reference" content="citation_journal_title=Annu Rev Genomics Hum Genet; citation_title=CRISPR/Cas9 for human genome engineering and disease research; citation_author=X Xiong, M Chen, WA Lim, D Zhao, LS Qi; citation_volume=17; citation_publication_date=2016; citation_pages=131-154; citation_doi=10.1146/annurev-genom-083115-022258; citation_id=CR29">

    <meta name="citation_reference" content="citation_journal_title=Mol Ther; citation_title=Evaluation of TCR gene editing achieved by TALENs, CRISPR/Cas9, and megaTAL nucleases; citation_author=MJ Osborn, BR Webber, F Knipping, CL Lonetree, N Tennis, AP DeFeo, AN McElroy, CG Starker, C Lee, S Merkel; citation_volume=24; citation_issue=3; citation_publication_date=2016; citation_pages=570-581; citation_doi=10.1038/mt.2015.197; citation_id=CR30">

    <meta name="citation_reference" content="citation_journal_title=Hum Gene Ther; citation_title=Fanconi anemia gene editing by the CRISPR/Cas9 system; citation_author=MJ Osborn, R Gabriel, BR Webber, AP DeFeo, AN McElroy, J Jarjour, CG Starker, JE Wagner, JK Joung, DF Voytas; citation_volume=26; citation_issue=2; citation_publication_date=2015; citation_pages=114-126; citation_doi=10.1089/hum.2014.111; citation_id=CR31">

    <meta name="citation_reference" content="citation_journal_title=Oncotarget; citation_title=The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia; citation_author=I Garcia-Tunon, M Hernandez-Sanchez, JL Ordonez, V Alonso-Perez, M Alamo-Quijada, R Benito, C Guerrero, JM Hernandez-Rivas, M Sanchez-Martin; citation_volume=8; citation_issue=16; citation_publication_date=2017; citation_pages=26027-26040; citation_doi=10.18632/oncotarget.15215; citation_id=CR32">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia; citation_author=CG Mullighan, S Goorha, I Radtke, CB Miller, E Coustan-Smith, JD Dalton, K Girtman, S Mathew, J Ma, SB Pounds; citation_volume=446; citation_issue=7137; citation_publication_date=2007; citation_pages=758-764; citation_doi=10.1038/nature05690; citation_id=CR33">

    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia; citation_author=CG Mullighan, LA Phillips, X Su, J Ma, CB Miller, SA Shurtleff, JR Downing; citation_volume=322; citation_issue=5906; citation_publication_date=2008; citation_pages=1377-1380; citation_doi=10.1126/science.1164266; citation_id=CR34">

    <meta name="citation_reference" content="citation_journal_title=Biol Pharm Bull; citation_title=Pseudokinase tribbles 1 (TRB1) negatively regulates tumor-suppressor activity of p53 through p53 deacetylation; citation_author=C Miyajima, Y Inoue, H Hayashi; citation_volume=38; citation_issue=4; citation_publication_date=2015; citation_pages=618-624; citation_doi=10.1248/bpb.b15-00003; citation_id=CR35">

    <meta name="citation_reference" content="citation_journal_title=Cancer Cell; citation_title=Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia; citation_author=T Sanda, LN Lawton, MI Barrasa, ZP Fan, H Kohlhammer, A Gutierrez, W Ma, J Tatarek, Y Ahn, MA Kelliher; citation_volume=22; citation_issue=2; citation_publication_date=2012; citation_pages=209-221; citation_doi=10.1016/j.ccr.2012.06.007; citation_id=CR36">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia; citation_author=AA Ferrando, S Herblot, T Palomero, M Hansen, T Hoang, EA Fox, AT Look; citation_volume=103; citation_issue=5; citation_publication_date=2004; citation_pages=1909-1911; citation_doi=10.1182/blood-2003-07-2577; citation_id=CR37">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Cancer; citation_title=Origins of chromosome translocations in childhood leukaemia; citation_author=MF Greaves, J Wiemels; citation_volume=3; citation_issue=9; citation_publication_date=2003; citation_pages=639-649; citation_doi=10.1038/nrc1164; citation_id=CR38">

    <meta name="citation_reference" content="Greaves M. A causal mechanism for childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2018;">

    <meta name="citation_reference" content="citation_journal_title=Dev Cell; citation_title=A human IPS model implicates embryonic B-myeloid fate restriction as developmental susceptibility to B acute lymphoblastic leukemia-associated ETV6-RUNX1; citation_author=C Boiers, SE Richardson, E Laycock, A Zriwil, VA Turati, J Brown, JP Wray, D Wang, C James, J Herrero; citation_volume=44; citation_issue=3; citation_publication_date=2018; citation_pages=362-377; citation_doi=10.1016/j.devcel.2017.12.005; citation_id=CR40">

    <meta name="citation_reference" content="Weinstock DM, Brunet E, Jasin M. Induction of chromosomal translocations in mouse and human cells using site-specific endonucleases. J Natl Cancer Inst Monogr. 2008;2008(39):20–4.">

    <meta name="citation_reference" content="citation_journal_title=PLoS One; citation_title=Use of genome engineering to create patient specific MLL translocations in primary human hematopoietic stem and progenitor cells; citation_author=EH Breese, C Buechele, C Dawson, ML Cleary, MH Porteus; citation_volume=10; citation_issue=9; citation_publication_date=2015; citation_pages=e0136644; citation_doi=10.1371/journal.pone.0136644; citation_id=CR42">

    <meta name="citation_reference" content="citation_journal_title=Blood Adv; citation_title=MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing; citation_author=C Schneidawind, J Jeong, D Schneidawind, IS Kim, J Duque-Afonso, SHK Wong, M Iwasaki, EH Breese, JL Zehnder, M Porteus; citation_volume=2; citation_issue=8; citation_publication_date=2018; citation_pages=832-845; citation_doi=10.1182/bloodadvances.2017013748; citation_id=CR43">

    <meta name="citation_reference" content="citation_journal_title=Carcinogenesis; citation_title=Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells; citation_author=C Bueno, P Catalina, GJ Melen, R Montes, L Sanchez, G Ligero, JL Garcia-Perez, P Menendez; citation_volume=30; citation_issue=9; citation_publication_date=2009; citation_pages=1628-1637; citation_doi=10.1093/carcin/bgp169; citation_id=CR44">

    <meta name="citation_reference" content="citation_journal_title=PLoS One; citation_title=Dysregulation of the DNA damage response and KMT2A rearrangement in fetal liver hematopoietic cells; citation_author=M Nanya, M Sato, K Tanimoto, M Tozuka, S Mizutani, M Takagi; citation_volume=10; citation_issue=12; citation_publication_date=2015; citation_pages=e0144540; citation_doi=10.1371/journal.pone.0144540; citation_id=CR45">

    <meta name="citation_reference" content="citation_journal_title=Oncotarget; citation_title=Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair; citation_author=J Castano, AB Herrero, A Bursen, F Gonzalez, R Marschalek, NC Gutierrez, P Menendez; citation_volume=7; citation_issue=21; citation_publication_date=2016; citation_pages=30440-30452; citation_doi=10.18632/oncotarget.8938; citation_id=CR46">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765; citation_author=SE Herman, AL Gordon, E Hertlein, A Ramanunni, X Zhang, S Jaglowski, J Flynn, J Jones, KA Blum, JJ Buggy; citation_volume=117; citation_issue=23; citation_publication_date=2011; citation_pages=6287-6296; citation_doi=10.1182/blood-2011-01-328484; citation_id=CR47">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo; citation_author=S Ponader, SS Chen, JJ Buggy, K Balakrishnan, V Gandhi, WG Wierda, MJ Keating, S O'Brien, N Chiorazzi, JA Burger; citation_volume=119; citation_issue=5; citation_publication_date=2012; citation_pages=1182-1189; citation_doi=10.1182/blood-2011-10-386417; citation_id=CR48">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma; citation_author=RE Davis, VN Ngo, G Lenz, P Tolar, RM Young, PB Romesser, H Kohlhammer, L Lamy, H Zhao, Y Yang; citation_volume=463; citation_issue=7277; citation_publication_date=2010; citation_pages=88-92; citation_doi=10.1038/nature08638; citation_id=CR49">

    <meta name="citation_reference" content="citation_journal_title=Leuk Lymphoma; citation_title=Defective expression of Bruton's tyrosine kinase in acute lymphoblastic leukemia; citation_author=PA Goodman, CM Wood, AO Vassilev, C Mao, FM Uckun; citation_volume=44; citation_issue=6; citation_publication_date=2003; citation_pages=1011-1018; citation_doi=10.1080/1042819031000067576; citation_id=CR50">

    <meta name="citation_reference" content="citation_journal_title=J Exp Med; citation_title=Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells; citation_author=N Feldhahn, F Klein, JL Mooster, P Hadweh, M Sprangers, M Wartenberg, MM Bekhite, WK Hofmann, S Herzog, H Jumaa; citation_volume=201; citation_issue=11; citation_publication_date=2005; citation_pages=1837-1852; citation_doi=10.1084/jem.20042101; citation_id=CR51">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=The genetic basis of early T-cell precursor acute lymphoblastic leukaemia; citation_author=J Zhang, L Ding, L Holmfeldt, G Wu, SL Heatley, D Payne-Turner, J Easton, X Chen, J Wang, M Rusch; citation_volume=481; citation_issue=7380; citation_publication_date=2012; citation_pages=157-163; citation_doi=10.1038/nature10725; citation_id=CR52">

    <meta name="citation_reference" content="citation_journal_title=Int J Cancer; citation_title=The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation; citation_author=PJ van der Watt, CP Maske, DT Hendricks, MI Parker, L Denny, D Govender, MJ Birrer, VD Leaner; citation_volume=124; citation_issue=8; citation_publication_date=2009; citation_pages=1829-1840; citation_doi=10.1002/ijc.24146; citation_id=CR53">

    <meta name="citation_reference" content="citation_journal_title=Neurosurgery; citation_title=Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis; citation_author=A Shen, Y Wang, Y Zhao, L Zou, L Sun, C Cheng; citation_volume=65; citation_issue=1; citation_publication_date=2009; citation_pages=153-159; citation_doi=10.1227/01.NEU.0000348550.47441.4B; citation_id=CR54">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia; citation_author=R Lapalombella, Q Sun, K Williams, L Tangeman, S Jha, Y Zhong, V Goettl, E Mahoney, C Berglund, S Gupta; citation_volume=120; citation_issue=23; citation_publication_date=2012; citation_pages=4621-4634; citation_doi=10.1182/blood-2012-05-429506; citation_id=CR55">

    <meta name="citation_reference" content="citation_journal_title=Chem Biol; citation_title=Identifying drug-target selectivity of small-molecule CRM1/XPO1 inhibitors by CRISPR/Cas9 genome editing; citation_author=JE Neggers, T Vercruysse, M Jacquemyn, E Vanstreels, E Baloglu, S Shacham, M Crochiere, Y Landesman, D Daelemans; citation_volume=22; citation_issue=1; citation_publication_date=2015; citation_pages=107-116; citation_doi=10.1016/j.chembiol.2014.11.015; citation_id=CR56">

    <meta name="citation_reference" content="citation_journal_title=Clin Cancer Res; citation_title=The second-generation Exportin-1 inhibitor KPT-8602 demonstrates potent activity against acute lymphoblastic leukemia; citation_author=T Vercruysse, J De Bie, JE Neggers, M Jacquemyn, E Vanstreels, JL Schmid-Burgk, V Hornung, E Baloglu, Y Landesman, W Senapedis; citation_volume=23; citation_issue=10; citation_publication_date=2017; citation_pages=2528-2541; citation_doi=10.1158/1078-0432.CCR-16-1580; citation_id=CR57">

    <meta name="citation_reference" content="citation_journal_title=Leuk Res; citation_title=Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in Delta9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells; citation_author=C Lombard, M Nagarkatti, PS Nagarkatti; citation_volume=29; citation_issue=8; citation_publication_date=2005; citation_pages=915-922; citation_doi=10.1016/j.leukres.2005.01.014; citation_id=CR58">

    <meta name="citation_reference" content="citation_journal_title=PLoS One; citation_title=Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines; citation_author=K Takahashi, T Inukai, T Imamura, M Yano, C Tomoyasu, DM Lucas, A Nemoto, H Sato, M Huang, M Abe; citation_volume=12; citation_issue=12; citation_publication_date=2017; citation_pages=e0188680; citation_doi=10.1371/journal.pone.0188680; citation_id=CR59">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation; citation_author=JN Kochenderfer, ME Dudley, RO Carpenter, SH Kassim, JJ Rose, WG Telford, FT Hakim, DC Halverson, DH Fowler, NM Hardy; citation_volume=122; citation_issue=25; citation_publication_date=2013; citation_pages=4129-4139; citation_doi=10.1182/blood-2013-08-519413; citation_id=CR60">

    <meta name="citation_reference" content="citation_journal_title=N Engl J Med; citation_title=Chimeric antigen receptor T cells for sustained remissions in leukemia; citation_author=SL Maude, N Frey, PA Shaw, R Aplenc, DM Barrett, NJ Bunin, A Chew, VE Gonzalez, Z Zheng, SF Lacey; citation_volume=371; citation_issue=16; citation_publication_date=2014; citation_pages=1507-1517; citation_doi=10.1056/NEJMoa1407222; citation_id=CR61">

    <meta name="citation_reference" content="citation_journal_title=Lancet; citation_title=T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial; citation_author=DW Lee, JN Kochenderfer, M Stetler-Stevenson, YK Cui, C Delbrook, SA Feldman, TJ Fry, R Orentas, M Sabatino, NN Shah; citation_volume=385; citation_issue=9967; citation_publication_date=2015; citation_pages=517-528; citation_doi=10.1016/S0140-6736(14)61403-3; citation_id=CR62">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection; citation_author=J Eyquem, J Mansilla-Soto, T Giavridis, SJ van der Stegen, M Hamieh, KM Cunanan, A Odak, M Gonen, M Sadelain; citation_volume=543; citation_issue=7643; citation_publication_date=2017; citation_pages=113-117; citation_doi=10.1038/nature21405; citation_id=CR63">

    <meta name="citation_reference" content="citation_journal_title=J Clin Oncol; citation_title=Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia; citation_author=MS Topp, N Gokbuget, G Zugmaier, P Klappers, M Stelljes, S Neumann, A Viardot, R Marks, H Diedrich, C Faul; citation_volume=32; citation_issue=36; citation_publication_date=2014; citation_pages=4134-4140; citation_doi=10.1200/JCO.2014.56.3247; citation_id=CR64">

    <meta name="citation_reference" content="citation_journal_title=Cancer Discov; citation_title=Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy; citation_author=E Sotillo, DM Barrett, KL Black, A Bagashev, D Oldridge, G Wu, R Sussman, C Lanauze, M Ruella, MR Gazzara; citation_volume=5; citation_issue=12; citation_publication_date=2015; citation_pages=1282-1295; citation_doi=10.1158/2159-8290.CD-15-1020; citation_id=CR65">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=How I treat relapsed childhood acute lymphoblastic leukemia; citation_author=F Locatelli, M Schrappe, ME Bernardo, S Rutella; citation_volume=120; citation_issue=14; citation_publication_date=2012; citation_pages=2807-2816; citation_doi=10.1182/blood-2012-02-265884; citation_id=CR66">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=How I treat acute lymphoblastic leukemia in older adolescents and young adults; citation_author=E Curran, W Stock; citation_volume=125; citation_issue=24; citation_publication_date=2015; citation_pages=3702-3710; citation_doi=10.1182/blood-2014-11-551481; citation_id=CR67">

    <meta name="citation_reference" content="citation_journal_title=J Cell Biochem; citation_title=O-acetylation of GD3 prevents its apoptotic effect and promotes survival of lymphoblasts in childhood acute lymphoblastic leukaemia; citation_author=K Mukherjee, AK Chava, C Mandal, SN Dey, B Kniep, S Chandra, C Mandal; citation_volume=105; citation_issue=3; citation_publication_date=2008; citation_pages=724-734; citation_doi=10.1002/jcb.21867; citation_id=CR68">

    <meta name="citation_reference" content="citation_journal_title=J Exp Med; citation_title=O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia; citation_author=R Parameswaran, M Lim, A Arutyunyan, H Abdel-Azim, C Hurtz, K Lau, M Muschen, RK Yu, M von Itzstein, N Heisterkamp; citation_volume=210; citation_issue=4; citation_publication_date=2013; citation_pages=805-819; citation_doi=10.1084/jem.20121482; citation_id=CR69">

    <meta name="citation_reference" content="citation_journal_title=Nat Commun; citation_title=9-O-acetylation of sialic acids is catalysed by CASD1 via a covalent acetyl-enzyme intermediate; citation_author=AM Baumann, MJ Bakkers, FF Buettner, M Hartmann, M Grove, MA Langereis, RJ de Groot, M Muhlenhoff; citation_volume=6; citation_publication_date=2015; citation_pages=7673; citation_doi=10.1038/ncomms8673; citation_id=CR70">

    <meta name="citation_reference" content="citation_journal_title=Oncogene; citation_title=IAP-targeted therapies for cancer; citation_author=EC LaCasse, DJ Mahoney, HH Cheung, S Plenchette, S Baird, RG Korneluk; citation_volume=27; citation_issue=48; citation_publication_date=2008; citation_pages=6252-6275; citation_doi=10.1038/onc.2008.302; citation_id=CR71">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Cancer; citation_title=Cancer drug resistance: an evolving paradigm; citation_author=C Holohan, S Van Schaeybroeck, DB Longley, PG Johnston; citation_volume=13; citation_issue=10; citation_publication_date=2013; citation_pages=714-726; citation_doi=10.1038/nrc3599; citation_id=CR72">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell; citation_title=A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death; citation_author=Y Suzuki, Y Imai, H Nakayama, K Takahashi, K Takio, R Takahashi; citation_volume=8; citation_issue=3; citation_publication_date=2001; citation_pages=613-621; citation_doi=10.1016/S1097-2765(01)00341-0; citation_id=CR73">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell; citation_title=cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination; citation_author=MJ Bertrand, S Milutinovic, KM Dickson, WC Ho, A Boudreault, J Durkin, JW Gillard, JB Jaquith, SJ Morris, PA Barker; citation_volume=30; citation_issue=6; citation_publication_date=2008; citation_pages=689-700; citation_doi=10.1016/j.molcel.2008.05.014; citation_id=CR74">

    <meta name="citation_reference" content="citation_journal_title=Sci Transl Med; citation_title=Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL; citation_author=S McComb, J Aguade-Gorgorio, L Harder, B Marovca, G Cario, C Eckert, M Schrappe, M Stanulla, A von Stackelberg, JP Bourquin; citation_volume=8; citation_issue=339; citation_publication_date=2016; citation_pages=339ra370; citation_doi=10.1126/scitranslmed.aad2986; citation_id=CR75">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia; citation_author=A Manabe, E Coustan-Smith, FG Behm, SC Raimondi, D Campana; citation_volume=79; citation_issue=9; citation_publication_date=1992; citation_pages=2370-2377; citation_id=CR76">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=Has MRD monitoring superseded other prognostic factors in adult ALL?; citation_author=M Bruggemann, T Raff, M Kneba; citation_volume=120; citation_issue=23; citation_publication_date=2012; citation_pages=4470-4481; citation_doi=10.1182/blood-2012-06-379040; citation_id=CR77">

    <meta name="citation_reference" content="citation_journal_title=Cancer; citation_title=Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemia; citation_author=S Konoplev, JL Jorgensen, DA Thomas, E Lin, J Burger, HM Kantarjian, M Andreeff, LJ Medeiros, M Konopleva; citation_volume=117; citation_issue=20; citation_publication_date=2011; citation_pages=4689-4695; citation_doi=10.1002/cncr.26113; citation_id=CR78">

    <meta name="citation_reference" content="citation_journal_title=Leukemia; citation_title=Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro; citation_author=J Juarez, KF Bradstock, DJ Gottlieb, LJ Bendall; citation_volume=17; citation_issue=7; citation_publication_date=2003; citation_pages=1294-1300; citation_doi=10.1038/sj.leu.2402998; citation_id=CR79">

    <meta name="citation_reference" content="citation_journal_title=Leukemia; citation_title=CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment; citation_author=J Juarez, A Dela Pena, R Baraz, J Hewson, M Khoo, A Cisterne, S Fricker, N Fujii, KF Bradstock, LJ Bendall; citation_volume=21; citation_issue=6; citation_publication_date=2007; citation_pages=1249-1257; citation_doi=10.1038/sj.leu.2404684; citation_id=CR80">

    <meta name="citation_reference" content="citation_journal_title=DNA repair; citation_title=The democratization of gene editing: insights from site-specific cleavage and double-strand break repair; citation_author=M Jasin, JE Haber; citation_volume=44; citation_publication_date=2016; citation_pages=6-16; citation_doi=10.1016/j.dnarep.2016.05.001; citation_id=CR81">

    <meta name="citation_reference" content="citation_journal_title=Cold Spring Harb Perspect Biol; citation_title=Repair of double-strand breaks by end joining; citation_author=KK Chiruvella, Z Liang, TE Wilson; citation_volume=5; citation_issue=5; citation_publication_date=2013; citation_pages=a012757; citation_doi=10.1101/cshperspect.a012757; citation_id=CR82">

    <meta name="citation_reference" content="citation_journal_title=Nat Commun; citation_title=CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity; citation_author=E Jacoby, SM Nguyen, TJ Fountaine, K Welp, B Gryder, H Qin, Y Yang, CD Chien, AE Seif, H Lei; citation_volume=7; citation_publication_date=2016; citation_pages=12320; citation_doi=10.1038/ncomms12320; citation_id=CR83">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells; citation_author=M Legut, G Dolton, AA Mian, OG Ottmann, AK Sewell; citation_volume=131; citation_issue=3; citation_publication_date=2018; citation_pages=311-322; citation_doi=10.1182/blood-2017-05-787598; citation_id=CR84">

    <meta name="citation_reference" content="Cooper ML, Choi J, Staser K, Ritchey JK, Devenport JM, Eckardt K, Rettig MP, Wang B, Eissenberg LG, Ghobadi A, et al. An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies. Leukemia. 2018; 
                    https://doi.org/10.1038/s41375-018-0065-5
                    
                  .">

    <meta name="citation_reference" content="citation_journal_title=Sci Rep; citation_title=TALENs-mediated gene disruption of FLT3 in leukemia cells: using genome-editing approach for exploring the molecular basis of gene abnormality; citation_author=J Wang, T Li, M Zhou, Z Hu, X Zhou, S Zhou, N Wang, L Huang, L Zhao, Y Cao; citation_volume=5; citation_publication_date=2015; citation_pages=18454; citation_doi=10.1038/srep18454; citation_id=CR86">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=Crispr/Cas9 based Kinome screen identifies novel targets that determine sensitivity for Asparaginase therapy in acute lymphoblastic leukemia; citation_author=LT Van Der Meer, J Yu, M Butler, JMR Van der Meer, RP Kuiper, F van Leeuwen; citation_volume=126; citation_issue=23; citation_publication_date=2015; citation_pages=2629; citation_id=CR87">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Transcription control by the ENL YEATS domain in acute leukaemia; citation_author=MA Erb, TG Scott, BE Li, H Xie, J Paulk, HS Seo, A Souza, JM Roberts, S Dastjerdi, DL Buckley; citation_volume=543; citation_issue=7644; citation_publication_date=2017; citation_pages=270-274; citation_doi=10.1038/nature21688; citation_id=CR88">

    <meta name="citation_reference" content="Nishii R, Moriyama T, Janke LJ, Yang W, Suiter C, Lin TN, Li L, Kihira K, Toyoda H, Hofmann U, et al. Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and anti-leukemic efficacy. Blood. 2018;131(22):2466–74.">

    <meta name="citation_reference" content="citation_journal_title=Cancer Med; citation_title=Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression; citation_author=M Huang, T Inukai, K Miyake, Y Tanaka, K Kagami, M Abe, H Goto, M Minegishi, S Iwamoto, E Sugihara; citation_volume=7; citation_issue=4; citation_publication_date=2018; citation_pages=1297-1316; citation_doi=10.1002/cam4.1323; citation_id=CR90">

    <meta name="citation_reference" content="Burns MA, Liao ZW, Yamagata N, Pouliot GP, Stevenson KE, Neuberg DS, Thorner AR, Ducar M, Silverman EA, Hunger SP, et al. Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia. Leukemia. 2018; 
                    https://doi.org/10.1038/s41375-018-0097-x
                    
                  .">

    <meta name="citation_author" content="Adrián Montaño">

    <meta name="citation_author_institution" content="IBSAL, IBMCC, University of Salamanca-CSIC, Cancer Research Center, Salamanca, Spain">

    <meta name="citation_author" content="Maribel Forero-Castro">

    <meta name="citation_author_institution" content="School of Biological Sciences (GICBUPTC Research group), Universidad Pedagógica y Tecnológica de Colombia, Boyacá, Colombia">

    <meta name="citation_author" content="Jesús-María Hernández-Rivas">

    <meta name="citation_author_institution" content="IBSAL, IBMCC, University of Salamanca-CSIC, Cancer Research Center, Salamanca, Spain">

    <meta name="citation_author_institution" content="Department of Medicine, University of Salamanca, Spain, Department of Hematology, University Hospital of Salamanca, Salamanca, Spain">

    <meta name="citation_author_institution" content="IBMCC, CIC University of Salamanca-CSIC, University Hospital of Salamanca, Salamanca, Spain">

    <meta name="citation_author" content="Ignacio García-Tuñón">

    <meta name="citation_author_institution" content="IBSAL, IBMCC, University of Salamanca-CSIC, Cancer Research Center, Salamanca, Spain">

    <meta name="citation_author" content="Rocío Benito">

    <meta name="citation_author_institution" content="IBSAL, IBMCC, University of Salamanca-CSIC, Cancer Research Center, Salamanca, Spain">



        <meta charset="UTF-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="viewport" content="width=device-width, initial-scale=1">
        <meta name="format-detection" content="telephone=no">

        <link rel="shortcut icon" href="https://bmcbiotechnol.biomedcentral.com/static/images/favicons/bmc/favicon-9ff1bf1161.ico">
<link rel="apple-touch-icon" sizes="114x114" href="https://bmcbiotechnol.biomedcentral.com/static/images/favicons/bmc/app-icon-114x114-aa3514ee38.png">
<link rel="apple-touch-icon" sizes="144x144" href="https://bmcbiotechnol.biomedcentral.com/static/images/favicons/bmc/app-icon-144x144-67f5b60136.png">
<link rel="apple-touch-icon" sizes="180x180" href="https://bmcbiotechnol.biomedcentral.com/static/images/favicons/bmc/app-icon-180x180-230f795aee.png">
<link rel="icon" type="image/png" sizes="16x16" href="https://bmcbiotechnol.biomedcentral.com/static/images/favicons/bmc/favicon-16x16-25a0239eec.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://bmcbiotechnol.biomedcentral.com/static/images/favicons/bmc/favicon-32x32-637712e609.png">
<link rel="icon" type="image/png" sizes="96x96" href="https://bmcbiotechnol.biomedcentral.com/static/images/favicons/bmc/favicon-96x96-9f5dc535c7.png">
<link rel="icon" type="image/png" sizes="194x194" href="https://bmcbiotechnol.biomedcentral.com/static/images/favicons/bmc/favicon-194x194-d2a2617de2.png">
<meta name="msapplication-TileColor" content="#e6e6e6">
<meta name="msapplication-TileImage" content="/static/images/favicons/bmc/app-icon-144x144-67f5b60136.png">
<meta name="theme-color" content="#1b3051">

        <script type="text/javascript" async="" src="https://www.google-analytics.com/analytics.js"></script><script type="text/javascript" async="" src="https://cdn.krxd.net/controltag/KDqylSLE.js"></script><script type="text/javascript" async="" src="MathJax.js"></script><script async="" src="gtm.js"></script><script>(function(H){H.className=H.className.replace(/\bno-js\b/,'js')})(document.documentElement)</script>
        <link rel="stylesheet" media="screen" href="basic-0600efa430.css">
<link rel="stylesheet" media="print" href="print-7680b1a80b.css">

<link rel="stylesheet" id="js-mustard" href="main-d8316f23af.css" media="only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)">


        

        <script>
            window.airbrakeErrors = [];
            window.onerror = function(error) {window.airbrakeErrors.push(error);}
        </script>

        
    <script type="text/javascript">
        config = {
            env: 'live',
            site: 'bmcbiotechnol.biomedcentral.com',
            siteWithPath: 'bmcbiotechnol.biomedcentral.com' + window.location.pathname,
            twitterHashtag: 'bmcbiotechnol',
            cmsPrefix: 'https://studio-cms.springernature.com/studio/',
            
            doi: '10.1186/s12896-018-0455-9',
            figshareScriptUrl: 'https://widgets.figshare.com/static/figshare.js',
            hasFigshareInvoked: false,
            publisherBrand: 'BioMed Central',
            mustardcut: false
        };
    </script>

        <!-- SpringerLink's event tracker, as per: https://github.com/springernature/springerlink-event-tracker -->

<script type="text/javascript">
document.addEventListener('dataLayerCreated', function() {
    var script = document.createElement('script');
    script.id = 'springerlink-event-tracker';
    script.src = 'https://event-tracker.springernature.com/dist/eventTracker.js';
    script.onload = function () {
        var dL;
        var doi;
        var imprint;
        var bpids;
        var publisher;
        var pageType;
        var eventObject;

        for (var i = 0; i < window.dataLayer.length; i++) {
            if (window.dataLayer[i].event === "dataLayerCreated") {
                dL = window.dataLayer[i];
            }
        }

        if (!dL || !dL.content.article || !dL.content.article.doi) { return false;}

        doi = dL.content.article.doi;
        imprint = dL.content.contentInfo.imprint;
        bpids = dL.session.authentication.authenticationID;
        pageType = dL.page.category.pageType;

        if (pageType) {
            pageType = pageType.charAt(0).toUpperCase() + pageType.substring(1);
        }

        eventObject = {'content_type': pageType, 'doi': doi};

        if (imprint === 'BioMed Central') {
            publisher = 'BMC';
        }
        else if (imprint === 'SpringerOpen') {
            publisher = 'SpringerOpen';
        }
        else {
            throw new Error('Event Tracker Error: The publisher has an unexpected value');
        }

        if (bpids.length > 0) {
            eventObject['business_partner_ids'] = bpids;
        }

        new EventTracker({'platform': publisher}).sendEvent('display', eventObject);
    };
    document.head.appendChild(script);
});
</script>

        <!--Polyfills CustomEvent constructor in IE. Allows us to use events to manage race conditions in client side js-->
<script>
    (function () {
        if (typeof window.CustomEvent === "function") { return false; } // If IE polyfill not needed just return

        function CustomEvent ( event, params ) {
            params = params || { bubbles: false, cancelable: false, detail: undefined };
            var evt = document.createEvent( 'CustomEvent' );
            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );
            return evt;
        }

        CustomEvent.prototype = window.Event.prototype;

        window.CustomEvent = CustomEvent;
    })();
</script> 
        
    <script type="text/javascript">
        window.dataLayer = [{"content":{"article":{"doi":"10.1186/s12896-018-0455-9","articleType":"Review","peerReviewType":"Closed","supplement":null,"keywords":"Acute lymphoblastic leukemia;CRISPR-Cas9;Genome editing"},"contentInfo":{"imprint":"BioMed Central","title":"Targeted genome editing in acute lymphoblastic leukemia: a review","publishedAt":1531785600000,"publishedAtDate":"2018-07-17","author":["Adrián Montaño","Maribel Forero-Castro","Jesús-María Hernández-Rivas","Ignacio García-Tuñón","Rocío Benito"],"collection":[]},"attributes":{"deliveryPlatform":"oscar","template":"rebrand","cms":null,"copyright":{"creativeCommonsType":"CC BY + CC0","openAccess":true},"environment":"live"},"journal":{"siteKey":"bmcbiotechnol.biomedcentral.com","volume":"18","issue":"1","title":"BMC Biotechnology","type":"SERIES","journalID":12896,"gaCode":"UA-62065396-6","section":[{"sectionId":"AC_518ef6abacb38ee6572883b6ef574126","sectionName":"Genetic engineering in animals and animal cell systems"}]},"category":{"pmc":{"primarySubject":"Chemistry"},"contentType":"Review","publishingSegment":"BMC-series Biology"}},"session":{"authentication":{"authenticationID":[]}},"version":"1.0.0","page":{"category":{"pageType":"article"}},"event":"dataLayerCreated"}];
        var event = new CustomEvent('dataLayerCreated');
        document.dispatchEvent(event);
    </script><script id="springerlink-event-tracker" src="eventTracker.txt"></script>


        <script>
            
            var mustardcutlink = document.getElementById('js-mustard');
            if (mustardcutlink && window.matchMedia && window.matchMedia(mustardcutlink.media).matches) {
                window.config.mustardcut = true;
            }
        </script>
        <script>
            (function(d){
                var config = window.config;
                if (config && config.mustardcut && config.publisherBrand && sessionStorage.fontsLoaded === 'true') {
                    if (window.config.publisherBrand === 'BioMed Central') {
                        d.style.setProperty('--font-family-sans', 'Europa');
                        d.style.setProperty('--font-family-serif', 'Noto Serif')
                    } else if (window.config.publisherBrand === 'SpringerOpen' || window.config.publisherBrand === 'Springer') {
                        d.style.setProperty('--font-family-sans', 'Source Sans Pro');
                    }
                }
            })(document.documentElement);
        </script>
        <script src="7d6f4b4f-77fb-43b9-b429-eb1e1eeac6aa.js" id="onetrust-bmc-control" charset="UTF-8"></script><script type="text/javascript" src="jquery.js"></script><link type="text/css" href="optanon.css" rel="stylesheet"><style>#optanon ul#optanon-menu li { background-color: #F8F8F8 !important }#optanon ul#optanon-menu li.menu-item-selected { background-color: #C5F6F9 !important }#optanon #optanon-popup-wrapper .optanon-white-button-middle { background-color: #1B3051 !important }.optanon-alert-box-wrapper .optanon-alert-box-button-middle { background-color: #1B3051 !important; border-color: #1B3051 !important; }#optanon #optanon-popup-wrapper .optanon-white-button-middle a { color: #ffffff !important }.optanon-alert-box-wrapper .optanon-alert-box-button-middle a { color: #ffffff !important }#optanon #optanon-popup-bottom { background-color: #FFFFFF !important }#optanon.modern #optanon-popup-top, #optanon.modern #optanon-popup-body-left-shading { background-color: #FFFFFF !important }.optanon-alert-box-wrapper { background-color:#EFF6FC !important }.optanon-alert-box-wrapper .optanon-alert-box-bg p { color:#333333 !important }</style>
        
    
        
    

        
    
        
            
                <!-- Google Tag Manager -->
                <script>
                    (function (w, d, s, l, i) {
                    w[l] = w[l] || [];
                    w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
                    var f = d.getElementsByTagName(s)[0],
                            j = d.createElement(s),
                            dl = l != 'dataLayer' ? '&l=' + l : '';
                    j.async = true;
                    j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl;
                    f.parentNode.insertBefore(j, f);
                })(window, document, 'script', 'dataLayer', 'GTM-TDGJHK');
                </script>
                <!-- End Google Tag Manager -->
            
        
    


        
    
    <link rel="canonical" href="https://bmcbiotechnol.biomedcentral.com/articles/10.1186/s12896-018-0455-9">
    

        
        
        <meta property="og:url" content="https://bmcbiotechnol.biomedcentral.com/articles/10.1186/s12896-018-0455-9">
        <meta property="og:type" content="article">
        <meta property="og:site_name" content="BMC Biotechnology">
        <meta property="og:title" content="Targeted genome editing in acute lymphoblastic leukemia: a review">
        <meta property="og:description" content="Genome editing technologies offers new opportunities for tackling diseases such as acute lymphoblastic leukemia (ALL) that have been beyond the reach of previous therapies. We show how the recent availability of genome-editing tools such as CRISPR-Cas9 are an important means of advancing functional studies of ALL through the incorporation, elimination and modification of somatic mutations and fusion genes in cell lines and mouse models. These tools not only broaden the understanding of the involvement of various genetic alterations in the pathogenesis of the disease but also identify new therapeutic targets for future clinical trials. New approaches including CRISPR-Cas9 are crucial for functional studies of genetic aberrations driving cancer progression, and that may be responsible for treatment resistance and relapses. By using this approach, diseases can be more faithfully reproduced and new therapeutic targets and approaches found.">
        <meta property="og:image" content="https://images.springer.com/sgw/journals/medium/12896.jpg">
    
    <script type="text/javascript" src="jquery_002.js"></script><script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js?V=2.7.5"></script></head>

    <body class="journal journal-fulltext">
        
    
        
            
                <!-- Google Tag Manager (noscript) -->
                <noscript>
                    <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-TDGJHK"
                            height="0" width="0" style="display:none;visibility:hidden"></iframe>
                </noscript>
                <!-- End Google Tag Manager (noscript) -->
            
        
    

        <div class="u-visually-hidden" aria-hidden="true">
    
    <!--?xml version="1.0" encoding="UTF-8"?--><svg xmlns="http://www.w3.org/2000/svg"><defs><filter id="a" filterUnits="userSpaceOnUse" x="0" y="0" width="60.643" height="31.01"><feColorMatrix values="1 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 1 0"></feColorMatrix></filter></defs><symbol id="icon-arrow-down" viewBox="0 0 16 8"><path d="M8 6l6-6h2L8 8 0 0h2l6 6"></path></symbol><symbol id="icon-arrow-left-bullet" viewBox="0 0 8 16"><path d="M3 8l5 5v3L0 8l8-8v3L3 8z"></path></symbol><symbol id="icon-arrow-right-bullet" viewBox="0 0 8 16"><path d="M5 8L0 3V0l8 8-8 8v-3l5-5z"></path></symbol><symbol id="icon-arrow-right" viewBox="0 0 32 64"><path d="M0 0v64l32-32z"></path></symbol><symbol id="icon-close" viewBox="0 0 23.998 23.999"><path d="M20.998 0l-8.999 9L3 0 0 3l8.999 9L0 20.999l3 3L11.999 15l8.999 8.999 3-3L14.999 12l8.999-9z"></path></symbol><symbol id="icon-community" viewBox="0 0 60.643 31.01"><mask maskUnits="userSpaceOnUse" x="0" y="0" width="60.643" height="31.01" id="b"><path fill="#FFF" d="M0 31.01h60.643V0H0z" filter="url(#a)"></path></mask><path mask="url(#b)" d="M60.643 25.497L50.005 14.86a7.925 7.925 0 1 0-7.669 0l-6.847 6.847-1.334-1.334a7.925 7.925 0 0 0-3.834-14.861 7.925 7.925 0 0 0-3.834 14.861l-1.334 1.334-6.847-6.847a7.925 7.925 0 1 0-7.669 0L0 25.497h21.362L15.85 31.01h28.943l-5.514-5.513h21.364z"></path></symbol><symbol id="icon-download" viewBox="-301 390 9 14"><path d="M-301 395.6l4.5 5.1 4.5-5.1h-3V390h-3v5.6h-3zm0 6.5h9v1.9h-9z"></path></symbol><symbol id="icon-ext-link" viewBox="0 0 16 16"><path fill="#676767" d="M12.9 16H3.1C1.4 16 0 14.6 0 12.9V3.2C0 1.4 1.4 0 3.1 0h3.7v1H3.1C2 1 1 2 1 3.2v9.7C1 14 2 15 3.1 15h9.7c1.2 0 2.1-1 2.1-2.1V8.7h1v4.2c.1 1.7-1.3 3.1-3 3.1z"></path><path fill="#676767" d="M12.8 2.5l.7.7-9 8.9-.7-.7 9-8.9z"></path><path fill="#676767" d="M9.7 0L16 6.2V0z"></path></symbol><symbol id="icon-info-bordered" viewBox="470.812 270.868 18 18"><path d="M479.812 270.868c-4.972 0-9 4.029-9 9s4.028 9 9 9c4.971 0 9-4.029 9-9s-4.029-9-9-9zm0 16.875a7.875 7.875 0 0 1-7.875-7.875 7.875 7.875 0 1 1 15.75 0 7.875 7.875 0 0 1-7.875 7.875z"></path><path d="M479.284 279.586c.089-.238-.024-.361-.13-.361-.489 0-1.123 1.16-1.359 1.16-.093 0-.173-.092-.173-.174 0-.238.581-.801.751-.971.526-.506 1.217-.895 1.979-.895.567 0 1.174.346.703 1.639l-.952 2.604c-.079.199-.224.531-.224.746 0 .092.054.186.159.186.395 0 1.121-1.135 1.304-1.135.067 0 .158.086.158.199 0 .385-1.542 2.043-2.874 2.043-.477 0-.804-.225-.804-.732 0-.641.447-1.734.538-1.963l.924-2.346zm.727-3.41c0-.586.498-1.066 1.082-1.066.527 0 .91.357.91.906 0 .615-.501 1.068-1.098 1.068-.541-.002-.894-.361-.894-.908z"></path></symbol><symbol id="icon-opr" viewBox="0 0 18 18"><path d="M.9 2.5c-.2-.2-.4-.3-.6-.2-.3.2-.3.4-.3.6 0 .8 0 1.7.1 2.5 0 .5.3.7.7.6.9 0 1.7-.2 2.5-.3h.2c.5-.2.6-.5.3-.8-.2-.2-.4-.4-.6-.5-.1-.1-.2-.2-.4-.3.5-.6 1-1.1 1.7-1.5 4.6-3 10.9-.5 12 4.9.9 4.4-2.2 8.6-6.7 9.2-3.7.5-7.2-1.6-8.4-5.1 0-.1-.1-.2-.1-.3-.1-.3-.5-.5-.8-.4-.3.1-.5.4-.4.8.4 1.3 1.1 2.4 2 3.4 1.4 1.5 3.1 2.4 5.1 2.8 3 .5 5.6-.2 7.8-2.2 2.1-1.9 3-4.2 3-6.9-.1-4-3.1-7.6-7.1-8.4-3.3-.9-6.2 0-8.6 2.3-.2.1-.3.3-.5.5-.3-.2-.6-.5-.9-.7z"></path><path d="M13 4.7c-2.6 1.6-4.5 3.6-5.3 4.6L5.6 7.7l-.9.7L8.3 12c.6-1.6 2.6-4.6 4.9-6.8l-.2-.5z"></path></symbol><symbol id="icon-quotation" viewBox="0 0.333 55.932 35.619"><path d="M43.738.333L31.545 12.207v23.745h24.387V12.207H43.738zm-31.545 0L0 12.207v23.745h24.386V12.207H12.193z"></path></symbol><symbol id="icon-remove" viewBox="-296 388 18 18"><path d="M-291.7 396.1h9v2h-9z"></path><path d="M-287 405.5c-4.7 0-8.5-3.8-8.5-8.5s3.8-8.5 8.5-8.5 8.5 3.8 8.5 8.5-3.8 8.5-8.5 8.5zm0-16c-4.1 0-7.5 3.4-7.5 7.5s3.4 7.5 7.5 7.5 7.5-3.4 7.5-7.5-3.4-7.5-7.5-7.5z"></path></symbol><symbol id="icon-ribbon" viewBox="0 0 36 72"><path d="M0 0v72h.053L18 54.054 35.945 72H36V0H0zm25.8 11.4l3.001 3L15 28.2l-7.801-7.8 3-3L15 22.201 25.8 11.4z"></path></symbol><symbol id="icon-rss" viewBox="0 0 24 24"><g fill="#F26822"><ellipse cx="3.305" cy="20.702" rx="3.306" ry="3.298"></ellipse><path d="M15.978 24h-4.684c0-6.224-5.057-11.27-11.294-11.27V8.058c8.824 0 15.978 7.137 15.978 15.942z"></path><path d="M19.2 23.95C19.2 13.366 10.604 4.79 0 4.79V0c13.255 0 24 10.723 24 23.95h-4.8z"></path></g></symbol><symbol id="icon-search" viewBox="0 0 16 16"><path d="M6.6 10.6c2.2 0 4-1.7 4-4s-1.7-4-4-4-4 1.7-4 4 1.8 4 4 4zm4 1.4l1.5-1.5 3.7 3.6c.4.5.4 1.2 0 1.6-.4.4-1.1.4-1.6 0L10.6 12zm-4 1.2C2.9 13.2 0 10.3 0 6.6S2.9 0 6.6 0s6.6 2.9 6.6 6.6-2.9 6.6-6.6 6.6z"></path></symbol><symbol id="icon-speech-bubble" viewBox="0 0 40 54"><path d="M0 0v40h6.667v13.334L20 40h20V0z"></path></symbol><symbol id="icon-error" viewBox="2.002 0 14 14"><path d="M16.002 11.949L13.951 14 9.002 9.051 4.053 14l-2.051-2.051L6.951 7 2.002 2.05 4.053 0l4.949 4.95L13.951 0l2.051 2.049L11.053 7l4.949 4.949z"></path></symbol><symbol id="icon-info" viewBox="5.502 0 7 14"><path d="M8.165 5.923c.146-.384-.04-.577-.209-.577-.783 0-1.798 1.856-2.177 1.856-.15 0-.277-.147-.277-.279 0-.383.933-1.282 1.203-1.557.846-.811 1.949-1.434 3.174-1.434.908 0 1.879.555 1.125 2.63l-1.526 4.167c-.126.32-.358.854-.358 1.198 0 .148.088.298.255.298.632 0 1.796-1.818 2.091-1.818.105 0 .252.134.252.321C11.717 11.345 9.245 14 7.11 14c-.763 0-1.289-.361-1.289-1.176 0-1.027.717-2.778.865-3.145l1.479-3.756zm1.144-4.211C9.309.771 10.111 0 11.045 0c.845 0 1.457.577 1.457 1.456 0 .983-.804 1.709-1.757 1.709-.866-.001-1.436-.578-1.436-1.453z"></path></symbol><symbol id="icon-success" viewBox="0 0 16 14"><path d="M15.592 0c-4.867 2.984-8.4 6.751-9.987 8.641L1.717 5.595 0 6.979l6.717 6.832c1.157-2.961 4.817-8.748 9.287-12.86L15.592 0z"></path></symbol><symbol id="icon-warning" viewBox="7.002 0 2.789 14"><path d="M7.002 11.211h2.789V14H7.002v-2.789zM7.002 0v3.436l.741 5.326h1.326l.723-5.326V0h-2.79z"></path></symbol><symbol id="icon-facebook-bordered" viewBox="463.812 263.868 32 32"><path d="M479.812 263.868c-8.837 0-16 7.163-16 16s7.163 16 16 16 16-7.163 16-16-7.163-16-16-16zm0 30c-7.732 0-14-6.269-14-14s6.268-14 14-14 14 6.269 14 14-6.267 14-14 14z"></path><path d="M483.025 280.48l.32-2.477h-2.453v-1.582c0-.715.199-1.207 1.227-1.207h1.311v-2.213a17.753 17.753 0 0 0-1.907-.098c-1.894 0-3.186 1.154-3.186 3.271V278h-2.142v2.477h2.142v6.354h2.557v-6.354l2.131.003z"></path></symbol><symbol id="icon-facebook" viewBox="0 0 24 24"><circle fill="#4D67A4" cx="12" cy="12" r="12"></circle><path fill="#FFF" d="M8.396 10.143h2.137V8.165s-.092-1.292.892-2.274c.979-.979 2.298-.887 4.177-.724v2.21h-1.387s-.586-.013-.861.303c-.271.315-.24.764-.24.875v1.588h2.41l-.311 2.458h-2.116v6.336h-2.56v-6.345H8.396v-2.449z"></path></symbol><symbol id="icon-linkedin" viewBox="0 0 24 24"><circle fill="#0178B5" cx="12" cy="12" r="12"></circle><g fill="#FFF"><circle cx="8.022" cy="8.043" r="1.256"></circle><path d="M6.929 10.246h2.17v6.967h-2.17zm3.533 6.967h2.157v-3.594s-.078-1.627 1.219-1.627c1.301 0 1.211 1.231 1.211 1.635v3.586h2.183v-3.775s.129-2.745-1.472-3.191c-1.605-.445-2.661.071-3.219.985v-.985h-2.079v6.966z"></path></g></symbol><symbol id="icon-reddit" viewBox="0 0 24 24"><circle fill="#BCBCBC" cx="12" cy="12" r="12"></circle><path fill="#FFF" d="M4.661 9.741c.941 0 1.703.761 1.703 1.704 0 .938-.762 1.705-1.703 1.705s-1.704-.767-1.704-1.705c0-.943.763-1.704 1.704-1.704zm13.844 0a1.704 1.704 0 1 1 .001 3.409 1.704 1.704 0 0 1-.001-3.409z"></path><path fill="#FFF" d="M11.736 8.732c4.285 0 7.762 2.283 7.762 5.104 0 2.812-3.477 5.1-7.762 5.1-4.288 0-7.762-2.285-7.762-5.1.001-2.82 3.474-5.104 7.762-5.104z"></path><path fill="#010101" d="M11.736 19.262c-4.461 0-8.088-2.437-8.088-5.426 0-2.994 3.626-5.431 8.088-5.431 4.457 0 8.087 2.437 8.087 5.431 0 2.989-3.63 5.426-8.087 5.426zm0-10.205c-4.104 0-7.438 2.145-7.438 4.779 0 2.633 3.334 4.773 7.438 4.773 4.098 0 7.437-2.142 7.437-4.773 0-2.636-3.339-4.779-7.437-4.779z"></path><circle fill="#FFF" cx="18.014" cy="5.765" r="1.385"></circle><path fill="#010101" d="M18.014 7.456a1.694 1.694 0 0 1-1.695-1.691c0-.934.764-1.694 1.695-1.694s1.693.762 1.693 1.694c0 .934-.762 1.691-1.693 1.691zm0-2.734c-.574 0-1.043.469-1.043 1.043s.469 1.041 1.043 1.041a1.042 1.042 0 0 0 0-2.084zM3.818 13.275a2.068 2.068 0 0 1-1.068-1.811 2.074 2.074 0 0 1 3.538-1.466l-.458.462a1.412 1.412 0 0 0-1.007-.42 1.424 1.424 0 0 0-.688 2.669l-.317.566zm15.866 0l-.316-.566a1.43 1.43 0 0 0 .73-1.245c0-.784-.635-1.424-1.42-1.424-.381 0-.736.149-1.008.42l-.459-.462a2.074 2.074 0 1 1 2.473 3.277z"></path><path fill="#F04B23" d="M9.165 11.604c.704 0 1.272.564 1.272 1.27a1.273 1.273 0 1 1-1.272-1.27zm5.321 0a1.274 1.274 0 1 1-1.275 1.27c0-.704.57-1.27 1.275-1.27z"></path><path fill="#010101" d="M11.79 8.915a.327.327 0 0 1-.307-.44l1.472-4.181 3.616.862c.177.044.283.22.238.395a.32.32 0 0 1-.391.239l-3.045-.729-1.275 3.632a.334.334 0 0 1-.308.222zm-.069 8.376c-2.076 0-2.908-.939-2.943-.982a.332.332 0 0 1 .035-.461.334.334 0 0 1 .459.033c.019.021.713.758 2.449.758 1.766 0 2.539-.763 2.549-.767a.324.324 0 1 1 .469.446c-.04.043-.954.973-3.018.973z"></path></symbol><symbol id="icon-twitter-bordered" viewBox="463.812 263.868 32 32"><path d="M486.416 276.191a5.622 5.622 0 0 1-1.554.429 2.718 2.718 0 0 0 1.19-1.502 5.456 5.456 0 0 1-1.72.657 2.71 2.71 0 0 0-1.979-.854 2.711 2.711 0 0 0-2.642 3.326 7.681 7.681 0 0 1-5.586-2.831 2.714 2.714 0 0 0 .839 3.618 2.748 2.748 0 0 1-1.227-.339v.031a2.71 2.71 0 0 0 2.174 2.656 2.735 2.735 0 0 1-1.229.049 2.726 2.726 0 0 0 2.531 1.883 5.442 5.442 0 0 1-4.01 1.123 7.672 7.672 0 0 0 4.155 1.215c4.983 0 7.71-4.129 7.71-7.711 0-.115-.004-.232-.006-.351a5.41 5.41 0 0 0 1.354-1.399z"></path><path d="M479.812 263.868c-8.837 0-16 7.163-16 16s7.163 16 16 16 16-7.163 16-16-7.163-16-16-16zm0 30c-7.732 0-14-6.269-14-14s6.268-14 14-14 14 6.269 14 14-6.267 14-14 14z"></path></symbol><symbol id="icon-twitter" viewBox="0 0 24 24"><circle fill="#26A7DF" cx="12" cy="12" r="12"></circle><path fill="#FFF" d="M5.903 6.768s2.176 2.883 5.953 3.082c0 0-.51-1.702 1.058-3.004 1.568-1.305 3.508-.2 3.879.292 0 0 1.104-.172 1.875-.691 0 0-.252.995-1.18 1.594 0 0 1.086-.146 1.596-.439 0 0-.533.853-1.447 1.503 0 0 .381 3.595-2.709 6.57-3.09 2.971-8.176 2.352-10.012.797 0 0 2.495.277 4.249-1.219 0 0-2.074-.037-2.671-1.973 0 0 1.036.08 1.215-.119 0 0-2.232-.539-2.254-2.873 0 0 .68.339 1.297.359 0-.001-2.153-1.557-.849-3.879z"></path></symbol><symbol id="icon-weibo-bordered" viewBox="463.812 263.868 32 32"><path d="M479.812 263.868c-8.838 0-16 7.163-16 16s7.162 16 16 16c8.837 0 16-7.163 16-16s-7.163-16-16-16zm0 30c-7.732 0-14-6.269-14-14s6.268-14 14-14c7.731 0 14 6.269 14 14s-6.267 14-14 14z"></path><path d="M478.552 285.348c-2.616.261-4.876-.926-5.044-2.649-.167-1.722 1.814-3.33 4.433-3.588 2.609-.263 4.871.926 5.041 2.647.165 1.721-1.818 3.331-4.43 3.59m5.23-5.718c-.226-.065-.374-.109-.259-.403.25-.639.276-1.188.005-1.581-.515-.734-1.915-.693-3.521-.021 0 0-.508.224-.378-.181.247-.798.209-1.468-.178-1.852-.87-.878-3.194.032-5.183 2.027-1.489 1.494-2.357 3.082-2.357 4.453 0 2.619 3.354 4.213 6.631 4.213 4.297 0 7.154-2.504 7.154-4.493.001-1.198-1.007-1.881-1.914-2.162"></path><path fill="#020202" d="M486.637 274.833a4.176 4.176 0 0 0-3.982-1.291.608.608 0 0 0-.465.72.604.604 0 0 0 .72.466 2.968 2.968 0 0 1 2.827.92 3 3 0 0 1 .625 2.918.602.602 0 0 0 .39.762.603.603 0 0 0 .763-.391v-.001a4.218 4.218 0 0 0-.878-4.103"></path><path fill="#020202" d="M485.041 276.276a2.037 2.037 0 0 0-1.938-.63.518.518 0 0 0-.396.621.517.517 0 0 0 .617.398c.336-.071.702.03.947.307s.312.649.207.979a.52.52 0 0 0 .336.654.523.523 0 0 0 .657-.336 2.038 2.038 0 0 0-.43-1.993m-6.347 5.951c-.09.156-.293.233-.451.166-.151-.062-.204-.235-.115-.389.093-.155.284-.229.44-.168.157.056.214.235.126.391m-.832 1.074c-.253.405-.795.58-1.202.396-.403-.186-.521-.655-.27-1.051.248-.39.771-.566 1.176-.393.413.17.543.636.296 1.048m.95-2.864c-1.244-.326-2.65.294-3.19 1.396-.553 1.119-.021 2.369 1.236 2.775 1.303.42 2.84-.225 3.374-1.436.526-1.183-.132-2.402-1.42-2.735"></path></symbol><symbol id="icon-weibo" viewBox="4 4 24 24"><circle fill="#C8E8F9" cx="16" cy="16" r="12"></circle><path fill="#FFF" d="M9.098 18.194c0 1.981 2.574 3.593 5.757 3.593 3.178 0 5.756-1.611 5.756-3.593 0-1.989-2.578-3.601-5.756-3.601-3.183.001-5.757 1.612-5.757 3.601"></path><path fill="#DF0A21" d="M14.991 21.496c-2.817.278-5.244-.996-5.428-2.85-.183-1.855 1.95-3.586 4.767-3.862 2.813-.278 5.243.996 5.428 2.849.18 1.855-1.957 3.584-4.767 3.863m5.628-6.155c-.24-.067-.404-.116-.279-.432.27-.688.299-1.278.004-1.699-.551-.791-2.062-.748-3.789-.022 0-.001-.548.241-.406-.191.266-.859.224-1.577-.191-1.993-.937-.942-3.437.037-5.577 2.18-1.602 1.61-2.533 3.317-2.533 4.789 0 2.817 3.606 4.533 7.13 4.533 4.626 0 7.701-2.696 7.701-4.834.001-1.292-1.085-2.027-2.06-2.331"></path><path fill="#F4992C" d="M23.689 10.182a4.492 4.492 0 0 0-4.283-1.39.651.651 0 1 0 .269 1.275 3.2 3.2 0 0 1 3.045.99 3.224 3.224 0 0 1 .672 3.138.647.647 0 0 0 .418.823.647.647 0 0 0 .816-.421v-.003a4.51 4.51 0 0 0-.937-4.412"></path><path fill="#F4992C" d="M21.973 11.736a2.183 2.183 0 0 0-2.086-.679.56.56 0 0 0-.428.667.554.554 0 0 0 .662.43v.001c.361-.075.754.034 1.018.33.266.299.34.698.227 1.054a.563.563 0 0 0 .359.706.563.563 0 0 0 .709-.362 2.2 2.2 0 0 0-.461-2.147"></path><path fill="#13110C" d="M15.143 18.139c-.1.17-.315.251-.483.179-.168-.07-.222-.255-.128-.42.097-.167.311-.248.479-.182.165.062.228.252.132.423m-.896 1.155c-.271.434-.854.625-1.295.425-.433-.195-.561-.707-.285-1.128.269-.426.832-.609 1.265-.427.443.183.58.688.315 1.13m1.024-3.084c-1.34-.351-2.852.32-3.434 1.506-.597 1.206-.021 2.546 1.33 2.984 1.402.453 3.055-.243 3.629-1.543.569-1.275-.142-2.587-1.525-2.947"></path></symbol></svg>
</div>


        

        

    <div class="u-vh-full">
        <div class="u-visually-hidden" aria-hidden="true">
    
    <!--?xml version="1.0" encoding="UTF-8"?--><svg xmlns="http://www.w3.org/2000/svg"><defs><filter id="a" filterUnits="userSpaceOnUse" x="0" y="0" width="60.643" height="31.01"><feColorMatrix values="1 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 1 0"></feColorMatrix></filter></defs><symbol id="icon-arrow-down" viewBox="0 0 16 8"><path d="M8 6l6-6h2L8 8 0 0h2l6 6"></path></symbol><symbol id="icon-arrow-left-bullet" viewBox="0 0 8 16"><path d="M3 8l5 5v3L0 8l8-8v3L3 8z"></path></symbol><symbol id="icon-arrow-right-bullet" viewBox="0 0 8 16"><path d="M5 8L0 3V0l8 8-8 8v-3l5-5z"></path></symbol><symbol id="icon-arrow-right" viewBox="0 0 32 64"><path d="M0 0v64l32-32z"></path></symbol><symbol id="icon-close" viewBox="0 0 23.998 23.999"><path d="M20.998 0l-8.999 9L3 0 0 3l8.999 9L0 20.999l3 3L11.999 15l8.999 8.999 3-3L14.999 12l8.999-9z"></path></symbol><symbol id="icon-community" viewBox="0 0 60.643 31.01"><mask maskUnits="userSpaceOnUse" x="0" y="0" width="60.643" height="31.01" id="b"><path fill="#FFF" d="M0 31.01h60.643V0H0z" filter="url(#a)"></path></mask><path mask="url(#b)" d="M60.643 25.497L50.005 14.86a7.925 7.925 0 1 0-7.669 0l-6.847 6.847-1.334-1.334a7.925 7.925 0 0 0-3.834-14.861 7.925 7.925 0 0 0-3.834 14.861l-1.334 1.334-6.847-6.847a7.925 7.925 0 1 0-7.669 0L0 25.497h21.362L15.85 31.01h28.943l-5.514-5.513h21.364z"></path></symbol><symbol id="icon-download" viewBox="-301 390 9 14"><path d="M-301 395.6l4.5 5.1 4.5-5.1h-3V390h-3v5.6h-3zm0 6.5h9v1.9h-9z"></path></symbol><symbol id="icon-ext-link" viewBox="0 0 16 16"><path fill="#676767" d="M12.9 16H3.1C1.4 16 0 14.6 0 12.9V3.2C0 1.4 1.4 0 3.1 0h3.7v1H3.1C2 1 1 2 1 3.2v9.7C1 14 2 15 3.1 15h9.7c1.2 0 2.1-1 2.1-2.1V8.7h1v4.2c.1 1.7-1.3 3.1-3 3.1z"></path><path fill="#676767" d="M12.8 2.5l.7.7-9 8.9-.7-.7 9-8.9z"></path><path fill="#676767" d="M9.7 0L16 6.2V0z"></path></symbol><symbol id="icon-info-bordered" viewBox="470.812 270.868 18 18"><path d="M479.812 270.868c-4.972 0-9 4.029-9 9s4.028 9 9 9c4.971 0 9-4.029 9-9s-4.029-9-9-9zm0 16.875a7.875 7.875 0 0 1-7.875-7.875 7.875 7.875 0 1 1 15.75 0 7.875 7.875 0 0 1-7.875 7.875z"></path><path d="M479.284 279.586c.089-.238-.024-.361-.13-.361-.489 0-1.123 1.16-1.359 1.16-.093 0-.173-.092-.173-.174 0-.238.581-.801.751-.971.526-.506 1.217-.895 1.979-.895.567 0 1.174.346.703 1.639l-.952 2.604c-.079.199-.224.531-.224.746 0 .092.054.186.159.186.395 0 1.121-1.135 1.304-1.135.067 0 .158.086.158.199 0 .385-1.542 2.043-2.874 2.043-.477 0-.804-.225-.804-.732 0-.641.447-1.734.538-1.963l.924-2.346zm.727-3.41c0-.586.498-1.066 1.082-1.066.527 0 .91.357.91.906 0 .615-.501 1.068-1.098 1.068-.541-.002-.894-.361-.894-.908z"></path></symbol><symbol id="icon-opr" viewBox="0 0 18 18"><path d="M.9 2.5c-.2-.2-.4-.3-.6-.2-.3.2-.3.4-.3.6 0 .8 0 1.7.1 2.5 0 .5.3.7.7.6.9 0 1.7-.2 2.5-.3h.2c.5-.2.6-.5.3-.8-.2-.2-.4-.4-.6-.5-.1-.1-.2-.2-.4-.3.5-.6 1-1.1 1.7-1.5 4.6-3 10.9-.5 12 4.9.9 4.4-2.2 8.6-6.7 9.2-3.7.5-7.2-1.6-8.4-5.1 0-.1-.1-.2-.1-.3-.1-.3-.5-.5-.8-.4-.3.1-.5.4-.4.8.4 1.3 1.1 2.4 2 3.4 1.4 1.5 3.1 2.4 5.1 2.8 3 .5 5.6-.2 7.8-2.2 2.1-1.9 3-4.2 3-6.9-.1-4-3.1-7.6-7.1-8.4-3.3-.9-6.2 0-8.6 2.3-.2.1-.3.3-.5.5-.3-.2-.6-.5-.9-.7z"></path><path d="M13 4.7c-2.6 1.6-4.5 3.6-5.3 4.6L5.6 7.7l-.9.7L8.3 12c.6-1.6 2.6-4.6 4.9-6.8l-.2-.5z"></path></symbol><symbol id="icon-quotation" viewBox="0 0.333 55.932 35.619"><path d="M43.738.333L31.545 12.207v23.745h24.387V12.207H43.738zm-31.545 0L0 12.207v23.745h24.386V12.207H12.193z"></path></symbol><symbol id="icon-remove" viewBox="-296 388 18 18"><path d="M-291.7 396.1h9v2h-9z"></path><path d="M-287 405.5c-4.7 0-8.5-3.8-8.5-8.5s3.8-8.5 8.5-8.5 8.5 3.8 8.5 8.5-3.8 8.5-8.5 8.5zm0-16c-4.1 0-7.5 3.4-7.5 7.5s3.4 7.5 7.5 7.5 7.5-3.4 7.5-7.5-3.4-7.5-7.5-7.5z"></path></symbol><symbol id="icon-ribbon" viewBox="0 0 36 72"><path d="M0 0v72h.053L18 54.054 35.945 72H36V0H0zm25.8 11.4l3.001 3L15 28.2l-7.801-7.8 3-3L15 22.201 25.8 11.4z"></path></symbol><symbol id="icon-rss" viewBox="0 0 24 24"><g fill="#F26822"><ellipse cx="3.305" cy="20.702" rx="3.306" ry="3.298"></ellipse><path d="M15.978 24h-4.684c0-6.224-5.057-11.27-11.294-11.27V8.058c8.824 0 15.978 7.137 15.978 15.942z"></path><path d="M19.2 23.95C19.2 13.366 10.604 4.79 0 4.79V0c13.255 0 24 10.723 24 23.95h-4.8z"></path></g></symbol><symbol id="icon-search" viewBox="0 0 16 16"><path d="M6.6 10.6c2.2 0 4-1.7 4-4s-1.7-4-4-4-4 1.7-4 4 1.8 4 4 4zm4 1.4l1.5-1.5 3.7 3.6c.4.5.4 1.2 0 1.6-.4.4-1.1.4-1.6 0L10.6 12zm-4 1.2C2.9 13.2 0 10.3 0 6.6S2.9 0 6.6 0s6.6 2.9 6.6 6.6-2.9 6.6-6.6 6.6z"></path></symbol><symbol id="icon-speech-bubble" viewBox="0 0 40 54"><path d="M0 0v40h6.667v13.334L20 40h20V0z"></path></symbol><symbol id="icon-error" viewBox="2.002 0 14 14"><path d="M16.002 11.949L13.951 14 9.002 9.051 4.053 14l-2.051-2.051L6.951 7 2.002 2.05 4.053 0l4.949 4.95L13.951 0l2.051 2.049L11.053 7l4.949 4.949z"></path></symbol><symbol id="icon-info" viewBox="5.502 0 7 14"><path d="M8.165 5.923c.146-.384-.04-.577-.209-.577-.783 0-1.798 1.856-2.177 1.856-.15 0-.277-.147-.277-.279 0-.383.933-1.282 1.203-1.557.846-.811 1.949-1.434 3.174-1.434.908 0 1.879.555 1.125 2.63l-1.526 4.167c-.126.32-.358.854-.358 1.198 0 .148.088.298.255.298.632 0 1.796-1.818 2.091-1.818.105 0 .252.134.252.321C11.717 11.345 9.245 14 7.11 14c-.763 0-1.289-.361-1.289-1.176 0-1.027.717-2.778.865-3.145l1.479-3.756zm1.144-4.211C9.309.771 10.111 0 11.045 0c.845 0 1.457.577 1.457 1.456 0 .983-.804 1.709-1.757 1.709-.866-.001-1.436-.578-1.436-1.453z"></path></symbol><symbol id="icon-success" viewBox="0 0 16 14"><path d="M15.592 0c-4.867 2.984-8.4 6.751-9.987 8.641L1.717 5.595 0 6.979l6.717 6.832c1.157-2.961 4.817-8.748 9.287-12.86L15.592 0z"></path></symbol><symbol id="icon-warning" viewBox="7.002 0 2.789 14"><path d="M7.002 11.211h2.789V14H7.002v-2.789zM7.002 0v3.436l.741 5.326h1.326l.723-5.326V0h-2.79z"></path></symbol><symbol id="icon-facebook-bordered" viewBox="463.812 263.868 32 32"><path d="M479.812 263.868c-8.837 0-16 7.163-16 16s7.163 16 16 16 16-7.163 16-16-7.163-16-16-16zm0 30c-7.732 0-14-6.269-14-14s6.268-14 14-14 14 6.269 14 14-6.267 14-14 14z"></path><path d="M483.025 280.48l.32-2.477h-2.453v-1.582c0-.715.199-1.207 1.227-1.207h1.311v-2.213a17.753 17.753 0 0 0-1.907-.098c-1.894 0-3.186 1.154-3.186 3.271V278h-2.142v2.477h2.142v6.354h2.557v-6.354l2.131.003z"></path></symbol><symbol id="icon-facebook" viewBox="0 0 24 24"><circle fill="#4D67A4" cx="12" cy="12" r="12"></circle><path fill="#FFF" d="M8.396 10.143h2.137V8.165s-.092-1.292.892-2.274c.979-.979 2.298-.887 4.177-.724v2.21h-1.387s-.586-.013-.861.303c-.271.315-.24.764-.24.875v1.588h2.41l-.311 2.458h-2.116v6.336h-2.56v-6.345H8.396v-2.449z"></path></symbol><symbol id="icon-linkedin" viewBox="0 0 24 24"><circle fill="#0178B5" cx="12" cy="12" r="12"></circle><g fill="#FFF"><circle cx="8.022" cy="8.043" r="1.256"></circle><path d="M6.929 10.246h2.17v6.967h-2.17zm3.533 6.967h2.157v-3.594s-.078-1.627 1.219-1.627c1.301 0 1.211 1.231 1.211 1.635v3.586h2.183v-3.775s.129-2.745-1.472-3.191c-1.605-.445-2.661.071-3.219.985v-.985h-2.079v6.966z"></path></g></symbol><symbol id="icon-reddit" viewBox="0 0 24 24"><circle fill="#BCBCBC" cx="12" cy="12" r="12"></circle><path fill="#FFF" d="M4.661 9.741c.941 0 1.703.761 1.703 1.704 0 .938-.762 1.705-1.703 1.705s-1.704-.767-1.704-1.705c0-.943.763-1.704 1.704-1.704zm13.844 0a1.704 1.704 0 1 1 .001 3.409 1.704 1.704 0 0 1-.001-3.409z"></path><path fill="#FFF" d="M11.736 8.732c4.285 0 7.762 2.283 7.762 5.104 0 2.812-3.477 5.1-7.762 5.1-4.288 0-7.762-2.285-7.762-5.1.001-2.82 3.474-5.104 7.762-5.104z"></path><path fill="#010101" d="M11.736 19.262c-4.461 0-8.088-2.437-8.088-5.426 0-2.994 3.626-5.431 8.088-5.431 4.457 0 8.087 2.437 8.087 5.431 0 2.989-3.63 5.426-8.087 5.426zm0-10.205c-4.104 0-7.438 2.145-7.438 4.779 0 2.633 3.334 4.773 7.438 4.773 4.098 0 7.437-2.142 7.437-4.773 0-2.636-3.339-4.779-7.437-4.779z"></path><circle fill="#FFF" cx="18.014" cy="5.765" r="1.385"></circle><path fill="#010101" d="M18.014 7.456a1.694 1.694 0 0 1-1.695-1.691c0-.934.764-1.694 1.695-1.694s1.693.762 1.693 1.694c0 .934-.762 1.691-1.693 1.691zm0-2.734c-.574 0-1.043.469-1.043 1.043s.469 1.041 1.043 1.041a1.042 1.042 0 0 0 0-2.084zM3.818 13.275a2.068 2.068 0 0 1-1.068-1.811 2.074 2.074 0 0 1 3.538-1.466l-.458.462a1.412 1.412 0 0 0-1.007-.42 1.424 1.424 0 0 0-.688 2.669l-.317.566zm15.866 0l-.316-.566a1.43 1.43 0 0 0 .73-1.245c0-.784-.635-1.424-1.42-1.424-.381 0-.736.149-1.008.42l-.459-.462a2.074 2.074 0 1 1 2.473 3.277z"></path><path fill="#F04B23" d="M9.165 11.604c.704 0 1.272.564 1.272 1.27a1.273 1.273 0 1 1-1.272-1.27zm5.321 0a1.274 1.274 0 1 1-1.275 1.27c0-.704.57-1.27 1.275-1.27z"></path><path fill="#010101" d="M11.79 8.915a.327.327 0 0 1-.307-.44l1.472-4.181 3.616.862c.177.044.283.22.238.395a.32.32 0 0 1-.391.239l-3.045-.729-1.275 3.632a.334.334 0 0 1-.308.222zm-.069 8.376c-2.076 0-2.908-.939-2.943-.982a.332.332 0 0 1 .035-.461.334.334 0 0 1 .459.033c.019.021.713.758 2.449.758 1.766 0 2.539-.763 2.549-.767a.324.324 0 1 1 .469.446c-.04.043-.954.973-3.018.973z"></path></symbol><symbol id="icon-twitter-bordered" viewBox="463.812 263.868 32 32"><path d="M486.416 276.191a5.622 5.622 0 0 1-1.554.429 2.718 2.718 0 0 0 1.19-1.502 5.456 5.456 0 0 1-1.72.657 2.71 2.71 0 0 0-1.979-.854 2.711 2.711 0 0 0-2.642 3.326 7.681 7.681 0 0 1-5.586-2.831 2.714 2.714 0 0 0 .839 3.618 2.748 2.748 0 0 1-1.227-.339v.031a2.71 2.71 0 0 0 2.174 2.656 2.735 2.735 0 0 1-1.229.049 2.726 2.726 0 0 0 2.531 1.883 5.442 5.442 0 0 1-4.01 1.123 7.672 7.672 0 0 0 4.155 1.215c4.983 0 7.71-4.129 7.71-7.711 0-.115-.004-.232-.006-.351a5.41 5.41 0 0 0 1.354-1.399z"></path><path d="M479.812 263.868c-8.837 0-16 7.163-16 16s7.163 16 16 16 16-7.163 16-16-7.163-16-16-16zm0 30c-7.732 0-14-6.269-14-14s6.268-14 14-14 14 6.269 14 14-6.267 14-14 14z"></path></symbol><symbol id="icon-twitter" viewBox="0 0 24 24"><circle fill="#26A7DF" cx="12" cy="12" r="12"></circle><path fill="#FFF" d="M5.903 6.768s2.176 2.883 5.953 3.082c0 0-.51-1.702 1.058-3.004 1.568-1.305 3.508-.2 3.879.292 0 0 1.104-.172 1.875-.691 0 0-.252.995-1.18 1.594 0 0 1.086-.146 1.596-.439 0 0-.533.853-1.447 1.503 0 0 .381 3.595-2.709 6.57-3.09 2.971-8.176 2.352-10.012.797 0 0 2.495.277 4.249-1.219 0 0-2.074-.037-2.671-1.973 0 0 1.036.08 1.215-.119 0 0-2.232-.539-2.254-2.873 0 0 .68.339 1.297.359 0-.001-2.153-1.557-.849-3.879z"></path></symbol><symbol id="icon-weibo-bordered" viewBox="463.812 263.868 32 32"><path d="M479.812 263.868c-8.838 0-16 7.163-16 16s7.162 16 16 16c8.837 0 16-7.163 16-16s-7.163-16-16-16zm0 30c-7.732 0-14-6.269-14-14s6.268-14 14-14c7.731 0 14 6.269 14 14s-6.267 14-14 14z"></path><path d="M478.552 285.348c-2.616.261-4.876-.926-5.044-2.649-.167-1.722 1.814-3.33 4.433-3.588 2.609-.263 4.871.926 5.041 2.647.165 1.721-1.818 3.331-4.43 3.59m5.23-5.718c-.226-.065-.374-.109-.259-.403.25-.639.276-1.188.005-1.581-.515-.734-1.915-.693-3.521-.021 0 0-.508.224-.378-.181.247-.798.209-1.468-.178-1.852-.87-.878-3.194.032-5.183 2.027-1.489 1.494-2.357 3.082-2.357 4.453 0 2.619 3.354 4.213 6.631 4.213 4.297 0 7.154-2.504 7.154-4.493.001-1.198-1.007-1.881-1.914-2.162"></path><path fill="#020202" d="M486.637 274.833a4.176 4.176 0 0 0-3.982-1.291.608.608 0 0 0-.465.72.604.604 0 0 0 .72.466 2.968 2.968 0 0 1 2.827.92 3 3 0 0 1 .625 2.918.602.602 0 0 0 .39.762.603.603 0 0 0 .763-.391v-.001a4.218 4.218 0 0 0-.878-4.103"></path><path fill="#020202" d="M485.041 276.276a2.037 2.037 0 0 0-1.938-.63.518.518 0 0 0-.396.621.517.517 0 0 0 .617.398c.336-.071.702.03.947.307s.312.649.207.979a.52.52 0 0 0 .336.654.523.523 0 0 0 .657-.336 2.038 2.038 0 0 0-.43-1.993m-6.347 5.951c-.09.156-.293.233-.451.166-.151-.062-.204-.235-.115-.389.093-.155.284-.229.44-.168.157.056.214.235.126.391m-.832 1.074c-.253.405-.795.58-1.202.396-.403-.186-.521-.655-.27-1.051.248-.39.771-.566 1.176-.393.413.17.543.636.296 1.048m.95-2.864c-1.244-.326-2.65.294-3.19 1.396-.553 1.119-.021 2.369 1.236 2.775 1.303.42 2.84-.225 3.374-1.436.526-1.183-.132-2.402-1.42-2.735"></path></symbol><symbol id="icon-weibo" viewBox="4 4 24 24"><circle fill="#C8E8F9" cx="16" cy="16" r="12"></circle><path fill="#FFF" d="M9.098 18.194c0 1.981 2.574 3.593 5.757 3.593 3.178 0 5.756-1.611 5.756-3.593 0-1.989-2.578-3.601-5.756-3.601-3.183.001-5.757 1.612-5.757 3.601"></path><path fill="#DF0A21" d="M14.991 21.496c-2.817.278-5.244-.996-5.428-2.85-.183-1.855 1.95-3.586 4.767-3.862 2.813-.278 5.243.996 5.428 2.849.18 1.855-1.957 3.584-4.767 3.863m5.628-6.155c-.24-.067-.404-.116-.279-.432.27-.688.299-1.278.004-1.699-.551-.791-2.062-.748-3.789-.022 0-.001-.548.241-.406-.191.266-.859.224-1.577-.191-1.993-.937-.942-3.437.037-5.577 2.18-1.602 1.61-2.533 3.317-2.533 4.789 0 2.817 3.606 4.533 7.13 4.533 4.626 0 7.701-2.696 7.701-4.834.001-1.292-1.085-2.027-2.06-2.331"></path><path fill="#F4992C" d="M23.689 10.182a4.492 4.492 0 0 0-4.283-1.39.651.651 0 1 0 .269 1.275 3.2 3.2 0 0 1 3.045.99 3.224 3.224 0 0 1 .672 3.138.647.647 0 0 0 .418.823.647.647 0 0 0 .816-.421v-.003a4.51 4.51 0 0 0-.937-4.412"></path><path fill="#F4992C" d="M21.973 11.736a2.183 2.183 0 0 0-2.086-.679.56.56 0 0 0-.428.667.554.554 0 0 0 .662.43v.001c.361-.075.754.034 1.018.33.266.299.34.698.227 1.054a.563.563 0 0 0 .359.706.563.563 0 0 0 .709-.362 2.2 2.2 0 0 0-.461-2.147"></path><path fill="#13110C" d="M15.143 18.139c-.1.17-.315.251-.483.179-.168-.07-.222-.255-.128-.42.097-.167.311-.248.479-.182.165.062.228.252.132.423m-.896 1.155c-.271.434-.854.625-1.295.425-.433-.195-.561-.707-.285-1.128.269-.426.832-.609 1.265-.427.443.183.58.688.315 1.13m1.024-3.084c-1.34-.351-2.852.32-3.434 1.506-.597 1.206-.021 2.546 1.33 2.984 1.402.453 3.055-.243 3.629-1.543.569-1.275-.142-2.587-1.525-2.947"></path></symbol></svg>
</div>

        <a class="u-visually-hidden u-visually-hidden-focus" href="#main-content">
    <span class="c-banner c-banner--info">Skip to content</span>
</a>

        
            
    <div class="adsbox c-ad c-ad--LB1">
        <div class="c-ad__inner">
            <p class="c-ad__label">Advertisement</p>
            <div id="div-gpt-ad-LB1" data-gpt-unitpath="/270604982/bmc/bmcbiotechnol/articles" data-gpt-sizes="728x90,970x90" data-gpt-targeting="pos=LB1;doi=10.1186/s12896-018-0455-9;kwrd=Acute lymphoblastic leukemia,CRISPR-Cas9,Genome editing;pmc=C12010,C12002,C12029,C12037,L24060,B24000;">
                <noscript>
                    <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/bmcbiotechnol/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/s12896-018-0455-9&amp;kwrd=Acute lymphoblastic leukemia,CRISPR-Cas9,Genome editing&amp;pmc=C12010,C12002,C12029,C12037,L24060,B24000&amp;">
                        <img data-test="gpt-advert-fallback-img"
                             src="//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/bmcbiotechnol/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/s12896-018-0455-9&amp;kwrd=Acute lymphoblastic leukemia,CRISPR-Cas9,Genome editing&amp;pmc=C12010,C12002,C12029,C12037,L24060,B24000&amp;"
                             alt="Advertisement"
                             width="728"
                             height="90">
                    </a>
                </noscript>
            </div>
        </div>
    </div>

        
         
    
        <div id="membership-message-loader-desktop" class="placeholder" data-placeholder="/placeholder/v1/membership/message"></div>
    
    
        <header class="c-popup-search" id="top" data-test="publisher-header">
    <nav class="c-navbar">
        <div class="c-navbar__container">
            
            <div class="basic-white-logo c-navbar__logo u-margin-right-xxl" itemscope="" itemtype="http://schema.org/Organization" data-test="navbar-logo-header">
                <link itemprop="parentOrganization" href="#parentOrganization">
                <div class="c-logo">
    <a href="https://www.biomedcentral.com/" itemprop="url">
        <img alt="BMC" itemprop="logo" src="logo-bmc-white-series-1da6525f4e.svg" width="76" height="18">
        <div class="c-logo__strapline">
            <img alt="Part of Springer Nature" src="logo-bmc-white-strapline-sn-e7b1d6e67f.svg" width="173" height="16">
        </div>
    </a>
</div>

            </div>
            <button type="button" class="c-navbar__link c-dropdown js-publisher-menu-button u-hidden-at-lg" id="publisher-header-menu-button" data-toggle="collapse" data-test="publisher-header-menu-toggle" data-toggle-linked="publisher-header" data-target="publisher-header-search publisher-header-menu" aria-controls="publisher-header-menu publisher-header-search" aria-expanded="false">
                <span class="c-dropdown__toggle">Menu</span>
            </button>
            <div class="c-navbar__content c-collapse" id="publisher-header-menu">
                
    <ul class="c-navbar__nav" data-test="publisher-navigation">
        
        <li class="c-navbar__item">
            <a class="c-navbar__link" href="https://www.biomedcentral.com/journals" data-track="click" data-track-action="click-nav-link" data-track-category="publisher-header" data-track-label="Explore journals">
                Explore journals
            </a>
        </li>
        
        <li class="c-navbar__item">
            <a class="c-navbar__link" href="https://www.biomedcentral.com/getpublished" data-track="click" data-track-action="click-nav-link" data-track-category="publisher-header" data-track-label="Get published">
                Get published
            </a>
        </li>
        
        <li class="c-navbar__item">
            <a class="c-navbar__link" href="https://www.biomedcentral.com/about" data-track="click" data-track-action="click-nav-link" data-track-category="publisher-header" data-track-label="About BMC">
                About BMC
            </a>
        </li>
        
    </ul>


                <ul class="c-navbar__nav c-navbar__nav--right">
                    <li class="c-navbar__item">
                        <button type="button" class="c-navbar__link js-publisher-search-button u-hidden-at-lt-lg" data-toggle="collapse" data-test="header-search-button" data-target="publisher-header-search publisher-header-menu publisher-header-menu-button" aria-controls="publisher-header-search publisher-header-menu" aria-expanded="false" data-track="click" data-track-action="click-nav-link" data-track-category="publisher-header" data-track-label="search">
                            <span class="c-flex c-flex--align-center">
                                Search
                                <svg class="c-icon u-margin-left-xs" width="14" height="14" aria-hidden="true">
                                    <use xlink:href="#icon-search"></use>
                                </svg>
                            </span>
                        </button>
                    </li>
                    <li class="c-navbar__item">
                        <a data-replace="true" data-placeholder="/placeholder/v1/username" class="c-navbar__link" href="https://www.biomedcentral.com/login" data-test="login-link">
                            <span class="u-js-shown" data-track="click" data-track-action="click-nav-link" data-track-category="publisher-header" data-track-label="Login">Login</span>
                            <span class="u-js-hidden" data-track="click" data-track-action="click-nav-link" data-track-category="publisher-header" data-track-label="My Account">My Account</span>
                        </a>
                    </li>
                </ul>
            </div>
        </div>
    </nav>
    <div class="c-popup-search__content c-collapse js-publisher-search-bar" id="publisher-header-search">
        <div class="u-container">
            <div class="c-popup-search__container">
                <div class="ctx-search">
    <form role="search" class="c-form-field" method="GET" action="//www.biomedcentral.com/search" data-track="submit" data-track-category="Search and Results" data-track-action="Submit search" data-dynamic-track-label="" data-track-label="" data-test="global-search" novalidate="">
        <label for="publisherSearch" class="c-form-field__label">Search all BMC articles</label>
        <div class="c-flex">
            <input id="publisherSearch" class="c-form-field__input js-publisher-search-input" autocomplete="off" role="textbox" data-test="search-input" name="query" type="text">
            <div>
                <button class="c-button" type="submit" data-test="search-submit-button">
    <span class="u-visually-hidden">Search</span>
    <svg class="c-icon" width="16" height="16" aria-hidden="true">
        <use xlink:href="#icon-search"></use>
    </svg>
</button>


            </div>
        </div>
        <input name="searchType" value="publisherSearch" type="hidden">
    </form>
</div>

            </div>
        </div>
    </div>
</header>

    

        
            <header class="c-journal-header c-journal-header--bmc-biotechnology ctx-journal-header">
                <div class="u-container">
                    <div class="c-journal-header__inner ">
                        
                        <div class="c-journal-title" id="journalTitle">
                            <a href="https://bmcbiotechnol.biomedcentral.com/">
    
        
    
    <span class="c-journal-title__text ">BMC Biotechnology</span>
    
</a>
                        </div>
                        
                    </div>
                </div>
                <div class="c-navbar">
                    <div class="c-navbar__container">
                        
                            <button type="button" class="c-navbar__link c-dropdown u-hidden-at-lg" data-toggle="collapse" data-test="journal-header-menu" data-toggle-linked="journal-header" data-target="journal-menu" aria-controls="journal-menu" aria-expanded="false">
                                    <span class="c-dropdown__toggle">Menu</span>
                            </button>
                            <div class="c-navbar__content c-collapse" id="journal-menu">
                                <nav class="c-navbar__nav">
                                    <ul class="c-navbar__nav c-navbar__nav--journal" role="menu" data-test="site-navigation">
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" href="https://bmcbiotechnol.biomedcentral.com/">Home</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" href="https://bmcbiotechnol.biomedcentral.com/about">About</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link c-navbar__link--is-shown" href="https://bmcbiotechnol.biomedcentral.com/articles">Articles</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" href="https://bmcbiotechnol.biomedcentral.com/submission-guidelines">Submission Guidelines</a>
                                            </li>
                                        
                                    </ul>
                                </nav>
                            </div>
                        
                    </div>
                </div>
                <div class="c-journal-header__identity c-journal-header__identity--default">
                    
                </div>
            </header>
            
        

        <div class="u-container u-margin-top-xl u-margin-bottom-xl" id="main-content">
            <div class="c-page-layout c-page-layout--fulltext" data-component="sticky-container">
                <div class="c-page-layout__nav u-hidden-at-lt-xl">
                    <nav xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="ArticleNavigation" aria-labelledby="toc-menu-title" data-component="sticky"><h3 id="toc-menu-title" class="u-visually-hidden" data-test="toc-title">Table of Contents</h3><ol class="c-nav c-nav--stacked" role="menu" id="tocMenu" aria-expanded="true" data-article-toc=""><li role="menuitem" class="c-nav__item"><a class="c-nav__link" href="#Abs1" data-track-category="Table of Contents" data-track="click" data-track-action="Link Clicked" data-track-label="Abstract" data-test="abstract-link">Abstract</a></li><li role="menuitem" class="c-nav__item"><a class="c-nav__link" href="#Sec1" data-track-category="Table of Contents" data-track="click" data-track-action="Link Clicked" data-track-label="Background">Background</a></li><li role="menuitem" class="c-nav__item"><a class="c-nav__link" href="#Sec8" data-track-category="Table of Contents" data-track="click" data-track-action="Link Clicked" data-track-label="Conclusions, challenges and future directions">Conclusions, challenges and future directions</a></li><li role="menuitem" class="c-nav__item"><a class="c-nav__link" href="#Decs" data-test="declarations-link" data-track-category="Table of Contents" data-track="click" data-track-action="Link Clicked" data-track-label="Declarations">
                  Declarations
                </a></li><li role="menuitem" class="c-nav__item"><a class="c-nav__link" href="#Bib1" data-track-category="Table of Contents" data-track="click" data-track-action="Link Clicked" data-track-label="References">References</a></li></ol></nav>
                </div>

                <main class="c-page-layout__main">
                    <article itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                        
                        
    <div class="FulltextWrapper">
        <ul class="c-article-identifiers u-reset-list">
            <li class="c-article-identifiers__item" data-test="article-category">Review</li>
            <li class="c-article-identifiers__item" data-test="open-access">
                <span class="u-text-open-access">Open Access</span>
            </li>
            
            
        </ul>
    </div>

                        <div class="FulltextWrapper"><div xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="MainTitleSection"><h1 xmlns="http://www.w3.org/1999/xhtml" class="ArticleTitle" itemprop="headline" lang="en">Targeted genome editing in acute lymphoblastic leukemia: a review</h1></div><div xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="AuthorNames" data-author-affiliations="true"><ul class="u-listReset"><li class="Author hasAffil" data-jumpto="Aff" data-test="author-name"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName" itemprop="author" itemscope="" itemtype="http://schema.org/Person">Adrián&nbsp;Montaño</span><span class="EqualContributionSymbol">†</span><sup><a href="#Aff1" class="AffiliationID">1</a></sup>, </li><li class="Author hasAffil" data-jumpto="Aff" data-test="author-name"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName" itemprop="author" itemscope="" itemtype="http://schema.org/Person">Maribel&nbsp;Forero-Castro</span><span class="EqualContributionSymbol">†</span><sup><a href="#Aff2" class="AffiliationID">2</a></sup>, </li><li class="Author hasAffil" data-jumpto="Aff" data-test="author-name"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName" itemprop="author" itemscope="" itemtype="http://schema.org/Person">Jesús-María&nbsp;Hernández-Rivas</span><sup><a href="#Aff1" class="AffiliationID">1</a>, <a href="#Aff3" class="AffiliationID">3</a>, <a href="#Aff4" class="AffiliationID">4</a></sup><a href="mailto:jmhr@usal.es" class="EmailAuthor" title="Email author"><span class="ContactIcon" aria-hidden="true"></span><span class="u-srOnly">Email author</span></a>, </li><li class="Author hasAffil" data-jumpto="Aff" data-test="author-name"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName" itemprop="author" itemscope="" itemtype="http://schema.org/Person">Ignacio&nbsp;García-Tuñón</span><sup><a href="#Aff1" class="AffiliationID">1</a></sup> and </li><li class="Author hasAffil" data-jumpto="Aff" data-test="author-name"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName" itemprop="author" itemscope="" itemtype="http://schema.org/Person">Rocío&nbsp;Benito</span><sup><a href="#Aff1" class="AffiliationID">1</a></sup></li></ul><div class="AffiliationLegend"><div class="AffiliationLegendLine"><span class="EqualContributionSymbol">†</span>Contributed equally</div></div></div><div xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="ArticleContextInformation"><div class="ContextInformation"><div class="ContextInformationJournalTitles"><span class="ArticleCitation"><span itemscope="" itemtype="http://schema.org/Periodical" itemid="#periodical"><span xmlns="http://www.w3.org/1999/xhtml" class="JournalTitle">BMC Biotechnology</span></span><span class="ArticleCitation_Year">2018</span><span class="ArticleCitation_Volume"><strong itemprop="isPartOf" itemtype="http://schema.org/PublicationVolume"><link itemprop="isPartOf" href="#periodical">18</strong>:45</span></span></div><p class="ArticleDOI"><a itemprop="sameAs" class="u-text-inherit" href="https://doi.org/10.1186/s12896-018-0455-9">https://doi.org/10.1186/s12896-018-0455-9</a></p><p class="Copyright">© &nbsp;The Author(s).&nbsp;2018</p></div></div><ul class="ArticleHistory u-reset-list"><li class="History HistoryReceived"><strong>Received: </strong><span>28&nbsp;February&nbsp;2018</span></li><li class="History HistoryAccepted"><strong>Accepted: </strong><span>5&nbsp;July&nbsp;2018</span></li><li class="History HistoryOnlineDate"><strong>Published: </strong><span itemprop="datePublished">17&nbsp;July&nbsp;2018</span></li></ul></div>
                        
                        
                        
    

                        <div class="FulltextWrapper"><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Abstract Section1 RenderAsSection1 c-section" id="Abs1" lang="en"><h2 class="c-section__heading"><a href="#Abstract" data-test="abstract-heading" data-disable-click-event-default="">Abstract</a></h2><div class="c-section__content" id="Abstract"><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AbstractSection" id="ASec1">
                <h3 xmlns="" class="Heading">Background</h3>
                <p id="Par1" class="Para">Genome editing technologies 
offers new opportunities for tackling diseases such as acute 
lymphoblastic leukemia (ALL) that have been beyond the reach of previous
 therapies.</p>
              </div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AbstractSection" id="ASec2">
                <h3 xmlns="" class="Heading">Results</h3>
                <p id="Par2" class="Para">We show how the recent 
availability of genome-editing tools such as CRISPR-Cas9 are an 
important means of advancing functional studies of ALL through the 
incorporation, elimination and modification of somatic mutations and 
fusion genes in cell lines and mouse models. These tools not only 
broaden the understanding of the involvement of various genetic 
alterations in the pathogenesis of the disease but also identify new 
therapeutic targets for future clinical trials.</p>
              </div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AbstractSection" id="ASec3">
                <h3 xmlns="" class="Heading">Conclusions</h3>
                <p id="Par3" class="Para">New approaches including 
CRISPR-Cas9 are crucial for functional studies of genetic aberrations 
driving cancer progression, and that may be responsible for treatment 
resistance and relapses. By using this approach, diseases can be more 
faithfully reproduced and new therapeutic targets and approaches found.</p>
              </div></div></section><section xmlns:func="http://oscar.fig.bmc.com" class="KeywordGroup Section1 RenderAsSection1 c-section" lang="en"><h2 xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Keywords" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Keywords">Keywords</a></h2><div class="js-CollapseSection CollapseSection c-section__content" data-test="collapse-section" id="Keywords"><ul class="c-keywords"><li class="c-keywords__item" itemprop="about">Acute lymphoblastic leukemia</li><li class="c-keywords__item" itemprop="about">CRISPR-Cas9</li><li class="c-keywords__item" itemprop="about">Genome editing</li></ul></div></section>
            <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="Sec1" class="Section1 RenderAsSection1 c-section"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Background" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Background">Background</a></h2><div class="js-CollapseSection CollapseSection c-section__content" id="Background" data-test="collapse-section"><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par26" class="Para">Acute
 lymphoblastic leukemia (ALL) is a malignant disorder originating from 
hematopoietic B- or T-cell precursors, characterized by marked 
heterogeneity at the molecular and clinical levels. Although a genetic 
event is known to occur in the majority of cases, and may be associated 
with outcome prediction, around 25–30% of pediatric and 50% of adult ALL
 patients have no defined genetic hallmarks of biological or clinical 
significance [<span class="CitationRef"><a href="#CR1" data-toggle="citation">1</a></span>].</p><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par27" class="Para">The
 development of new techniques of genetic editing such as TALENs or 
CRISPR-Cas9 has made it possible to produce powerful animal genetic 
models that recapitulate the cooperating oncogenic lesions affecting 
genes with an established role in the proliferation and establishment of
 the leukemic clone [<span class="CitationRef"><a href="#CR2" data-toggle="citation">2</a></span>]. In ALL, some approaches have been oriented towards analyzing the targeting of transcriptional factors such as <em xmlns="" class="EmphasisTypeItalic">PAX5</em>, which are involved in the pathogenesis of B-ALL, and <em xmlns="" class="EmphasisTypeItalic">TAL1</em> and <em xmlns="" class="EmphasisTypeItalic">LMO2</em>, which are highly deregulated in T-ALL [<span class="CitationRef"><a href="#CR3" data-toggle="citation">3</a></span><span>, <span class="CitationRef"><a href="#CR4" data-toggle="citation">4</a></span>, </span><span class="CitationRef"><a href="#CR5" data-toggle="citation">5</a></span>]. Targeting gene fusion expression has also been addressed through genome editing systems, as with <em xmlns="" class="EmphasisTypeItalic">MLL</em> and <em xmlns="" class="EmphasisTypeItalic">AF4,</em> whose fusion is associated with poor prognosis and which mainly affects B-ALL infants [<span class="CitationRef"><a href="#CR6" data-toggle="citation">6</a></span>]. Other genes have been modified to gain a better understanding of the mechanism of action of several drugs, for example, <em xmlns="" class="EmphasisTypeItalic">BTK</em>, target of ibrutinib, <em xmlns="" class="EmphasisTypeItalic">XPO1</em>, the target of KPT-8602, and <em xmlns="" class="EmphasisTypeItalic">CB1</em> and <em xmlns="" class="EmphasisTypeItalic">CB2</em>, the targets of dronabinol [<span class="CitationRef"><a href="#CR7" data-toggle="citation">7</a></span>, <span class="CitationRef"><a href="#CR8" data-toggle="citation">8</a></span>].
 However, genome editing techniques have gone a step further and they 
have been used with therapeutic and clinical approaches. Their use has 
facilitated the design of new therapies such as chimeric antigen 
receptors (CARs) and have allowed the study of genes involved in the 
evolution of pathogenesis [<span class="CitationRef"><a href="#CR9" data-toggle="citation">9</a></span>, <span class="CitationRef"><a href="#CR10" data-toggle="citation">10</a></span>].</p><section id="Sec2" class="Section2 RenderAsSection2">
                <h3 class="Heading">Targeted genome editing in ALL</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par28" class="Para">The
 development of next generation sequencing (NGS) techniques provided 
enormous amount of data to interpret, which generated the need to 
translate those data into functionally and clinically relevant knowledge
 that enable investigators to determinate how genotype influences 
phenotype. In the past decade, the integration of genome editing systems
 enables investigators to directly manipulate virtually any gene in a 
diverse range of cell types and organisms [<span class="CitationRef"><a href="#CR11" data-toggle="citation">11</a></span>].</p>
                <div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par29" class="Para">Genome
 editing system is based in the use of engineered nucleases composed of 
sequence-specific DNA-binding domains fused to a non-specific DNA 
cleavage module [<span class="CitationRef"><a href="#CR12" data-toggle="citation">12</a></span>, <span class="CitationRef"><a href="#CR13" data-toggle="citation">13</a></span>].
 These chimeric nucleases inducing DNA double-strand-breaks (DSBs) that 
stimulate the cellular DNA mechanisms, including error-prone 
non-homologous end joining (NHEJ) and homologous recombination (HR) [<span class="CitationRef"><a href="#CR14" data-toggle="citation">14</a></span>]. Several approaches have been used in the last years as genome editing technologies (Fig.&nbsp;<span class="InternalRef"><a href="#Fig1">1</a></span>).
 The combination of simplicity and flexibility has hurtled zinc-finger 
nucleases (ZFNs), transcription activator-like effector nucleases 
(TALENs) and short palindromic repeats interspersed with regular 
intervals (CRISPR) to the forefront of genetic engineering (Fig.&nbsp;<span class="InternalRef"><a href="#Fig2">2</a></span>) [<span class="CitationRef"><a href="#CR11" data-toggle="citation">11</a></span>].<figure xmlns="" class="Figure" id="Fig1"><div xmlns="http://www.w3.org/1999/xhtml" class="MediaObject" id="MO1">
                      <a target="_blank" rel="noopener" href="https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12896-018-0455-9/MediaObjects/12896_2018_455_Fig1_HTML.png"><img class="c-lazy-image u-js-shown" src="12896_2018_455_Fig1_HTML.png" alt="Fig. 1" data-lazy-load="true" data-src="https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs12896-018-0455-9/MediaObjects/12896_2018_455_Fig1_HTML.png"><noscript><img src="https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs12896-018-0455-9/MediaObjects/12896_2018_455_Fig1_HTML.png" alt="Fig. 1"></img></noscript></a>
                    </div><figcaption class="Caption" lang="en"><div xmlns="http://www.w3.org/1999/xhtml" class="CaptionContent"><span class="CaptionNumber">Fig. 1</span>
                        <p xmlns="" class="SimplePara">Timeline of genome editing engineering in ALL</p>
                      </div></figcaption></figure><figure xmlns="" class="Figure" id="Fig2"><div xmlns="http://www.w3.org/1999/xhtml" class="MediaObject" id="MO2">
                      <a target="_blank" rel="noopener" href="https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12896-018-0455-9/MediaObjects/12896_2018_455_Fig2_HTML.png"><img class="c-lazy-image u-js-shown" src="12896_2018_455_Fig2_HTML.png" alt="Fig. 2" data-lazy-load="true" data-src="https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs12896-018-0455-9/MediaObjects/12896_2018_455_Fig2_HTML.png"><noscript><img src="https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs12896-018-0455-9/MediaObjects/12896_2018_455_Fig2_HTML.png" alt="Fig. 2"></img></noscript></a>
                    </div><figcaption class="Caption" lang="en"><div xmlns="http://www.w3.org/1999/xhtml" class="CaptionContent"><span class="CaptionNumber">Fig. 2</span>
                        <p xmlns="" class="SimplePara">The nuclease 
genome editing technologies in ALL. The three most commonly used types 
of nucleases include programmable nucleases like Zinc Finger Nucleases 
(ZFNs), transcription activator-like effector nucleases (TALENs) and 
CRISPR systems (Clustered Regularly Interspaced Short Palindromic 
Repeats). These nucleases were able to induce double-strand breakgs 
(DSBs) in the target followed by the activation of DNA repair mechanisms
 [<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR30" data-toggle="citation">30</a></span>].
 On induction of double-stranded breaks or nicks at targeted regions, 
repairing is done by either Non-homologous end joining (NHEJ) or 
Homologous recombination (HR) pathway. NHEJ is an error prone repair 
mechanism where joining of broken ends takes place, which generally 
results in heterogeneous indels (insertions and deletions) whereas HR is
 a precise repair method in which homologous donor template DNA is being
 used in repair DNA damage target site. HR is the ideal strategy for 
generating knock in models [<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR81" data-toggle="citation">81</a></span>, <span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR82" data-toggle="citation">82</a></span>].</p>
                      </div></figcaption></figure></div>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par31" class="Para">ZFNs and TALENs were first used to generate knock-out rats in 2009 and 2011, respectively [<span class="CitationRef"><a href="#CR15" data-toggle="citation">15</a></span>, <span class="CitationRef"><a href="#CR16" data-toggle="citation">16</a></span>]. TALENs system was first used in human cells in the same year [<span class="CitationRef"><a href="#CR17" data-toggle="citation">17</a></span>]. CRISPR-Cas9 system, discovered as part of the prokaryotic adaptive immune system at the end of 1980s [<span class="CitationRef"><a href="#CR18" data-toggle="citation">18</a></span>], was introduced some years later. This was proposed as a genetic modification system in 2005 [<span class="CitationRef"><a href="#CR19" data-toggle="citation">19</a></span>] but was not tested until 2012 [<span class="CitationRef"><a href="#CR20" data-toggle="citation">20</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par32" class="Para">CRISPR-Cas9 is presented as a faster, cheaper, simpler system with the potential for multiplex genome editing [<span class="CitationRef"><a href="#CR21" data-toggle="citation">21</a></span>].
 The method is based on generating a directed cut in the double strand 
of DNA by the Cas9 nuclease. This is driven by a single 20-nucleotide 
RNA strand, which marks the exact breakage point. After DNA cutting, the
 DNA repair machinery of the host cell leads to repair errors and 
thereby promote a modification of the original sequence by a mutation 
such as an insertion, deletion or inversion, among others [<span class="CitationRef"><a href="#CR22" data-toggle="citation">22</a></span>].
 Based on CRISPR-Cas9 system, CRISPR interference (CRISPRi) and CRISPR 
activation (CRISPRa) emerged. CRISPRi uses a catalytically inactive 
version of Cas9 (dCas9) lacking endonucleolytic activity in combination 
with an sgRNA designed with a 20-bp complementary region to any gene of 
interest to silence a target gene [<span class="CitationRef"><a href="#CR23" data-toggle="citation">23</a></span>]. While CRISPRa uses fusions of dCas9 to activator domains to activate gene expression [<span class="CitationRef"><a href="#CR21" data-toggle="citation">21</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par33" class="Para">Genome editing strategies have been used in several organisms, including <em xmlns="" class="EmphasisTypeItalic">Drosophila</em> [<span class="CitationRef"><a href="#CR24" data-toggle="citation">24</a></span>], <em xmlns="" class="EmphasisTypeItalic">Caenorhabditis elegans</em> [<span class="CitationRef"><a href="#CR25" data-toggle="citation">25</a></span>], zebrafish [<span class="CitationRef"><a href="#CR26" data-toggle="citation">26</a></span>], mouse [<span class="CitationRef"><a href="#CR27" data-toggle="citation">27</a></span>], rat [<span class="CitationRef"><a href="#CR28" data-toggle="citation">28</a></span>], plants and humans [<span class="CitationRef"><a href="#CR21" data-toggle="citation">21</a></span>]
 and has allowed a large number of functional studies to be carried out,
 based on the generation of animal and plant models. The use of 
genetically modified cell lines and animal models to understand the 
functions of genes and their pathogenesis in diseases conditioned by 
molecular genetics could be of help and provide insights to better 
understand cancer. The method used until now to generate these animal 
models, especially mice, is tedious and time-consuming, but CRISPR-Cas9 
makes the procedure easier and more efficient [<span class="CitationRef"><a href="#CR29" data-toggle="citation">29</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par34" class="Para">Genome
 editing technologies, such as CRISPR-Cas9, have already been applied to
 the study of many diseases, including hematological diseases [<span class="CitationRef"><a href="#CR30" data-toggle="citation">30</a></span>].
 As exemplified by some very recent studies in Fanconi anemia (FA), a 
genetic DNA repair-deficient human disorder that results from mutations 
in FA genes [<span class="CitationRef"><a href="#CR31" data-toggle="citation">31</a></span>] or the study of BCR-ABL oncogene in chronic myeloid leukemia [<span class="CitationRef"><a href="#CR32" data-toggle="citation">32</a></span>].
 Specifically, most of the genetic modification studies in ALL have been
 with CRISPR-Cas9, more than 20 articles since 2015. The vast majority 
had the purpose of knocking out genes, either by introducing mutations, 
insertions or deletions.</p>
                <div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par35" class="Para">An overview of recent studies in genome editing in ALL is summarized in Table&nbsp;<span class="InternalRef"><a href="#Tab1">1</a></span>. Some of the most relevant studies included in the table are detailed below.<figure xmlns="" id="Tab1" class="FigureTable"><figcaption class="Caption" lang="en"><div xmlns="http://www.w3.org/1999/xhtml" class="CaptionContent"><span class="CaptionNumber">Table 1</span>
                        <p xmlns="" class="SimplePara">Applications of genome editing systems in ALL</p>
                      </div></figcaption><div class="Table"><table xmlns="http://www.w3.org/1999/xhtml" border="1"><colgroup><col><col><col><col><col><col><col></colgroup><thead><tr class="header"><th>&nbsp;</th><th><p xmlns="" class="SimplePara">Outcome</p></th><th><p xmlns="" class="SimplePara">Target Gene</p></th><th><p xmlns="" class="SimplePara">SSN Technique</p></th><th><p xmlns="" class="SimplePara">Modification Type</p></th><th><p xmlns="" class="SimplePara">Cell type</p></th><th><p xmlns="" class="SimplePara">Reference</p></th></tr></thead><tbody><tr class="noclass"><td rowspan="6"><p xmlns="" class="SimplePara">Targeting Transcriptional factors</p></td><td><p xmlns="" class="SimplePara">Point mutation (insertion/deletion)</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">TAL1</span>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">HR</p></td><td><p xmlns="" class="SimplePara">PEER (in vitro)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR4" data-toggle="citation">4</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Repress expression</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">PAX5</span>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-a</p></td><td><p xmlns="" class="SimplePara">NA</p></td><td rowspan="4"><p xmlns="" class="SimplePara">Patient-derived pre-B ALL cells (in vitro)</p></td><td rowspan="4"><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR3" data-toggle="citation">3</a></span>]</p></td></tr><tr class="noclass"><td rowspan="3"><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">NR3C1</span>
                            </p></td><td rowspan="3"><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td rowspan="3"><p xmlns="" class="SimplePara">NHEJ</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">TXNIP</span>
                            </p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">CB2</span>
                            </p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">LMO2</span>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">NHEJ</p></td><td><p xmlns="" class="SimplePara">PF-382 (in vitro)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR5" data-toggle="citation">5</a></span>]</p></td></tr><tr class="noclass"><td rowspan="7"><p xmlns="" class="SimplePara">Targeting gene fusion expression</p></td><td rowspan="2"><p xmlns="" class="SimplePara">Chromosomal rearrangement</p></td><td><p xmlns="" class="SimplePara">
                              <strong class="EmphasisTypeBold">MLL/AF4</strong>
                            </p></td><td rowspan="2"><p xmlns="" class="SimplePara">TALEN</p></td><td rowspan="2"><p xmlns="" class="SimplePara">NHEJ</p></td><td rowspan="2"><p xmlns="" class="SimplePara">K562, HSPCS (in vitro)</p></td><td rowspan="2"><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR42" data-toggle="citation">42</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">
                              <strong class="EmphasisTypeBold">MLL/AF9</strong>
                            </p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock in</p></td><td><p xmlns="" class="SimplePara">
                              <strong class="EmphasisTypeBold">MLL/AF4 AF4/MLL</strong>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">HR</p></td><td><p xmlns="" class="SimplePara">HEK293 (in vitro)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR46" data-toggle="citation">46</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Chromosomal rearrangement</p></td><td><p xmlns="" class="SimplePara">
                              <strong class="EmphasisTypeBold">MLL/ENL</strong>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">NHEJ</p></td><td><p xmlns="" class="SimplePara">HSPCS (in vitro / in vivo, xenograft)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR6" data-toggle="citation">6</a></span>]</p></td></tr><tr class="noclass"><td rowspan="2"><p xmlns="" class="SimplePara">Chromosomal rearrangement</p></td><td><p xmlns="" class="SimplePara">
                              <strong class="EmphasisTypeBold">MLL/AF9</strong>
                            </p></td><td rowspan="2"><p xmlns="" class="SimplePara">TALEN</p></td><td rowspan="2"><p xmlns="" class="SimplePara">NHEJ</p></td><td rowspan="2"><p xmlns="" class="SimplePara">CD34+ human cord blood (in vivo, xenograft)</p></td><td rowspan="2"><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR43" data-toggle="citation">43</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">
                              <strong class="EmphasisTypeBold">AF9/MLL</strong>
                            </p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock in</p></td><td><p xmlns="" class="SimplePara">
                              <strong class="EmphasisTypeBold">ETV6/RUNX1</strong>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">HR</p></td><td><p xmlns="" class="SimplePara">MIFF3 hIPSCs (in vitro)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR40" data-toggle="citation">40</a></span>]</p></td></tr><tr class="noclass"><td rowspan="6"><p xmlns="" class="SimplePara">Drug targts discovery and therapy</p></td><td rowspan="2"><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">CB1</span>
                            </p></td><td rowspan="2"><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td rowspan="2"><p xmlns="" class="SimplePara">NHEJ</p></td><td rowspan="2"><p xmlns="" class="SimplePara">Jurkat (in vitro)</p></td><td rowspan="2"><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR7" data-toggle="citation">7</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">CB2</span>
                            </p></td></tr><tr class="noclass"><td rowspan="2"><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">BTK</span>
                            </p></td><td rowspan="2"><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td rowspan="2"><p xmlns="" class="SimplePara">NHEJ</p></td><td rowspan="2"><p xmlns="" class="SimplePara">RCH-ACV (in vitro / in vivo, xenograft)</p></td><td rowspan="2"><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR8" data-toggle="citation">8</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">BLK</span>
                            </p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock in</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">XPO1</span>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">HR</p></td><td><p xmlns="" class="SimplePara">HL-60, Jurkat, K-562, and MOLT-4 (in vitro / in vivo, xenograft)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR57" data-toggle="citation">57</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">ABCB1</span>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">NHEJ</p></td><td><p xmlns="" class="SimplePara">HALO1 (in vitro)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR59" data-toggle="citation">59</a></span>]</p></td></tr><tr class="noclass"><td rowspan="11"><p xmlns="" class="SimplePara">Modification of CARs</p></td><td><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">CD19</span>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">NHEJ</p></td><td><p xmlns="" class="SimplePara">NALM6, 697 (in vitro / in vivo, xenograft)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR65" data-toggle="citation">65</a></span>]</p></td></tr><tr class="noclass"><td rowspan="3"><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">CD19</span>
                            </p></td><td rowspan="3"><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td rowspan="3"><p xmlns="" class="SimplePara">NHEJ</p></td><td rowspan="3"><p xmlns="" class="SimplePara">Murine leukemia cell lines E2a:PBX (in vitro / in vivo, xenograft)</p></td><td rowspan="3"><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR83" data-toggle="citation">83</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">PAX5</span>
                            </p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">EBF1</span>
                            </p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">TRAC</span>
                            </p></td><td rowspan="2"><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td rowspan="2"><p xmlns="" class="SimplePara">HR</p></td><td rowspan="2"><p xmlns="" class="SimplePara">NALM6 (in vitro / in vivo, xenograft)</p></td><td rowspan="2"><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR63" data-toggle="citation">63</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock in</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">CD19</span>
                            </p></td></tr><tr class="noclass"><td rowspan="2"><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">CD52</span>
                            </p></td><td rowspan="2"><p xmlns="" class="SimplePara">TALEN</p></td><td rowspan="2"><p xmlns="" class="SimplePara">NHEJ</p></td><td rowspan="2"><p xmlns="" class="SimplePara">Two infants (in vivo)</p></td><td rowspan="2"><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR9" data-toggle="citation">9</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">TCR ab</span>
                            </p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">TCR b</span>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">NHEJ</p></td><td><p xmlns="" class="SimplePara">PBMC (in vitro)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR84" data-toggle="citation">84</a></span>]</p></td></tr><tr class="noclass"><td rowspan="2"><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">CD7</span>
                            </p></td><td rowspan="2"><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td rowspan="2"><p xmlns="" class="SimplePara">NHEJ</p></td><td rowspan="2"><p xmlns="" class="SimplePara">T cell lines (in vitro / in vivo, xenograft)</p></td><td rowspan="2"><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR85" data-toggle="citation">85</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">TRAC</span>
                            </p></td></tr><tr class="noclass"><td rowspan="3"><p xmlns="" class="SimplePara">Evolution of pathogenesis</p></td><td><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">CASD1</span>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">NHEJ</p></td><td><p xmlns="" class="SimplePara">HAP1 (in vitro)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR70" data-toggle="citation">70</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">RIP1</span>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">NHEJ</p></td><td><p xmlns="" class="SimplePara">Patient-derived ALL cells (in vitro / in vivo, xenograft)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR75" data-toggle="citation">75</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">CXCR4</span>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">NHEJ</p></td><td><p xmlns="" class="SimplePara">NALM6 (in vitro / in vivo, xenograft)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR10" data-toggle="citation">10</a></span>]</p></td></tr><tr class="noclass"><td rowspan="6"><p xmlns="" class="SimplePara">Others</p></td><td><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">FLT3</span>
                            </p></td><td><p xmlns="" class="SimplePara">TALEN</p></td><td><p xmlns="" class="SimplePara">NHEJ</p></td><td><p xmlns="" class="SimplePara">K562 (in vitro)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR86" data-toggle="citation">86</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock out screen</p></td><td><p xmlns="" class="SimplePara">NA</p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">NHEJ</p></td><td><p xmlns="" class="SimplePara">NALM6 (in vitro)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR87" data-toggle="citation">87</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock out screen</p></td><td><p xmlns="" class="SimplePara">NA</p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">NHEJ</p></td><td><p xmlns="" class="SimplePara">MV4,11 (in vitro)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR88" data-toggle="citation">88</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">NUDT15</span>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">NHEJ</p></td><td><p xmlns="" class="SimplePara">Mouse (in vivo)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR89" data-toggle="citation">89</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">DCK</span>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">NHEJ</p></td><td><p xmlns="" class="SimplePara">KOPN41 (in vitro)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR90" data-toggle="citation">90</a></span>]</p></td></tr><tr class="noclass"><td><p xmlns="" class="SimplePara">Knock out</p></td><td><p xmlns="" class="SimplePara">
                              <span class="EmphasisTypeBoldItalic">PTCH1</span>
                            </p></td><td><p xmlns="" class="SimplePara">CRISPR-Cas9</p></td><td><p xmlns="" class="SimplePara">NHEJ</p></td><td><p xmlns="" class="SimplePara">Zebrafish embryos (in vivo, xenograft)</p></td><td><p xmlns="" class="SimplePara">[<span xmlns="http://www.w3.org/1999/xhtml" class="CitationRef"><a href="#CR91" data-toggle="citation">91</a></span>]</p></td></tr></tbody></table></div><div xmlns="http://www.w3.org/1999/xhtml" class="TableFooter">
                      <p xmlns="" class="SimplePara">This table shows 
the main genetic editing studies carried out in ALL, classified 
according to the target. The different columns indicate: the outcome of 
edition, the target of edition (highlighted in bold), the technique 
used, the type of modification, the cell type and the reference</p>
                    </div></figure></div>
              </section><section id="Sec3" class="Section2 RenderAsSection2">
                <h3 class="Heading">Targeting transcriptional factors</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par36" class="Para">Deregulation
 of Transcription factors (TFs) is a common mechanism in the 
pathogenesis of human cancer, in particular in leukemia cells, genes 
encoding TFs are often amplified, deleted, rearranged via chromosomal 
translocation, or subjected to point mutations that result in a gain- or
 loss-of-function. Consequently, targeting of TFs can be highly 
effective in treating ALL. TFs such as <em xmlns="" class="EmphasisTypeItalic">PAX5</em> and <em xmlns="" class="EmphasisTypeItalic">IKZF1</em> were altered in nearly 80% of patients with B-ALL [<span class="CitationRef"><a href="#CR33" data-toggle="citation">33</a></span>, <span class="CitationRef"><a href="#CR34" data-toggle="citation">34</a></span>].
 These alterations affected glucose metabolism and energy supply, 
whereby the transcription factors act as metabolic repressors by 
limiting the amount of ATP available. A CRISPR-Cas9-based screen of <em xmlns="" class="EmphasisTypeItalic">PAX5</em> and <em xmlns="" class="EmphasisTypeItalic">IKZF1</em> transcriptional targets identified some target genes such as <em xmlns="" class="EmphasisTypeItalic">NR3C1</em>, <em xmlns="" class="EmphasisTypeItalic">TXNIP</em> and <em xmlns="" class="EmphasisTypeItalic">CB2</em> as central effectors of B-lymphoid restriction of glucose and energy supply and therefore new targets for treating B-ALL [<span class="CitationRef"><a href="#CR3" data-toggle="citation">3</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par37" class="Para">In human T-cell acute lymphoblastic leukemia (T-ALL) cells, a CRISPR-Cas9 editing tool was used to disrupt <em xmlns="" class="EmphasisTypeItalic">TAL1</em> (<em xmlns="" class="EmphasisTypeItalic">SCL</em>) [<span class="CitationRef"><a href="#CR4" data-toggle="citation">4</a></span>] or <em xmlns="" class="EmphasisTypeItalic">TRIB1</em> (<em xmlns="" class="EmphasisTypeItalic">TRB1</em>) [<span class="CitationRef"><a href="#CR35" data-toggle="citation">35</a></span>] genes to delineate their biological functions. <em xmlns="" class="EmphasisTypeItalic">TAL1</em> is one of the oncogenes most frequently deregulated in T-ALL [<span class="CitationRef"><a href="#CR36" data-toggle="citation">36</a></span>]. This deregulation is produced by t (1;14) (p34;q11) (1–2%) or <em xmlns="" class="EmphasisTypeItalic">SIL(STIL)-TAL1</em>
 deletions (del(1)(p32)) (15–20%), although there is still a large group
 of patients in whom the gene is deregulated but not altered. 
Epigenetics must therefore play an important role in these patients [<span class="CitationRef"><a href="#CR37" data-toggle="citation">37</a></span>]. CRISPR-Cas9 was used in a cell line to reproduce two known alterations in <em xmlns="" class="EmphasisTypeItalic">TAL1</em>
 (insertion and deletion) and it was observed how these alterations 
triggered their expression. Furthermore, a change in methylation 
acetylation of H3K27 was observed, suggesting a causal relationship 
between mutagenesis, epigenetic modulation and expression of <em xmlns="" class="EmphasisTypeItalic">TAL1</em> [<span class="CitationRef"><a href="#CR4" data-toggle="citation">4</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par38" class="Para"><em xmlns="" class="EmphasisTypeItalic">LMO2</em>
 is another gene deregulated in T-ALL. It is a potent oncogene that is 
essential for the formation of a large transcriptional complex in which 
genes such as <em xmlns="" class="EmphasisTypeItalic">TAL1</em>, <em xmlns="" class="EmphasisTypeItalic">LDB1</em>, <em xmlns="" class="EmphasisTypeItalic">GATA1</em>, <em xmlns="" class="EmphasisTypeItalic">GATA2</em>, <em xmlns="" class="EmphasisTypeItalic">GATA3</em>, <em xmlns="" class="EmphasisTypeItalic">RUNX1</em>, <em xmlns="" class="EmphasisTypeItalic">ETS1</em>, and <em xmlns="" class="EmphasisTypeItalic">MYB</em>
 intervene. Furthermore, its overexpression has been associated with the
 development of T-ALL. However, the reasons why this gene is 
overexpressed remain unclear, because few mutations have been described.
 Mutations targeted to the non-coding region of <em xmlns="" class="EmphasisTypeItalic">LMO2</em> were introduced in a T-ALL cell line by CRISPR-Cas9 and proved to be a possible cause of the deregulation of <em xmlns="" class="EmphasisTypeItalic">LMO2</em> expression [<span class="CitationRef"><a href="#CR5" data-toggle="citation">5</a></span>].</p>
              </section><section id="Sec4" class="Section2 RenderAsSection2">
                <h3 class="Heading">Targeting gene fusion expression in ALL with chromosomal rearrangements</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par39" class="Para">As
 indicated above, chromosomal translocations are very frequent in ALL 
and can be used to stratify the risk of ALL patients. It is well known 
that <em xmlns="" class="EmphasisTypeItalic">MLL</em> rearrangements 
occur in a small percentage of B-ALL patients, where they are associated
 with very poor prognosis. Several studies have proposed that <em xmlns="" class="EmphasisTypeItalic">MLL</em>
 rearrangements are an initiating event in leukemic transformation, 
unlike ETV6-RUNX1 and BCR-ABL translocations, in which second events are
 necessary to initiate leukemia [<span class="CitationRef"><a href="#CR33" data-toggle="citation">33</a></span>, <span class="CitationRef"><a href="#CR38" data-toggle="citation">38</a></span>, <span class="CitationRef"><a href="#CR39" data-toggle="citation">39</a></span>].
 This was demonstrated by Enver T’s group, who used a homologous 
recombination knock-in approach by CRISPR-Cas9 to introduce the cDNA 
encoding of <em xmlns="" class="EmphasisTypeItalic">RUNX1</em> exons 2–8 into the native <em xmlns="" class="EmphasisTypeItalic">ETV6</em>
 locus of hIPSC. ETV6-RUNX1 expression induced a partial block of the 
maturation of B lymphocytes, at which time the second events required 
for leukemia development occurs [<span class="CitationRef"><a href="#CR40" data-toggle="citation">40</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par40" class="Para">Matthew Porteus’s group wanted to test the oncogenic potential as initiator event of the <em xmlns="" class="EmphasisTypeItalic">MLL</em>
 translocations, and for this purpose, they generated the MLL-AF4 and 
MLL-AF9 translocations by genetic modification in primary hematopoietic 
stem and progenitor cells (HSPCs). This strategy was based on previous 
studies that demonstrated that the double-stranded DNA breakage at 
specific positions of two chromosomes could lead to translocation [<span class="CitationRef"><a href="#CR41" data-toggle="citation">41</a></span>]. They used TALENs to generate cuts directed at specific positions of MLL-AF4 and AF9<em xmlns="" class="EmphasisTypeItalic">,</em>
 based on the breakage points described in patients. In vitro, the cells
 that acquired the translocation showed a proliferative advantage over 
the others but were not able to transform completely because they 
eventually disappeared from the culture [<span class="CitationRef"><a href="#CR42" data-toggle="citation">42</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par41" class="Para">Shortly after, Heckl D.’s group showed strong evidence for the formation of true t (11;19)<em xmlns="" class="EmphasisTypeItalic">/</em>MLL-AF9
 translocations in vitro and in vivo by CRISPR-Cas9. No full 
transformation was observed in liquid cultures or methylcellulose-based 
in vitro assays using CD34+ HSPC, while in vivo assays demonstrated that
 endogenous t (11;19) can initiate a monocytic leukemia-like phenotype. 
This study is in line with the Matthew Porteus’s study, which emphasizes
 the importance of environmental cues for the oncogenic transformation 
in <em xmlns="" class="EmphasisTypeItalic">MLL</em>r leukemias [<span class="CitationRef"><a href="#CR6" data-toggle="citation">6</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par42" class="Para">More
 recently, Stanford’s group managed to generate t (9;11) chromosomal 
translocations encoding MLL-AF9 and reciprocal AF9-MLL fusion products 
in CD34+ human cord blood cells by TALENs. Transplantation of these 
cells into immune-compromised mice induced myeloid leukemias with 
absence of secondary lesions studied by targeted exome sequencing and 
RNAseq [<span class="CitationRef"><a href="#CR43" data-toggle="citation">43</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par43" class="Para">The prevailing theory is that <em xmlns="" class="EmphasisTypeItalic">MLL</em>
 rearrangements occur in the uterus due to exposure to certain chemicals
 during pregnancy that cause errors in DNA repair, as has been 
demonstrated in vitro and in vivo [<span class="CitationRef"><a href="#CR44" data-toggle="citation">44</a></span>, <span class="CitationRef"><a href="#CR45" data-toggle="citation">45</a></span>].
 The group of Pablo Menéndez examined how it affected the expression of 
the fusion protein in repairing DNA damage. To this end, MLL-AF4 protein
 and its reciprocal, AF4-MLL were induced in the AAVS1 locus of the 
HEK293 cell line by CRISPR-Cas9. They subsequently induced DNA damage by
 exposing the cells to etoposide and ionizing radiation (IR), with no 
differences in repair between WT cells and those expressing proteins. 
Thus, they demonstrated that the expression of the fusion proteins 
caused by <em xmlns="" class="EmphasisTypeItalic">MLL</em> rearrangements, did not influence susceptibility to DNA damage or repair mechanisms [<span class="CitationRef"><a href="#CR46" data-toggle="citation">46</a></span>].</p>
              </section><section id="Sec5" class="Section2 RenderAsSection2">
                <h3 class="Heading">Drug targets discovery and therapy</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par44" class="Para">The
 targets against which a drug acts must be identified and combined with 
the data provided by the NGS. This may sometimes identify patients with 
mutations in genes associated with some type of resistance. It can also 
help to generate other new drugs, when there is prior knowledge of the 
altered pathway we wish to attack. For example, ibrutinib has recently 
been proposed for the treatment of pre-BCR and <em xmlns="" class="EmphasisTypeItalic">TCF3</em>-r-positive
 cases. Ibrutinib is an inhibitor kinase targeted to those ALL subtypes 
with affected BCR signaling. In order to understand the mechanism of 
action of ibrutinib in this ALL subtype, Bruton tyrosine kinase (<em xmlns="" class="EmphasisTypeItalic">BTK</em>) KO, B lymphocyte kinase (<em xmlns="" class="EmphasisTypeItalic">BLK</em>) KO and <em xmlns="" class="EmphasisTypeItalic">BTK / BLK</em> KO cells have been generated by CRISPR-Cas9 [<span class="CitationRef"><a href="#CR8" data-toggle="citation">8</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par45" class="Para">The importance of <em xmlns="" class="EmphasisTypeItalic">BTK</em>
 in the pathogenesis of chronic lymphocytic leukemia, diffuse large 
B-cell lymphoma, and other mature B-cell malignancies is well 
established [<span class="CitationRef"><a href="#CR47" data-toggle="citation">47</a></span><span>, <span class="CitationRef"><a href="#CR48" data-toggle="citation">48</a></span>, </span><span class="CitationRef"><a href="#CR49" data-toggle="citation">49</a></span>], while there is less information about the role of <em xmlns="" class="EmphasisTypeItalic">BTK</em> in ALL. Early studies reported unaltered levels of <em xmlns="" class="EmphasisTypeItalic">BTK</em> in childhood ALL cells, whereas frequent <em xmlns="" class="EmphasisTypeItalic">BTK</em> deficiency due to aberrant splicing was reported later [<span class="CitationRef"><a href="#CR50" data-toggle="citation">50</a></span>, <span class="CitationRef"><a href="#CR51" data-toggle="citation">51</a></span>]. <em xmlns="" class="EmphasisTypeItalic">BLK</em> and <em xmlns="" class="EmphasisTypeItalic">BTK</em> were the only kinase genes overexpressed in this subtype of ALL, as revealed by arrays [<span class="CitationRef"><a href="#CR52" data-toggle="citation">52</a></span>].
 Only the elimination of the expression of both kinases managed to 
reduce the proliferation in a similar way to ibrutinib. However, these 
should not be the only targets of ibrutinib since the decrease in 
proliferation was still greater when the drug was used. To confirm that <em xmlns="" class="EmphasisTypeItalic">BTK</em> and <em xmlns="" class="EmphasisTypeItalic">BLK</em>
 were actually drug targets, ibrutinib was tested in cell lines 
generated with KO genes. This indicated that ibrutinib requires the 
presence of both kinases for maximum effectiveness [<span class="CitationRef"><a href="#CR8" data-toggle="citation">8</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par46" class="Para">In a subsequent study, Thomas Vercruysse and coworkers focused on exportin 1 (<em xmlns="" class="EmphasisTypeItalic">XPO1</em>). <em xmlns="" class="EmphasisTypeItalic">XPO1</em>
 plays an important role in the transport through the nucleus of cycle 
regulatory proteins and tumor suppressor proteins, among others. The 
overexpression of this gene is associated with several types of cancer, 
and with poor patient outcome [<span class="CitationRef"><a href="#CR53" data-toggle="citation">53</a></span>, <span class="CitationRef"><a href="#CR54" data-toggle="citation">54</a></span>]. <em xmlns="" class="EmphasisTypeItalic">XPO1</em>
 inhibitors act by binding to the reactive cysteine residue located at 
position 528, preventing the export of charged proteins to the cytoplasm
 [<span class="CitationRef"><a href="#CR55" data-toggle="citation">55</a></span>, <span class="CitationRef"><a href="#CR56" data-toggle="citation">56</a></span>]. To verify that the drug binds specifically to act against <em xmlns="" class="EmphasisTypeItalic">XPO1,</em>
 a point mutation was inserted at residue 528 by CRISPR-Cas9. When this 
occurred, the drug was not able to act, and the cells became resistant. 
Therefore, this study demonstrated that the drug is highly specific to <em xmlns="" class="EmphasisTypeItalic">XPO1</em> and is potent against ALL [<span class="CitationRef"><a href="#CR57" data-toggle="citation">57</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par47" class="Para">More
 recently, Dronabinol (Tetrahydrocannabinol, THC), a US Food and Drug 
Administration-approved cannabinoid receptor (CNB) agonist for the 
treatment of chemotherapy-induced nausea and vomiting, was found to 
induce apoptosis in acute leukaemia cells, as evidenced by the 
abrogation of pro-apoptotic effects of CRISPR-mediated knockout of <em xmlns="" class="EmphasisTypeItalic">CB1</em> or <em xmlns="" class="EmphasisTypeItalic">CB2</em> following THC treatment [<span class="CitationRef"><a href="#CR7" data-toggle="citation">7</a></span>, <span class="CitationRef"><a href="#CR58" data-toggle="citation">58</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par48" class="Para">Furthermore,
 new drugs are being proposed as an alternative to current therapy. An 
example is Carfilzomib (CFZ), as a substitute of proteasome inhibitor 
Bortezomib (BTZ), who demonstrated favorable clinical outcomes for 
refractory childhood ALL. CFZ showed significantly higher activity than 
BTZ in vitro, except for the P-glycoprotein-positive t (17;19) ALL cell 
lines. Takahashi et al. generated a knock-out of <em xmlns="" class="EmphasisTypeItalic">ABCB1</em>,
 who codes for P-glycoprotein, by genome editing with a CRISPR-Cas9 
system and sensitized P-glycoprotein-positive t (17;19) ALL cell line to
 CFZ [<span class="CitationRef"><a href="#CR59" data-toggle="citation">59</a></span>].</p>
              </section><section id="Sec6" class="Section2 RenderAsSection2">
                <h3 class="Heading">Modification of CAR</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par49" class="Para">Chemotherapy
 and/or radiotherapy have been standard treatments for ALL to date. 
However, immunological therapies have gained importance. These work by 
harnessing the immune system of patients to fight the disease. One 
example is chimeric antigen receptors (CARs), which are proteins 
genetically engineered to allow T cells to recognize a specific antigen 
in tumor cells. It had already been proposed as a standard therapy for 
ALL patients in 2013 by Rosenberg. In this case, the CARs were directed 
against CD19, an antigen of B cells [<span class="CitationRef"><a href="#CR60" data-toggle="citation">60</a></span>]. Its efficacy had already been demonstrated in cases of refractory or relapsed ALL [<span class="CitationRef"><a href="#CR61" data-toggle="citation">61</a></span>, <span class="CitationRef"><a href="#CR62" data-toggle="citation">62</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par50" class="Para">CRISPR-Cas9
 may be key to carry out this genetic modification. This was 
demonstrated by Michel Sadelain’s group. The strategy followed was the 
combination of knock-out and knock-in. On the one hand, they interrupted
 the TRAC locus, and on the other, they added a CAR directed to CD19, 
inserting it in the AAVS1 locus. hey compared responses to CD19 antigens
 from these cells with those from others in which CAR had been randomly 
integrated. In this way, they were able to demonstrate that targeted CAR
 integration under the control of endogenous regulatory elements is much
 more effective, reduces tonic signaling, avoids the differentiation and
 accelerated depletion of T cells, and increases the therapeutic 
potential of these cells [<span class="CitationRef"><a href="#CR63" data-toggle="citation">63</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par51" class="Para">Paul
 Veys’s group demonstrated the use of TALEN-modified T lymphocytes in 
two infants with refractory B-ALL. They generated universal T-cells 
against CD19 (CAR19), targeting the TALENs against the T-cell receptor 
(TCR) and simultaneously transfecting with non-human leukocyte donor 
cell antigens. As treated cells, they disrupted the CD52 gene, the 
target of the drug alemtuzumab, by TALEN, and also disrupted the 
expression of the αβ T cell surface receptor (TCR αβ). This minimized 
the risk of graft-versus-host disease (GVHD). The newborns were treated 
with lymphoplasty, chemotherapy and anti-CD52 serotherapy before 
infusion of CAR19. The results were very positive, yielding remissions 
within 28&nbsp;days before allogeneic stem cell transplantation [<span class="CitationRef"><a href="#CR9" data-toggle="citation">9</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par52" class="Para">Despite
 the good results with CAR19 therapy, 10–20% of treated patients suffer 
relapses due to partial loss of the CD19 epitope [<span class="CitationRef"><a href="#CR61" data-toggle="citation">61</a></span>, <span class="CitationRef"><a href="#CR64" data-toggle="citation">64</a></span>].
 Andrei Thomas-Tikhonenko and his group have provided evidence that 
epitope loss is closely linked to alterations in exon 2 of CD19, 
detected in some samples from patients with relapses. These alterations 
include frameshift-type mutations and the total loss of the exon, 
resulting from an alternative splicing event that encodes a deficient 
isoform of exon 2. To assess the relevance of the detected isoforms, 
they eliminated CD19 expression by CRISPR-Cas9 from ALL cell lines, and 
then reconstituted them with different isoforms. They observed that the 
depleted isoform of exon 2 was located mostly in the cytosol, which 
could explain its mechanism of escape in front of CAR19. Thus, these 
deleterious mutations and the selection of isoforms resulting from 
alternative splicing could be the cause of this mechanism of resistance [<span class="CitationRef"><a href="#CR65" data-toggle="citation">65</a></span>].</p>
              </section><section id="Sec7" class="Section2 RenderAsSection2">
                <h3 class="Heading">Evolution of pathogenesis</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par53" class="Para">Although
 there have been great advances in the treatment and cure of ALL, there 
is still a large group of patients who experience relapses, persistent 
minimal residual disease, and drug resistance, and who ultimately have a
 poor prognosis [<span class="CitationRef"><a href="#CR66" data-toggle="citation">66</a></span>, <span class="CitationRef"><a href="#CR67" data-toggle="citation">67</a></span>].
 Efforts have therefore focused on trying to understand why these 
resistances occur, to counteract them, and to look for new, more 
personalized drugs that avoid resistance.</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par54" class="Para">In ALL, survival and drug resistance of lymphoblasts critically depend on 9-O-acetylation of sialic acids (Sias) [<span class="CitationRef"><a href="#CR68" data-toggle="citation">68</a></span>, <span class="CitationRef"><a href="#CR69" data-toggle="citation">69</a></span>]. Baumann AM et al., generated a <em xmlns="" class="EmphasisTypeItalic">CASD1</em> knock-out cells by CRISPR-Cas9-mediated genome editing and demonstrated that <em xmlns="" class="EmphasisTypeItalic">CASD1</em> is essential for 9-O-acetylation [<span class="CitationRef"><a href="#CR70" data-toggle="citation">70</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par55" class="Para">Second
 mitochondrial-derived caspase-activators (SMACs) act by inhibiting 
inhibitors of apoptosis proteins (IAPs). One of the possible causes of 
resistance is revealed by the action of these proteins, which act to 
counteract the effects of drugs. These are also overexpressed in many 
types of cancer [<span class="CitationRef"><a href="#CR71" data-toggle="citation">71</a></span>, <span class="CitationRef"><a href="#CR72" data-toggle="citation">72</a></span>]. The main mechanism of action of IAPs is the inhibition of apoptosis through proteins such as caspases [<span class="CitationRef"><a href="#CR73" data-toggle="citation">73</a></span>] or receptor interaction of protein kinase 1 (<em xmlns="" class="EmphasisTypeItalic">RIP1</em>)<em xmlns="" class="EmphasisTypeItalic">,</em> a potent activator of death [<span class="CitationRef"><a href="#CR74" data-toggle="citation">74</a></span>]. In this study, they set out to demonstrate that SMAC acted by reactivating apoptosis of these cells, mediated by <em xmlns="" class="EmphasisTypeItalic">RIP1.</em>
 They used CRISPR-Cas9 system to knock out this gene in vivo in 
xenograft models, and thereby eliminate its expression. The results 
showed that <em xmlns="" class="EmphasisTypeItalic">RIP1</em> was necessary for the induction of cell death by SMAC [<span class="CitationRef"><a href="#CR75" data-toggle="citation">75</a></span>].</p>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par56" class="Para">CXCR4
 encodes a membrane receptor whose function is to attract and confine 
the stromal cells of the bone marrow stromal cells (BMSCs). This 
interaction with BMSCs gives B cells a degree of protection, associated 
with increased survival, resistance to treatment, relapse and worse 
prognosis [<span class="CitationRef"><a href="#CR76" data-toggle="citation">76</a></span>, <span class="CitationRef"><a href="#CR77" data-toggle="citation">77</a></span>]. <em xmlns="" class="EmphasisTypeItalic">CXCR4</em> is highly expressed in B-ALL cells and has also been correlated with poor patient outcome [<span class="CitationRef"><a href="#CR78" data-toggle="citation">78</a></span>]. Inhibitors of <em xmlns="" class="EmphasisTypeItalic">CXCR4</em> have already been examined in the preclinical setting, in vitro and in vivo [<span class="CitationRef"><a href="#CR79" data-toggle="citation">79</a></span>, <span class="CitationRef"><a href="#CR80" data-toggle="citation">80</a></span>] and may be <em xmlns="" class="EmphasisTypeItalic">CXCR4</em> antagonists or agonists. To test whether the efficacy of these compounds was due to the inhibition of <em xmlns="" class="EmphasisTypeItalic">CXCR4</em> and not to their own activity as agonists, they generated a B-ALL cell line with <em xmlns="" class="EmphasisTypeItalic">CXCR4</em> knock-out by CRISPR-Cas9. They demonstrated that the agonistic activity of <em xmlns="" class="EmphasisTypeItalic">CXCR4</em> antagonists did not affect antitumor activity. In addition, in vivo <em xmlns="" class="EmphasisTypeItalic">CXCR4</em> knock-out models reduced the burden of leukemia and disease progression. In this way, the importance of <em xmlns="" class="EmphasisTypeItalic">CXCR4</em> in the pathogenesis of B-ALL and in its use as a therapeutic target to fight drug resistance is demonstrated [<span class="CitationRef"><a href="#CR10" data-toggle="citation">10</a></span>].</p>
              </section></div></section>
            <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="Sec8" class="Section1 RenderAsSection1 c-section"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Conclusionschallengesandfuturedirections" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Conclusionschallengesandfuturedirections">Conclusions, challenges and future directions</a></h2><div class="js-CollapseSection CollapseSection c-section__content" id="Conclusionschallengesandfuturedirections" data-test="collapse-section"><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par57" class="Para">Genome
 editing technologies have already demonstrated its potential to study 
molecular biology and pathogenesis of the genetic aberrations in ALL, in
 vitro and in vivo.</p><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par58" class="Para">From
 a future perspective, the development of the genomic editing tools 
could also help to the generation of murine models of leukemias that 
resemble the human disease. In this sense, multigenic nature of the 
disease entails great difficulties. In the case of ALL, murine models 
based on a single alteration have failed, at least in part, to fully 
develop the disease. Combining several of the gene alterations found in 
patients in a murine model, we could approach to the real pathological 
conditions, giving rise to a more efficient model for the investigation 
of this type of tumors. Until recently, to generate an animal model with
 several genetic alterations was a long and expensive process, however, 
tools such us, CRISPR-Cas9, will allow introducing multiple mutations in
 a single step. Thus, it will be possible to generate, in short periods 
of time, more complex animal models that allow us to simulate more 
faithfully the conditions that occur in patients, providing the 
appropriate platform to study and to develop new therapeutic strategies.</p><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par59" class="Para">Furthermore,
 in the clinic, genome editing systems could facilitate the rapid 
screening of new drugs and will promote the development of personalized 
medicine, connecting genomics, disease phenotypes and therapeutic goals.
 The use of these technologies will broaden our understanding of the 
mechanism of action of these novel drugs and enable the identification 
of novel mechanisms of acquired resistance to pathway target 
therapeutics. However, translating genome editing technologies to the 
clinical setting requires two main concerns to be addressed: the safety 
and efficacy of treatments. The off-target effect remains one of the 
major obstacles of this technology. Researches will need to improve our 
genetic tools in order to eliminate any off-target effects and to 
improve the gene edition efficiency in the future. Despite this, genome 
editing offers new opportunities for tackling diseases such as ALL that 
have been beyond the reach of previous therapies.</p></div></section>
          <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Section1 RenderAsSection1 c-section ArticleNotes" id="ArticleNotes"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Notes" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Notes">Notes</a></h2><div class="js-CollapseSection CollapseSection c-section__content c-section__content" data-test="collapse-section" id="Notes"><aside xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="ArticleNote ArticleNoteAuthorContribution"><p xmlns="" class="SimplePara">Adrián Montaño and Maribel Forero-Castro contributed equally to this work.</p></aside></div></section><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="AbbreviationGroup Section1 RenderAsSection1 c-section"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Abbreviations" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Abbreviations">Abbreviations</a></h2><div class="js-CollapseSection CollapseSection c-section__content" data-test="collapse-section" id="Abbreviations"><div class="DefinitionList">
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>ALL:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par4" class="Para">Acute lymphoblastic leukemia</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>AML:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par5" class="Para">Acute myeloid leukemia</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>BCR:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par6" class="Para">B-cell receptor signaling</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>BMSCs:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par7" class="Para">Bone marrow stromal cells</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>CARs:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par8" class="Para">Chimeric antigen receptors</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>CRISPR:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par9" class="Para">Short palindromic repeats interspersed with regular intervals</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>DSBs:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par10" class="Para">Double-strand breaks</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>HiPSC:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par11" class="Para">Human induced pluripotent stem cell</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>HR:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par12" class="Para">Homologous recombination</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>HSPCs:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par13" class="Para">Hematopoietic stem and progenitor cells</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>IAPs:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par14" class="Para">Inhibitors of apoptosis proteins</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>IR:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par15" class="Para">Ionizing radiation</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>MMEJ:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par16" class="Para">Micro-homology-mediated end-joining</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>NGS:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par17" class="Para">Next generation sequencing</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>NHEJ:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par18" class="Para">Non-homologous end-joining</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>PBMC:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par19" class="Para">Peripheral blood mononuclear cell</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>Sias:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par20" class="Para">Sialic acids</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>SMACs:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par21" class="Para">Second mitochondrial-derived caspase-activators</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>TALENs:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par22" class="Para">Transcription-activating type nucleases</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>TCR:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par23" class="Para">T-cell receptor</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>THC:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par24" class="Para">Tetrahydrocannabinol</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>ZFNs:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par25" class="Para">Zinc finger nucleases</p>
                  </dd></dl>
              </div></div></section><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Section1 RenderAsSection1 c-section" data-test="declarations-section" id="Decs"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Declarations" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Declarations">Declarations</a></h2><div class="js-CollapseSection CollapseSection c-section__content" data-test="collapse-section" id="Declarations"><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Acknowledgments"><h3 xmlns="" class="Heading">Acknowledgements</h3><p xmlns="" class="SimplePara">Part
 of this work was support by a grant to AM from the Junta Provincial de 
Salamanca of the Asociación Española Contra el Cáncer (AECC), and a 
grant to MFC from the Universidad Pedagógica y Tecnológica de Colombia –
 Vicerrectoría de Investigación y Extensión (Grupo de Investigación en 
Ciencias Biomédicas UPTC – GICBUPTC, Escuela de Ciencias Biológicas).</p><div id="FPar1" class="FormalPara FormalParaRenderingStyle1">
                <h3 xmlns="" class="Heading">Funding</h3>
                <p id="Par60" class="Para">This work was financially 
supported in part by a grant from the Consejería de Educación, Junta de 
Castilla y León, Fondos FEDER (SA085U16), Proyectos de Investigación del
 SACYL, Spain (BIO/SA10/14), a grant to AM from the Junta Provincial de 
Salamanca of the Asociación Española Contra el Cáncer (AECC), and a 
grant to MFC from the Universidad Pedagógica y Tecnológica de Colombia –
 Vicerrectoría de Investigación y Extensión (Grupo de Investigación en 
Ciencias Biomédicas UPTC – GICBUPTC, Escuela de Ciencias Biológicas).</p>
              </div></div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="FormalPara FormalParaRenderingStyle1"><h3 xmlns="" class="Heading">Authors’ contributions</h3><p xmlns="" class="SimplePara">AMB and MFC wrote the manuscript. All authors contributed to editing and approval of the final manuscript.</p></div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Ethics">
              <div id="FPar2" class="FormalPara FormalParaRenderingStyle1">
                <h3 xmlns="" class="Heading">Ethics approval and consent to participate</h3>
                <p id="Par61" class="Para">Not applicable.</p>
              </div>
              <div id="FPar3" class="FormalPara FormalParaRenderingStyle1">
                <h3 xmlns="" class="Heading">Consent for publication</h3>
                <p id="Par62" class="Para">Not applicable.</p>
              </div>
              <div id="FPar4" class="FormalPara FormalParaRenderingStyle1">
                <h3 xmlns="" class="Heading">Competing interests</h3>
                <p id="Par63" class="Para">The authors declare that they have no competing interests.</p>
              </div>
              <div id="FPar5" class="FormalPara FormalParaRenderingStyle1">
                <h3 xmlns="" class="Heading">Publisher’s Note</h3>
                <p id="Par64" class="Para">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </div>
            </div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="License">
                <p xmlns="" class="SimplePara"><strong class="EmphasisTypeBold">Open Access</strong>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<span xmlns="http://www.w3.org/1999/xhtml" class="ExternalRef"><a href="http://creativecommons.org/licenses/by/4.0/" target="_blank" class="ext-link"><span class="RefSource">http://creativecommons.org/licenses/by/4.0/</span></a></span>),
 which permits unrestricted use, distribution, and reproduction in any 
medium, provided you give appropriate credit to the original author(s) 
and the source, provide a link to the Creative Commons license, and 
indicate if changes were made. The Creative Commons Public Domain 
Dedication waiver (<span xmlns="http://www.w3.org/1999/xhtml" class="ExternalRef"><a href="http://creativecommons.org/publicdomain/zero/1.0/" target="_blank" class="ext-link"><span class="RefSource">http://creativecommons.org/publicdomain/zero/1.0/</span></a></span>) applies to the data made available in this article, unless otherwise stated.</p>
              </div></div></section></div>
                        <div class="FulltextWrapper"><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Section1 RenderAsSection1 c-section Affiliations" id="Aff"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Author-Affiliations" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Author-Affiliations">Authors’ Affiliations</a></h2><div class="js-CollapseSection CollapseSection c-section__content c-section__content" data-test="collapse-section" id="Author-Affiliations"><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Affiliation" id="Aff1"><span class="AffiliationNumber">(1)</span><div class="AffiliationText">IBSAL, IBMCC, University of Salamanca-CSIC, Cancer Research Center, Salamanca, Spain</div></div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Affiliation" id="Aff2"><span class="AffiliationNumber">(2)</span><div class="AffiliationText">School of Biological Sciences (GICBUPTC Research group), Universidad Pedagógica y Tecnológica de Colombia, Boyacá, Colombia</div></div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Affiliation" id="Aff3"><span class="AffiliationNumber">(3)</span><div class="AffiliationText">Department
 of Medicine, University of Salamanca, Spain, Department of Hematology, 
University Hospital of Salamanca, Salamanca, Spain</div></div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Affiliation" id="Aff4"><span class="AffiliationNumber">(4)</span><div class="AffiliationText">IBMCC, CIC University of Salamanca-CSIC, University Hospital of Salamanca, Salamanca, Spain</div></div></div></section></div>
                        <div class="FulltextWrapper"><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Section1 RenderAsSection1 c-section SectionTypeMaterialsAndMethods" id="Bib1"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#References" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="References">References</a></h2><div class="js-CollapseSection CollapseSection c-section__content" data-test="collapse-section" id="References"><ol class="BibliographyWrapper"><li class="Citation"><cite class="CitationContent" id="CR1" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Iacobucci I, Mullighan CG. Genetic basis of acute lymphoblastic leukemia. J Clin Oncol. 2017;35(9):975–83.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1200/JCO.2016.70.7836"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5455679"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455679"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Genetic%20basis%20of%20acute%20lymphoblastic%20leukemia&amp;author=I.%20Iacobucci&amp;author=CG.%20Mullighan&amp;journal=J%20Clin%20Oncol&amp;volume=35&amp;issue=9&amp;pages=975-983&amp;publication_year=2017"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR2" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Nemudryi
 AA, Valetdinova KR, Medvedev SP, Zakian SM. TALEN and CRISPR/Cas genome
 editing systems: tools of discovery. Acta Nat. 2014;6(3):19–40.</span><span class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=TALEN%20and%20CRISPR%2FCas%20genome%20editing%20systems%3A%20tools%20of%20discovery&amp;author=AA.%20Nemudryi&amp;author=KR.%20Valetdinova&amp;author=SP.%20Medvedev&amp;author=SM.%20Zakian&amp;journal=Acta%20Nat&amp;volume=6&amp;issue=3&amp;pages=19-40&amp;publication_year=2014"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR3" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Chan
 LN, Chen Z, Braas D, Lee JW, Xiao G, Geng H, Cosgun KN, Hurtz C, 
Shojaee S, Cazzaniga V, et al. Metabolic gatekeeper function of 
B-lymphoid transcription factors. Nature. 2017;542(7642):479–83.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nature21076"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5621518"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621518"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Metabolic%20gatekeeper%20function%20of%20B-lymphoid%20transcription%20factors&amp;author=LN.%20Chan&amp;author=Z.%20Chen&amp;author=D.%20Braas&amp;author=JW.%20Lee&amp;author=G.%20Xiao&amp;author=H.%20Geng&amp;author=KN.%20Cosgun&amp;author=C.%20Hurtz&amp;author=S.%20Shojaee&amp;author=V.%20Cazzaniga&amp;journal=Nature&amp;volume=542&amp;issue=7642&amp;pages=479-483&amp;publication_year=2017"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR4" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Navarro
 JM, Touzart A, Pradel LC, Loosveld M, Koubi M, Fenouil R, Le Noir S, 
Maqbool MA, Morgado E, Gregoire C, et al. Site- and allele-specific 
polycomb dysregulation in T-cell leukaemia. Nat Commun. 2015;6:6094.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/ncomms7094"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4317503"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317503"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Site-%20and%20allele-specific%20polycomb%20dysregulation%20in%20T-cell%20leukaemia&amp;author=JM.%20Navarro&amp;author=A.%20Touzart&amp;author=LC.%20Pradel&amp;author=M.%20Loosveld&amp;author=M.%20Koubi&amp;author=R.%20Fenouil&amp;author=S.%20Le%20Noir&amp;author=MA.%20Maqbool&amp;author=E.%20Morgado&amp;author=C.%20Gregoire&amp;journal=Nat%20Commun&amp;volume=6&amp;pages=6094&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR5" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Rahman
 S, Magnussen M, Leon TE, Farah N, Li Z, Abraham BJ, Alapi KZ, Mitchell 
RJ, Naughton T, Fielding AK, et al. Activation of the LMO2 oncogene 
through a somatically acquired neomorphic promoter in T-cell acute 
lymphoblastic leukemia. Blood. 2017;129(24):3221–6.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1182/blood-2016-09-742148"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5472898"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472898"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Activation%20of%20the%20LMO2%20oncogene%20through%20a%20somatically%20acquired%20neomorphic%20promoter%20in%20T-cell%20acute%20lymphoblastic%20leukemia&amp;author=S.%20Rahman&amp;author=M.%20Magnussen&amp;author=TE.%20Leon&amp;author=N.%20Farah&amp;author=Z.%20Li&amp;author=BJ.%20Abraham&amp;author=KZ.%20Alapi&amp;author=RJ.%20Mitchell&amp;author=T.%20Naughton&amp;author=AK.%20Fielding&amp;journal=Blood&amp;volume=129&amp;issue=24&amp;pages=3221-3226&amp;publication_year=2017"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR6" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Reimer
 J, Knoss S, Labuhn M, Charpentier EM, Gohring G, Schlegelberger B, 
Klusmann JH, Heckl D. CRISPR-Cas9-induced t(11;19)/MLL-ENL 
translocations initiate leukemia in human hematopoietic progenitor cells
 in vivo. Haematologica. 2017;102(9):1558–66.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.3324/haematol.2017.164046"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5685230"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685230"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=CRISPR-Cas9-induced%20t%2811%3B19%29%2FMLL-ENL%20translocations%20initiate%20leukemia%20in%20human%20hematopoietic%20progenitor%20cells%20in%20vivo&amp;author=J.%20Reimer&amp;author=S.%20Knoss&amp;author=M.%20Labuhn&amp;author=EM.%20Charpentier&amp;author=G.%20Gohring&amp;author=B.%20Schlegelberger&amp;author=JH.%20Klusmann&amp;author=D.%20Heckl&amp;journal=Haematologica&amp;volume=102&amp;issue=9&amp;pages=1558-1566&amp;publication_year=2017"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR7" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Kampa-Schittenhelm
 KM, Salitzky O, Akmut F, Illing B, Kanz L, Salih HR, Schittenhelm MM. 
Dronabinol has preferential antileukemic activity in acute lymphoblastic
 and myeloid leukemia with lymphoid differentiation patterns. BMC 
Cancer. 2016;16:25.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1186/s12885-015-2029-8"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4715874"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715874"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Dronabinol%20has%20preferential%20antileukemic%20activity%20in%20acute%20lymphoblastic%20and%20myeloid%20leukemia%20with%20lymphoid%20differentiation%20patterns&amp;author=KM.%20Kampa-Schittenhelm&amp;author=O.%20Salitzky&amp;author=F.%20Akmut&amp;author=B.%20Illing&amp;author=L.%20Kanz&amp;author=HR.%20Salih&amp;author=MM.%20Schittenhelm&amp;journal=BMC%20Cancer&amp;volume=16&amp;pages=25&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR8" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Kim
 E, Hurtz C, Koehrer S, Wang Z, Balasubramanian S, Chang BY, Muschen M, 
Davis RE, Burger JA. Ibrutinib inhibits pre-BCR+ B-cell acute 
lymphoblastic leukemia progression by targeting BTK and BLK. Blood. 
2017;129(9):1155–65.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1182/blood-2016-06-722900"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5374732"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374732"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Ibrutinib%20inhibits%20pre-BCR%2B%20B-cell%20acute%20lymphoblastic%20leukemia%20progression%20by%20targeting%20BTK%20and%20BLK&amp;author=E.%20Kim&amp;author=C.%20Hurtz&amp;author=S.%20Koehrer&amp;author=Z.%20Wang&amp;author=S.%20Balasubramanian&amp;author=BY.%20Chang&amp;author=M.%20Muschen&amp;author=RE.%20Davis&amp;author=JA.%20Burger&amp;journal=Blood&amp;volume=129&amp;issue=9&amp;pages=1155-1165&amp;publication_year=2017"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR9" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Qasim
 W, Zhan H, Samarasinghe S, Adams S, Amrolia P, Stafford S, Butler K, 
Rivat C, Wright G, Somana K, et al. Molecular remission of infant B-ALL 
after infusion of universal TALEN gene-edited CAR T cells. Sci Transl 
Med. 2017;9(374)<span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="https://scholar.google.com/scholar?hl=en&amp;q=Qasim%20W%2C%20Zhan%20H%2C%20Samarasinghe%20S%2C%20Adams%20S%2C%20Amrolia%20P%2C%20Stafford%20S%2C%20Butler%20K%2C%20Rivat%20C%2C%20Wright%20G%2C%20Somana%20K%2C%20et%20al.%20Molecular%20remission%20of%20infant%20B-ALL%20after%20infusion%20of%20universal%20TALEN%20gene-edited%20CAR%20T%20cells.%20Sci%20Transl%20Med.%202017%3B9%28374%29"><span><span>Google Scholar</span></span></a></span></span></span><span class="Occurrences"></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR10" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Randhawa
 S, Cho BS, Ghosh D, Sivina M, Koehrer S, Muschen M, Peled A, Davis RE, 
Konopleva M, Burger JA. Effects of pharmacological and genetic 
disruption of CXCR4 chemokine receptor function in B-cell acute 
lymphoblastic leukaemia. Br J Haematol. 2016;174(3):425–36.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1111/bjh.14075"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4959949"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959949"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Effects%20of%20pharmacological%20and%20genetic%20disruption%20of%20CXCR4%20chemokine%20receptor%20function%20in%20B-cell%20acute%20lymphoblastic%20leukaemia&amp;author=S.%20Randhawa&amp;author=BS.%20Cho&amp;author=D.%20Ghosh&amp;author=M.%20Sivina&amp;author=S.%20Koehrer&amp;author=M.%20Muschen&amp;author=A.%20Peled&amp;author=RE.%20Davis&amp;author=M.%20Konopleva&amp;author=JA.%20Burger&amp;journal=Br%20J%20Haematol&amp;volume=174&amp;issue=3&amp;pages=425-436&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR11" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Gaj
 T, Gersbach CA, Barbas CF 3rd. ZFN, TALEN, and CRISPR/Cas-based methods
 for genome engineering. Trends Biotechnol. 2013;31(7):397–405.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.tibtech.2013.04.004"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3694601"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694601"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=ZFN%2C%20TALEN%2C%20and%20CRISPR%2FCas-based%20methods%20for%20genome%20engineering&amp;author=T.%20Gaj&amp;author=CA.%20Gersbach&amp;author=CF.%20Barbas&amp;journal=Trends%20Biotechnol&amp;volume=31&amp;issue=7&amp;pages=397-405&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR12" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Urnov
 FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. Genome editing with 
engineered zinc finger nucleases. Nat Rev Genet. 2010;11(9):636–46.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nrg2842"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Genome%20editing%20with%20engineered%20zinc%20finger%20nucleases&amp;author=FD.%20Urnov&amp;author=EJ.%20Rebar&amp;author=MC.%20Holmes&amp;author=HS.%20Zhang&amp;author=PD.%20Gregory&amp;journal=Nat%20Rev%20Genet&amp;volume=11&amp;issue=9&amp;pages=636-646&amp;publication_year=2010"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR13" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Carroll D. Genome engineering with zinc-finger nucleases. Genetics. 2011;188(4):773–82.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1534/genetics.111.131433"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3176093"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176093"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Genome%20engineering%20with%20zinc-finger%20nucleases&amp;author=D.%20Carroll&amp;journal=Genetics&amp;volume=188&amp;issue=4&amp;pages=773-782&amp;publication_year=2011"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR14" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Wyman C, Kanaar R. DNA double-strand break repair: all's well that ends well. Annu Rev Genet. 2006;40:363–83.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1146/annurev.genet.40.110405.090451"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=DNA%20double-strand%20break%20repair%3A%20all%27s%20well%20that%20ends%20well&amp;author=C.%20Wyman&amp;author=R.%20Kanaar&amp;journal=Annu%20Rev%20Genet&amp;volume=40&amp;pages=363-383&amp;publication_year=2006"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR15" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Geurts
 AM, Cost GJ, Freyvert Y, Zeitler Z, Miller JC, Choi VM, Jenkins SS, 
Wood A, Cui X, Meng X, et al. Knockout rats produced using designed zinc
 finger nucleases. Science. 2009;325(5939):433.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1126/science.1172447"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=2831805"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831805"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Knockout%20rats%20produced%20using%20designed%20zinc%20finger%20nucleases&amp;author=AM.%20Geurts&amp;author=GJ.%20Cost&amp;author=Y.%20Freyvert&amp;author=Z.%20Zeitler&amp;author=JC.%20Miller&amp;author=VM.%20Choi&amp;author=SS.%20Jenkins&amp;author=A.%20Wood&amp;author=X.%20Cui&amp;author=X.%20Meng&amp;journal=Science&amp;volume=325&amp;issue=5939&amp;pages=433&amp;publication_year=2009"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR16" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Tesson
 L, Usal C, Menoret S, Leung E, Niles BJ, Remy S, Santiago Y, Vincent 
AI, Meng X, Zhang L, et al. Knockout rats generated by embryo 
microinjection of TALENs. Nat Biotechnol. 2011;29(8):695–6.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nbt.1940"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Knockout%20rats%20generated%20by%20embryo%20microinjection%20of%20TALENs&amp;author=L.%20Tesson&amp;author=C.%20Usal&amp;author=S.%20Menoret&amp;author=E.%20Leung&amp;author=BJ.%20Niles&amp;author=S.%20Remy&amp;author=Y.%20Santiago&amp;author=AI.%20Vincent&amp;author=X.%20Meng&amp;author=L.%20Zhang&amp;journal=Nat%20Biotechnol&amp;volume=29&amp;issue=8&amp;pages=695-696&amp;publication_year=2011"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR17" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Miller
 JC, Tan S, Qiao G, Barlow KA, Wang J, Xia DF, Meng X, Paschon DE, Leung
 E, Hinkley SJ, et al. A TALE nuclease architecture for efficient genome
 editing. Nat Biotechnol. 2011;29(2):143–8.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nbt.1755"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=A%20TALE%20nuclease%20architecture%20for%20efficient%20genome%20editing&amp;author=JC.%20Miller&amp;author=S.%20Tan&amp;author=G.%20Qiao&amp;author=KA.%20Barlow&amp;author=J.%20Wang&amp;author=DF.%20Xia&amp;author=X.%20Meng&amp;author=DE.%20Paschon&amp;author=E.%20Leung&amp;author=SJ.%20Hinkley&amp;journal=Nat%20Biotechnol&amp;volume=29&amp;issue=2&amp;pages=143-148&amp;publication_year=2011"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR18" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Ishino
 Y, Shinagawa H, Makino K, Amemura M, Nakata A. Nucleotide sequence of 
the iap gene, responsible for alkaline phosphatase isozyme conversion in
 Escherichia coli, and identification of the gene product. J Bacteriol. 
1987;169(12):5429–33.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1128/jb.169.12.5429-5433.1987"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=213968"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC213968"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Nucleotide%20sequence%20of%20the%20iap%20gene%2C%20responsible%20for%20alkaline%20phosphatase%20isozyme%20conversion%20in%20Escherichia%20coli%2C%20and%20identification%20of%20the%20gene%20product&amp;author=Y.%20Ishino&amp;author=H.%20Shinagawa&amp;author=K.%20Makino&amp;author=M.%20Amemura&amp;author=A.%20Nakata&amp;journal=J%20Bacteriol&amp;volume=169&amp;issue=12&amp;pages=5429-5433&amp;publication_year=1987"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR19" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Mojica
 FJ, Diez-Villasenor C, Garcia-Martinez J, Soria E. Intervening 
sequences of regularly spaced prokaryotic repeats derive from foreign 
genetic elements. J Mol Evol. 2005;60(2):174–82.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1007/s00239-004-0046-3"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Intervening%20sequences%20of%20regularly%20spaced%20prokaryotic%20repeats%20derive%20from%20foreign%20genetic%20elements&amp;author=FJ.%20Mojica&amp;author=C.%20Diez-Villasenor&amp;author=J.%20Garcia-Martinez&amp;author=E.%20Soria&amp;journal=J%20Mol%20Evol&amp;volume=60&amp;issue=2&amp;pages=174-182&amp;publication_year=2005"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR20" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Jinek
 M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A 
programmable dual-RNA-guided DNA endonuclease in adaptive bacterial 
immunity. Science. 2012;337(6096):816–21.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1126/science.1225829"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=A%20programmable%20dual-RNA-guided%20DNA%20endonuclease%20in%20adaptive%20bacterial%20immunity&amp;author=M.%20Jinek&amp;author=K.%20Chylinski&amp;author=I.%20Fonfara&amp;author=M.%20Hauer&amp;author=JA.%20Doudna&amp;author=E.%20Charpentier&amp;journal=Science&amp;volume=337&amp;issue=6096&amp;pages=816-821&amp;publication_year=2012"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR21" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Mali
 P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church 
GM. RNA-guided human genome engineering via Cas9. Science. 
2013;339(6121):823–6.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1126/science.1232033"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3712628"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712628"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=RNA-guided%20human%20genome%20engineering%20via%20Cas9&amp;author=P.%20Mali&amp;author=L.%20Yang&amp;author=KM.%20Esvelt&amp;author=J.%20Aach&amp;author=M.%20Guell&amp;author=JE.%20DiCarlo&amp;author=JE.%20Norville&amp;author=GM.%20Church&amp;journal=Science&amp;volume=339&amp;issue=6121&amp;pages=823-826&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR22" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Cong
 L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, 
Marraffini LA, et al. Multiplex genome engineering using CRISPR/Cas 
systems. Science. 2013;339(6121):819–23.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1126/science.1231143"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3795411"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795411"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Multiplex%20genome%20engineering%20using%20CRISPR%2FCas%20systems&amp;author=L.%20Cong&amp;author=FA.%20Ran&amp;author=D.%20Cox&amp;author=S.%20Lin&amp;author=R.%20Barretto&amp;author=N.%20Habib&amp;author=PD.%20Hsu&amp;author=X.%20Wu&amp;author=W.%20Jiang&amp;author=LA.%20Marraffini&amp;journal=Science&amp;volume=339&amp;issue=6121&amp;pages=819-823&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR23" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Larson
 MH, Gilbert LA, Wang X, Lim WA, Weissman JS, Qi LS. CRISPR interference
 (CRISPRi) for sequence-specific control of gene expression. Nat Protoc.
 2013;8(11):2180–96.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nprot.2013.132"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3922765"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922765"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=CRISPR%20interference%20%28CRISPRi%29%20for%20sequence-specific%20control%20of%20gene%20expression&amp;author=MH.%20Larson&amp;author=LA.%20Gilbert&amp;author=X.%20Wang&amp;author=WA.%20Lim&amp;author=JS.%20Weissman&amp;author=LS.%20Qi&amp;journal=Nat%20Protoc&amp;volume=8&amp;issue=11&amp;pages=2180-2196&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR24" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Yu
 Z, Ren M, Wang Z, Zhang B, Rong YS, Jiao R, Gao G. Highly efficient 
genome modifications mediated by CRISPR/Cas9 in Drosophila. Genetics. 
2013;195(1):289–91.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1534/genetics.113.153825"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3761309"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3761309"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Highly%20efficient%20genome%20modifications%20mediated%20by%20CRISPR%2FCas9%20in%20Drosophila&amp;author=Z.%20Yu&amp;author=M.%20Ren&amp;author=Z.%20Wang&amp;author=B.%20Zhang&amp;author=YS.%20Rong&amp;author=R.%20Jiao&amp;author=G.%20Gao&amp;journal=Genetics&amp;volume=195&amp;issue=1&amp;pages=289-291&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR25" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Dickinson
 DJ, Ward JD, Reiner DJ, Goldstein B. Engineering the Caenorhabditis 
elegans genome using Cas9-triggered homologous recombination. Nat 
Methods. 2013;10(10):1028–34.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nmeth.2641"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3905680"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905680"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Engineering%20the%20Caenorhabditis%20elegans%20genome%20using%20Cas9-triggered%20homologous%20recombination&amp;author=DJ.%20Dickinson&amp;author=JD.%20Ward&amp;author=DJ.%20Reiner&amp;author=B.%20Goldstein&amp;journal=Nat%20Methods&amp;volume=10&amp;issue=10&amp;pages=1028-1034&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR26" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Chang
 N, Sun C, Gao L, Zhu D, Xu X, Zhu X, Xiong JW, Xi JJ. Genome editing 
with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res. 
2013;23(4):465–72.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/cr.2013.45"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3616424"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616424"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Genome%20editing%20with%20RNA-guided%20Cas9%20nuclease%20in%20zebrafish%20embryos&amp;author=N.%20Chang&amp;author=C.%20Sun&amp;author=L.%20Gao&amp;author=D.%20Zhu&amp;author=X.%20Xu&amp;author=X.%20Zhu&amp;author=JW.%20Xiong&amp;author=JJ.%20Xi&amp;journal=Cell%20Res&amp;volume=23&amp;issue=4&amp;pages=465-472&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR27" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Wang
 H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. 
One-step generation of mice carrying mutations in multiple genes by 
CRISPR/Cas-mediated genome engineering. Cell. 2013;153(4):910–8.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.cell.2013.04.025"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3969854"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969854"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=One-step%20generation%20of%20mice%20carrying%20mutations%20in%20multiple%20genes%20by%20CRISPR%2FCas-mediated%20genome%20engineering&amp;author=H.%20Wang&amp;author=H.%20Yang&amp;author=CS.%20Shivalila&amp;author=MM.%20Dawlaty&amp;author=AW.%20Cheng&amp;author=F.%20Zhang&amp;author=R.%20Jaenisch&amp;journal=Cell&amp;volume=153&amp;issue=4&amp;pages=910-918&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR28" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Li
 D, Qiu Z, Shao Y, Chen Y, Guan Y, Liu M, Li Y, Gao N, Wang L, Lu X, et 
al. Heritable gene targeting in the mouse and rat using a CRISPR-Cas 
system. Nat Biotechnol. 2013;31(8):681–3.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nbt.2661"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Heritable%20gene%20targeting%20in%20the%20mouse%20and%20rat%20using%20a%20CRISPR-Cas%20system&amp;author=D.%20Li&amp;author=Z.%20Qiu&amp;author=Y.%20Shao&amp;author=Y.%20Chen&amp;author=Y.%20Guan&amp;author=M.%20Liu&amp;author=Y.%20Li&amp;author=N.%20Gao&amp;author=L.%20Wang&amp;author=X.%20Lu&amp;journal=Nat%20Biotechnol&amp;volume=31&amp;issue=8&amp;pages=681-683&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR29" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Xiong
 X, Chen M, Lim WA, Zhao D, Qi LS. CRISPR/Cas9 for human genome 
engineering and disease research. Annu Rev Genomics Hum Genet. 
2016;17:131–54.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1146/annurev-genom-083115-022258"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=CRISPR%2FCas9%20for%20human%20genome%20engineering%20and%20disease%20research&amp;author=X.%20Xiong&amp;author=M.%20Chen&amp;author=WA.%20Lim&amp;author=D.%20Zhao&amp;author=LS.%20Qi&amp;journal=Annu%20Rev%20Genomics%20Hum%20Genet&amp;volume=17&amp;pages=131-154&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR30" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Osborn
 MJ, Webber BR, Knipping F, Lonetree CL, Tennis N, DeFeo AP, McElroy AN,
 Starker CG, Lee C, Merkel S, et al. Evaluation of TCR gene editing 
achieved by TALENs, CRISPR/Cas9, and megaTAL nucleases. Mol Ther. 
2016;24(3):570–81.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/mt.2015.197"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4786913"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786913"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Evaluation%20of%20TCR%20gene%20editing%20achieved%20by%20TALENs%2C%20CRISPR%2FCas9%2C%20and%20megaTAL%20nucleases&amp;author=MJ.%20Osborn&amp;author=BR.%20Webber&amp;author=F.%20Knipping&amp;author=CL.%20Lonetree&amp;author=N.%20Tennis&amp;author=AP.%20DeFeo&amp;author=AN.%20McElroy&amp;author=CG.%20Starker&amp;author=C.%20Lee&amp;author=S.%20Merkel&amp;journal=Mol%20Ther&amp;volume=24&amp;issue=3&amp;pages=570-581&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR31" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Osborn
 MJ, Gabriel R, Webber BR, DeFeo AP, McElroy AN, Jarjour J, Starker CG, 
Wagner JE, Joung JK, Voytas DF, et al. Fanconi anemia gene editing by 
the CRISPR/Cas9 system. Hum Gene Ther. 2015;26(2):114–26.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1089/hum.2014.111"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Fanconi%20anemia%20gene%20editing%20by%20the%20CRISPR%2FCas9%20system&amp;author=MJ.%20Osborn&amp;author=R.%20Gabriel&amp;author=BR.%20Webber&amp;author=AP.%20DeFeo&amp;author=AN.%20McElroy&amp;author=J.%20Jarjour&amp;author=CG.%20Starker&amp;author=JE.%20Wagner&amp;author=JK.%20Joung&amp;author=DF.%20Voytas&amp;journal=Hum%20Gene%20Ther&amp;volume=26&amp;issue=2&amp;pages=114-126&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR32" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Garcia-Tunon
 I, Hernandez-Sanchez M, Ordonez JL, Alonso-Perez V, Alamo-Quijada M, 
Benito R, Guerrero C, Hernandez-Rivas JM, Sanchez-Martin M. The 
CRISPR/Cas9 system efficiently reverts the tumorigenic ability of 
BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia. 
Oncotarget. 2017;8(16):26027–40.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.18632/oncotarget.15215"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5432235"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432235"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=The%20CRISPR%2FCas9%20system%20efficiently%20reverts%20the%20tumorigenic%20ability%20of%20BCR%2FABL%20in%20vitro%20and%20in%20a%20xenograft%20model%20of%20chronic%20myeloid%20leukemia&amp;author=I.%20Garcia-Tunon&amp;author=M.%20Hernandez-Sanchez&amp;author=JL.%20Ordonez&amp;author=V.%20Alonso-Perez&amp;author=M.%20Alamo-Quijada&amp;author=R.%20Benito&amp;author=C.%20Guerrero&amp;author=JM.%20Hernandez-Rivas&amp;author=M.%20Sanchez-Martin&amp;journal=Oncotarget&amp;volume=8&amp;issue=16&amp;pages=26027-26040&amp;publication_year=2017"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR33" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Mullighan
 CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman 
K, Mathew S, Ma J, Pounds SB, et al. Genome-wide analysis of genetic 
alterations in acute lymphoblastic leukaemia. Nature. 
2007;446(7137):758–64.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nature05690"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Genome-wide%20analysis%20of%20genetic%20alterations%20in%20acute%20lymphoblastic%20leukaemia&amp;author=CG.%20Mullighan&amp;author=S.%20Goorha&amp;author=I.%20Radtke&amp;author=CB.%20Miller&amp;author=E.%20Coustan-Smith&amp;author=JD.%20Dalton&amp;author=K.%20Girtman&amp;author=S.%20Mathew&amp;author=J.%20Ma&amp;author=SB.%20Pounds&amp;journal=Nature&amp;volume=446&amp;issue=7137&amp;pages=758-764&amp;publication_year=2007"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR34" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Mullighan
 CG, Phillips LA, Su X, Ma J, Miller CB, Shurtleff SA, Downing JR. 
Genomic analysis of the clonal origins of relapsed acute lymphoblastic 
leukemia. Science. 2008;322(5906):1377–80.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1126/science.1164266"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=2746051"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746051"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Genomic%20analysis%20of%20the%20clonal%20origins%20of%20relapsed%20acute%20lymphoblastic%20leukemia&amp;author=CG.%20Mullighan&amp;author=LA.%20Phillips&amp;author=X.%20Su&amp;author=J.%20Ma&amp;author=CB.%20Miller&amp;author=SA.%20Shurtleff&amp;author=JR.%20Downing&amp;journal=Science&amp;volume=322&amp;issue=5906&amp;pages=1377-1380&amp;publication_year=2008"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR35" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Miyajima
 C, Inoue Y, Hayashi H. Pseudokinase tribbles 1 (TRB1) negatively 
regulates tumor-suppressor activity of p53 through p53 deacetylation. 
Biol Pharm Bull. 2015;38(4):618–24.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1248/bpb.b15-00003"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Pseudokinase%20tribbles%201%20%28TRB1%29%20negatively%20regulates%20tumor-suppressor%20activity%20of%20p53%20through%20p53%20deacetylation&amp;author=C.%20Miyajima&amp;author=Y.%20Inoue&amp;author=H.%20Hayashi&amp;journal=Biol%20Pharm%20Bull&amp;volume=38&amp;issue=4&amp;pages=618-624&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR36" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Sanda
 T, Lawton LN, Barrasa MI, Fan ZP, Kohlhammer H, Gutierrez A, Ma W, 
Tatarek J, Ahn Y, Kelliher MA, et al. Core transcriptional regulatory 
circuit controlled by the TAL1 complex in human T cell acute 
lymphoblastic leukemia. Cancer Cell. 2012;22(2):209–21.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.ccr.2012.06.007"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3422504"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422504"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Core%20transcriptional%20regulatory%20circuit%20controlled%20by%20the%20TAL1%20complex%20in%20human%20T%20cell%20acute%20lymphoblastic%20leukemia&amp;author=T.%20Sanda&amp;author=LN.%20Lawton&amp;author=MI.%20Barrasa&amp;author=ZP.%20Fan&amp;author=H.%20Kohlhammer&amp;author=A.%20Gutierrez&amp;author=W.%20Ma&amp;author=J.%20Tatarek&amp;author=Y.%20Ahn&amp;author=MA.%20Kelliher&amp;journal=Cancer%20Cell&amp;volume=22&amp;issue=2&amp;pages=209-221&amp;publication_year=2012"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR37" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Ferrando
 AA, Herblot S, Palomero T, Hansen M, Hoang T, Fox EA, Look AT. 
Biallelic transcriptional activation of oncogenic transcription factors 
in T-cell acute lymphoblastic leukemia. Blood. 2004;103(5):1909–11.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1182/blood-2003-07-2577"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Biallelic%20transcriptional%20activation%20of%20oncogenic%20transcription%20factors%20in%20T-cell%20acute%20lymphoblastic%20leukemia&amp;author=AA.%20Ferrando&amp;author=S.%20Herblot&amp;author=T.%20Palomero&amp;author=M.%20Hansen&amp;author=T.%20Hoang&amp;author=EA.%20Fox&amp;author=AT.%20Look&amp;journal=Blood&amp;volume=103&amp;issue=5&amp;pages=1909-1911&amp;publication_year=2004"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR38" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer. 2003;3(9):639–49.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nrc1164"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Origins%20of%20chromosome%20translocations%20in%20childhood%20leukaemia&amp;author=MF.%20Greaves&amp;author=J.%20Wiemels&amp;journal=Nat%20Rev%20Cancer&amp;volume=3&amp;issue=9&amp;pages=639-649&amp;publication_year=2003"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR39" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Greaves M. A causal mechanism for childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2018;<span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="https://scholar.google.com/scholar?hl=en&amp;q=Greaves%20M.%20A%20causal%20mechanism%20for%20childhood%20acute%20lymphoblastic%20leukaemia.%20Nat%20Rev%20Cancer.%202018%3B"><span><span>Google Scholar</span></span></a></span></span></span><span class="Occurrences"></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR40" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Boiers
 C, Richardson SE, Laycock E, Zriwil A, Turati VA, Brown J, Wray JP, 
Wang D, James C, Herrero J, et al. A human IPS model implicates 
embryonic B-myeloid fate restriction as developmental susceptibility to B
 acute lymphoblastic leukemia-associated ETV6-RUNX1. Dev Cell. 
2018;44(3):362–77. e367</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.devcel.2017.12.005"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5807056"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807056"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=A%20human%20IPS%20model%20implicates%20embryonic%20B-myeloid%20fate%20restriction%20as%20developmental%20susceptibility%20to%20B%20acute%20lymphoblastic%20leukemia-associated%20ETV6-RUNX1&amp;author=C.%20Boiers&amp;author=SE.%20Richardson&amp;author=E.%20Laycock&amp;author=A.%20Zriwil&amp;author=VA.%20Turati&amp;author=J.%20Brown&amp;author=JP.%20Wray&amp;author=D.%20Wang&amp;author=C.%20James&amp;author=J.%20Herrero&amp;journal=Dev%20Cell&amp;volume=44&amp;issue=3&amp;pages=362-377&amp;publication_year=2018"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR41" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Weinstock
 DM, Brunet E, Jasin M. Induction of chromosomal translocations in mouse
 and human cells using site-specific endonucleases. J Natl Cancer Inst 
Monogr. 2008;2008(39):20–4.<span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="https://scholar.google.com/scholar?hl=en&amp;q=Weinstock%20DM%2C%20Brunet%20E%2C%20Jasin%20M.%20Induction%20of%20chromosomal%20translocations%20in%20mouse%20and%20human%20cells%20using%20site-specific%20endonucleases.%20J%20Natl%20Cancer%20Inst%20Monogr.%202008%3B2008%2839%29%3A20%E2%80%934."><span><span>Google Scholar</span></span></a></span></span></span><span class="Occurrences"></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR42" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Breese
 EH, Buechele C, Dawson C, Cleary ML, Porteus MH. Use of genome 
engineering to create patient specific MLL translocations in primary 
human hematopoietic stem and progenitor cells. PLoS One. 
2015;10(9):e0136644.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1371/journal.pone.0136644"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4564237"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564237"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Use%20of%20genome%20engineering%20to%20create%20patient%20specific%20MLL%20translocations%20in%20primary%20human%20hematopoietic%20stem%20and%20progenitor%20cells&amp;author=EH.%20Breese&amp;author=C.%20Buechele&amp;author=C.%20Dawson&amp;author=ML.%20Cleary&amp;author=MH.%20Porteus&amp;journal=PLoS%20One&amp;volume=10&amp;issue=9&amp;pages=e0136644&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR43" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Schneidawind
 C, Jeong J, Schneidawind D, Kim IS, Duque-Afonso J, Wong SHK, Iwasaki 
M, Breese EH, Zehnder JL, Porteus M, et al. MLL leukemia induction by 
t(9;11) chromosomal translocation in human hematopoietic stem cells 
using genome editing. Blood Adv. 2018;2(8):832–45.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1182/bloodadvances.2017013748"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5916000"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916000"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=MLL%20leukemia%20induction%20by%20t%289%3B11%29%20chromosomal%20translocation%20in%20human%20hematopoietic%20stem%20cells%20using%20genome%20editing&amp;author=C.%20Schneidawind&amp;author=J.%20Jeong&amp;author=D.%20Schneidawind&amp;author=IS.%20Kim&amp;author=J.%20Duque-Afonso&amp;author=SHK.%20Wong&amp;author=M.%20Iwasaki&amp;author=EH.%20Breese&amp;author=JL.%20Zehnder&amp;author=M.%20Porteus&amp;journal=Blood%20Adv&amp;volume=2&amp;issue=8&amp;pages=832-845&amp;publication_year=2018"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR44" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Bueno
 C, Catalina P, Melen GJ, Montes R, Sanchez L, Ligero G, Garcia-Perez 
JL, Menendez P. Etoposide induces MLL rearrangements and other 
chromosomal abnormalities in human embryonic stem cells. Carcinogenesis.
 2009;30(9):1628–37.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1093/carcin/bgp169"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Etoposide%20induces%20MLL%20rearrangements%20and%20other%20chromosomal%20abnormalities%20in%20human%20embryonic%20stem%20cells&amp;author=C.%20Bueno&amp;author=P.%20Catalina&amp;author=GJ.%20Melen&amp;author=R.%20Montes&amp;author=L.%20Sanchez&amp;author=G.%20Ligero&amp;author=JL.%20Garcia-Perez&amp;author=P.%20Menendez&amp;journal=Carcinogenesis&amp;volume=30&amp;issue=9&amp;pages=1628-1637&amp;publication_year=2009"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR45" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Nanya
 M, Sato M, Tanimoto K, Tozuka M, Mizutani S, Takagi M. Dysregulation of
 the DNA damage response and KMT2A rearrangement in fetal liver 
hematopoietic cells. PLoS One. 2015;10(12):e0144540.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1371/journal.pone.0144540"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4686171"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686171"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Dysregulation%20of%20the%20DNA%20damage%20response%20and%20KMT2A%20rearrangement%20in%20fetal%20liver%20hematopoietic%20cells&amp;author=M.%20Nanya&amp;author=M.%20Sato&amp;author=K.%20Tanimoto&amp;author=M.%20Tozuka&amp;author=S.%20Mizutani&amp;author=M.%20Takagi&amp;journal=PLoS%20One&amp;volume=10&amp;issue=12&amp;pages=e0144540&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR46" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Castano
 J, Herrero AB, Bursen A, Gonzalez F, Marschalek R, Gutierrez NC, 
Menendez P. Expression of MLL-AF4 or AF4-MLL fusions does not impact the
 efficiency of DNA damage repair. Oncotarget. 2016;7(21):30440–52.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.18632/oncotarget.8938"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5058691"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058691"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Expression%20of%20MLL-AF4%20or%20AF4-MLL%20fusions%20does%20not%20impact%20the%20efficiency%20of%20DNA%20damage%20repair&amp;author=J.%20Castano&amp;author=AB.%20Herrero&amp;author=A.%20Bursen&amp;author=F.%20Gonzalez&amp;author=R.%20Marschalek&amp;author=NC.%20Gutierrez&amp;author=P.%20Menendez&amp;journal=Oncotarget&amp;volume=7&amp;issue=21&amp;pages=30440-30452&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR47" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Herman
 SE, Gordon AL, Hertlein E, Ramanunni A, Zhang X, Jaglowski S, Flynn J, 
Jones J, Blum KA, Buggy JJ, et al. Bruton tyrosine kinase represents a 
promising therapeutic target for treatment of chronic lymphocytic 
leukemia and is effectively targeted by PCI-32765. Blood. 
2011;117(23):6287–96.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1182/blood-2011-01-328484"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3122947"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122947"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Bruton%20tyrosine%20kinase%20represents%20a%20promising%20therapeutic%20target%20for%20treatment%20of%20chronic%20lymphocytic%20leukemia%20and%20is%20effectively%20targeted%20by%20PCI-32765&amp;author=SE.%20Herman&amp;author=AL.%20Gordon&amp;author=E.%20Hertlein&amp;author=A.%20Ramanunni&amp;author=X.%20Zhang&amp;author=S.%20Jaglowski&amp;author=J.%20Flynn&amp;author=J.%20Jones&amp;author=KA.%20Blum&amp;author=JJ.%20Buggy&amp;journal=Blood&amp;volume=117&amp;issue=23&amp;pages=6287-6296&amp;publication_year=2011"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR48" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Ponader
 S, Chen SS, Buggy JJ, Balakrishnan K, Gandhi V, Wierda WG, Keating MJ, 
O'Brien S, Chiorazzi N, Burger JA. The Bruton tyrosine kinase inhibitor 
PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue 
homing in vitro and in vivo. Blood. 2012;119(5):1182–9.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1182/blood-2011-10-386417"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4916557"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916557"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=The%20Bruton%20tyrosine%20kinase%20inhibitor%20PCI-32765%20thwarts%20chronic%20lymphocytic%20leukemia%20cell%20survival%20and%20tissue%20homing%20in%20vitro%20and%20in%20vivo&amp;author=S.%20Ponader&amp;author=SS.%20Chen&amp;author=JJ.%20Buggy&amp;author=K.%20Balakrishnan&amp;author=V.%20Gandhi&amp;author=WG.%20Wierda&amp;author=MJ.%20Keating&amp;author=S.%20O%27Brien&amp;author=N.%20Chiorazzi&amp;author=JA.%20Burger&amp;journal=Blood&amp;volume=119&amp;issue=5&amp;pages=1182-1189&amp;publication_year=2012"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR49" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Davis
 RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy 
L, Zhao H, Yang Y, et al. Chronic active B-cell-receptor signalling in 
diffuse large B-cell lymphoma. Nature. 2010;463(7277):88–92.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nature08638"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=2845535"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845535"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Chronic%20active%20B-cell-receptor%20signalling%20in%20diffuse%20large%20B-cell%20lymphoma&amp;author=RE.%20Davis&amp;author=VN.%20Ngo&amp;author=G.%20Lenz&amp;author=P.%20Tolar&amp;author=RM.%20Young&amp;author=PB.%20Romesser&amp;author=H.%20Kohlhammer&amp;author=L.%20Lamy&amp;author=H.%20Zhao&amp;author=Y.%20Yang&amp;journal=Nature&amp;volume=463&amp;issue=7277&amp;pages=88-92&amp;publication_year=2010"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR50" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Goodman
 PA, Wood CM, Vassilev AO, Mao C, Uckun FM. Defective expression of 
Bruton's tyrosine kinase in acute lymphoblastic leukemia. Leuk Lymphoma.
 2003;44(6):1011–8.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1080/1042819031000067576"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Defective%20expression%20of%20Bruton%27s%20tyrosine%20kinase%20in%20acute%20lymphoblastic%20leukemia&amp;author=PA.%20Goodman&amp;author=CM.%20Wood&amp;author=AO.%20Vassilev&amp;author=C.%20Mao&amp;author=FM.%20Uckun&amp;journal=Leuk%20Lymphoma&amp;volume=44&amp;issue=6&amp;pages=1011-1018&amp;publication_year=2003"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR51" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Feldhahn
 N, Klein F, Mooster JL, Hadweh P, Sprangers M, Wartenberg M, Bekhite 
MM, Hofmann WK, Herzog S, Jumaa H, et al. Mimicry of a constitutively 
active pre-B cell receptor in acute lymphoblastic leukemia cells. J Exp 
Med. 2005;201(11):1837–52.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1084/jem.20042101"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=2213268"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213268"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Mimicry%20of%20a%20constitutively%20active%20pre-B%20cell%20receptor%20in%20acute%20lymphoblastic%20leukemia%20cells&amp;author=N.%20Feldhahn&amp;author=F.%20Klein&amp;author=JL.%20Mooster&amp;author=P.%20Hadweh&amp;author=M.%20Sprangers&amp;author=M.%20Wartenberg&amp;author=MM.%20Bekhite&amp;author=WK.%20Hofmann&amp;author=S.%20Herzog&amp;author=H.%20Jumaa&amp;journal=J%20Exp%20Med&amp;volume=201&amp;issue=11&amp;pages=1837-1852&amp;publication_year=2005"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR52" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Zhang
 J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, 
Chen X, Wang J, Rusch M, et al. The genetic basis of early T-cell 
precursor acute lymphoblastic leukaemia. Nature. 2012;481(7380):157–63.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nature10725"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3267575"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267575"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=The%20genetic%20basis%20of%20early%20T-cell%20precursor%20acute%20lymphoblastic%20leukaemia&amp;author=J.%20Zhang&amp;author=L.%20Ding&amp;author=L.%20Holmfeldt&amp;author=G.%20Wu&amp;author=SL.%20Heatley&amp;author=D.%20Payne-Turner&amp;author=J.%20Easton&amp;author=X.%20Chen&amp;author=J.%20Wang&amp;author=M.%20Rusch&amp;journal=Nature&amp;volume=481&amp;issue=7380&amp;pages=157-163&amp;publication_year=2012"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR53" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">van
 der Watt PJ, Maske CP, Hendricks DT, Parker MI, Denny L, Govender D, 
Birrer MJ, Leaner VD. The Karyopherin proteins, Crm1 and Karyopherin 
beta1, are overexpressed in cervical cancer and are critical for cancer 
cell survival and proliferation. Int J Cancer. 2009;124(8):1829–40.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1002/ijc.24146"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=The%20Karyopherin%20proteins%2C%20Crm1%20and%20Karyopherin%20beta1%2C%20are%20overexpressed%20in%20cervical%20cancer%20and%20are%20critical%20for%20cancer%20cell%20survival%20and%20proliferation&amp;author=PJ.%20van%20der%20Watt&amp;author=CP.%20Maske&amp;author=DT.%20Hendricks&amp;author=MI.%20Parker&amp;author=L.%20Denny&amp;author=D.%20Govender&amp;author=MJ.%20Birrer&amp;author=VD.%20Leaner&amp;journal=Int%20J%20Cancer&amp;volume=124&amp;issue=8&amp;pages=1829-1840&amp;publication_year=2009"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR54" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Shen
 A, Wang Y, Zhao Y, Zou L, Sun L, Cheng C. Expression of CRM1 in human 
gliomas and its significance in p27 expression and clinical prognosis. 
Neurosurgery. 2009;65(1):153–9. discussion 159-160</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1227/01.NEU.0000348550.47441.4B"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Expression%20of%20CRM1%20in%20human%20gliomas%20and%20its%20significance%20in%20p27%20expression%20and%20clinical%20prognosis&amp;author=A.%20Shen&amp;author=Y.%20Wang&amp;author=Y.%20Zhao&amp;author=L.%20Zou&amp;author=L.%20Sun&amp;author=C.%20Cheng&amp;journal=Neurosurgery&amp;volume=65&amp;issue=1&amp;pages=153-159&amp;publication_year=2009"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR55" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Lapalombella
 R, Sun Q, Williams K, Tangeman L, Jha S, Zhong Y, Goettl V, Mahoney E, 
Berglund C, Gupta S, et al. Selective inhibitors of nuclear export show 
that CRM1/XPO1 is a target in chronic lymphocytic leukemia. Blood. 
2012;120(23):4621–34.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1182/blood-2012-05-429506"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3512237"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512237"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Selective%20inhibitors%20of%20nuclear%20export%20show%20that%20CRM1%2FXPO1%20is%20a%20target%20in%20chronic%20lymphocytic%20leukemia&amp;author=R.%20Lapalombella&amp;author=Q.%20Sun&amp;author=K.%20Williams&amp;author=L.%20Tangeman&amp;author=S.%20Jha&amp;author=Y.%20Zhong&amp;author=V.%20Goettl&amp;author=E.%20Mahoney&amp;author=C.%20Berglund&amp;author=S.%20Gupta&amp;journal=Blood&amp;volume=120&amp;issue=23&amp;pages=4621-4634&amp;publication_year=2012"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR56" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Neggers
 JE, Vercruysse T, Jacquemyn M, Vanstreels E, Baloglu E, Shacham S, 
Crochiere M, Landesman Y, Daelemans D. Identifying drug-target 
selectivity of small-molecule CRM1/XPO1 inhibitors by CRISPR/Cas9 genome
 editing. Chem Biol. 2015;22(1):107–16.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.chembiol.2014.11.015"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Identifying%20drug-target%20selectivity%20of%20small-molecule%20CRM1%2FXPO1%20inhibitors%20by%20CRISPR%2FCas9%20genome%20editing&amp;author=JE.%20Neggers&amp;author=T.%20Vercruysse&amp;author=M.%20Jacquemyn&amp;author=E.%20Vanstreels&amp;author=E.%20Baloglu&amp;author=S.%20Shacham&amp;author=M.%20Crochiere&amp;author=Y.%20Landesman&amp;author=D.%20Daelemans&amp;journal=Chem%20Biol&amp;volume=22&amp;issue=1&amp;pages=107-116&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR57" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Vercruysse
 T, De Bie J, Neggers JE, Jacquemyn M, Vanstreels E, Schmid-Burgk JL, 
Hornung V, Baloglu E, Landesman Y, Senapedis W, et al. The 
second-generation Exportin-1 inhibitor KPT-8602 demonstrates potent 
activity against acute lymphoblastic leukemia. Clin Cancer Res. 
2017;23(10):2528–41.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1158/1078-0432.CCR-16-1580"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=The%20second-generation%20Exportin-1%20inhibitor%20KPT-8602%20demonstrates%20potent%20activity%20against%20acute%20lymphoblastic%20leukemia&amp;author=T.%20Vercruysse&amp;author=J.%20De%20Bie&amp;author=JE.%20Neggers&amp;author=M.%20Jacquemyn&amp;author=E.%20Vanstreels&amp;author=JL.%20Schmid-Burgk&amp;author=V.%20Hornung&amp;author=E.%20Baloglu&amp;author=Y.%20Landesman&amp;author=W.%20Senapedis&amp;journal=Clin%20Cancer%20Res&amp;volume=23&amp;issue=10&amp;pages=2528-2541&amp;publication_year=2017"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR58" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Lombard
 C, Nagarkatti M, Nagarkatti PS. Targeting cannabinoid receptors to 
treat leukemia: role of cross-talk between extrinsic and intrinsic 
pathways in Delta9-tetrahydrocannabinol (THC)-induced apoptosis of 
Jurkat cells. Leuk Res. 2005;29(8):915–22.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.leukres.2005.01.014"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Targeting%20cannabinoid%20receptors%20to%20treat%20leukemia%3A%20role%20of%20cross-talk%20between%20extrinsic%20and%20intrinsic%20pathways%20in%20Delta9-tetrahydrocannabinol%20%28THC%29-induced%20apoptosis%20of%20Jurkat%20cells&amp;author=C.%20Lombard&amp;author=M.%20Nagarkatti&amp;author=PS.%20Nagarkatti&amp;journal=Leuk%20Res&amp;volume=29&amp;issue=8&amp;pages=915-922&amp;publication_year=2005"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR59" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Takahashi
 K, Inukai T, Imamura T, Yano M, Tomoyasu C, Lucas DM, Nemoto A, Sato H,
 Huang M, Abe M, et al. Anti-leukemic activity of bortezomib and 
carfilzomib on B-cell precursor ALL cell lines. PLoS One. 
2017;12(12):e0188680.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1371/journal.pone.0188680"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5728482"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728482"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Anti-leukemic%20activity%20of%20bortezomib%20and%20carfilzomib%20on%20B-cell%20precursor%20ALL%20cell%20lines&amp;author=K.%20Takahashi&amp;author=T.%20Inukai&amp;author=T.%20Imamura&amp;author=M.%20Yano&amp;author=C.%20Tomoyasu&amp;author=DM.%20Lucas&amp;author=A.%20Nemoto&amp;author=H.%20Sato&amp;author=M.%20Huang&amp;author=M.%20Abe&amp;journal=PLoS%20One&amp;volume=12&amp;issue=12&amp;pages=e0188680&amp;publication_year=2017"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR60" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Kochenderfer
 JN, Dudley ME, Carpenter RO, Kassim SH, Rose JJ, Telford WG, Hakim FT, 
Halverson DC, Fowler DH, Hardy NM, et al. Donor-derived CD19-targeted T 
cells cause regression of malignancy persisting after allogeneic 
hematopoietic stem cell transplantation. Blood. 2013;122(25):4129–39.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1182/blood-2013-08-519413"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3862276"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862276"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Donor-derived%20CD19-targeted%20T%20cells%20cause%20regression%20of%20malignancy%20persisting%20after%20allogeneic%20hematopoietic%20stem%20cell%20transplantation&amp;author=JN.%20Kochenderfer&amp;author=ME.%20Dudley&amp;author=RO.%20Carpenter&amp;author=SH.%20Kassim&amp;author=JJ.%20Rose&amp;author=WG.%20Telford&amp;author=FT.%20Hakim&amp;author=DC.%20Halverson&amp;author=DH.%20Fowler&amp;author=NM.%20Hardy&amp;journal=Blood&amp;volume=122&amp;issue=25&amp;pages=4129-4139&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR61" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Maude
 SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, Chew A, Gonzalez 
VE, Zheng Z, Lacey SF, et al. Chimeric antigen receptor T cells for 
sustained remissions in leukemia. N Engl J Med. 2014;371(16):1507–17.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1056/NEJMoa1407222"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4267531"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267531"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Chimeric%20antigen%20receptor%20T%20cells%20for%20sustained%20remissions%20in%20leukemia&amp;author=SL.%20Maude&amp;author=N.%20Frey&amp;author=PA.%20Shaw&amp;author=R.%20Aplenc&amp;author=DM.%20Barrett&amp;author=NJ.%20Bunin&amp;author=A.%20Chew&amp;author=VE.%20Gonzalez&amp;author=Z.%20Zheng&amp;author=SF.%20Lacey&amp;journal=N%20Engl%20J%20Med&amp;volume=371&amp;issue=16&amp;pages=1507-1517&amp;publication_year=2014"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR62" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Lee
 DW, Kochenderfer JN, Stetler-Stevenson M, Cui YK, Delbrook C, Feldman 
SA, Fry TJ, Orentas R, Sabatino M, Shah NN, et al. T cells expressing 
CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in 
children and young adults: a phase 1 dose-escalation trial. Lancet. 
2015;385(9967):517–28.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/S0140-6736%2814%2961403-3"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=T%20cells%20expressing%20CD19%20chimeric%20antigen%20receptors%20for%20acute%20lymphoblastic%20leukaemia%20in%20children%20and%20young%20adults%3A%20a%20phase%201%20dose-escalation%20trial&amp;author=DW.%20Lee&amp;author=JN.%20Kochenderfer&amp;author=M.%20Stetler-Stevenson&amp;author=YK.%20Cui&amp;author=C.%20Delbrook&amp;author=SA.%20Feldman&amp;author=TJ.%20Fry&amp;author=R.%20Orentas&amp;author=M.%20Sabatino&amp;author=NN.%20Shah&amp;journal=Lancet&amp;volume=385&amp;issue=9967&amp;pages=517-528&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR63" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Eyquem
 J, Mansilla-Soto J, Giavridis T, van der Stegen SJ, Hamieh M, Cunanan 
KM, Odak A, Gonen M, Sadelain M. Targeting a CAR to the TRAC locus with 
CRISPR/Cas9 enhances tumour rejection. Nature. 2017;543(7643):113–7.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nature21405"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5558614"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558614"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Targeting%20a%20CAR%20to%20the%20TRAC%20locus%20with%20CRISPR%2FCas9%20enhances%20tumour%20rejection&amp;author=J.%20Eyquem&amp;author=J.%20Mansilla-Soto&amp;author=T.%20Giavridis&amp;author=SJ.%20van%20der%20Stegen&amp;author=M.%20Hamieh&amp;author=KM.%20Cunanan&amp;author=A.%20Odak&amp;author=M.%20Gonen&amp;author=M.%20Sadelain&amp;journal=Nature&amp;volume=543&amp;issue=7643&amp;pages=113-117&amp;publication_year=2017"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR64" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Topp
 MS, Gokbuget N, Zugmaier G, Klappers P, Stelljes M, Neumann S, Viardot 
A, Marks R, Diedrich H, Faul C, et al. Phase II trial of the anti-CD19 
bispecific T cell-engager blinatumomab shows hematologic and molecular 
remissions in patients with relapsed or refractory B-precursor acute 
lymphoblastic leukemia. J Clin Oncol. 2014;32(36):4134–40.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1200/JCO.2014.56.3247"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Phase%20II%20trial%20of%20the%20anti-CD19%20bispecific%20T%20cell-engager%20blinatumomab%20shows%20hematologic%20and%20molecular%20remissions%20in%20patients%20with%20relapsed%20or%20refractory%20B-precursor%20acute%20lymphoblastic%20leukemia&amp;author=MS.%20Topp&amp;author=N.%20Gokbuget&amp;author=G.%20Zugmaier&amp;author=P.%20Klappers&amp;author=M.%20Stelljes&amp;author=S.%20Neumann&amp;author=A.%20Viardot&amp;author=R.%20Marks&amp;author=H.%20Diedrich&amp;author=C.%20Faul&amp;journal=J%20Clin%20Oncol&amp;volume=32&amp;issue=36&amp;pages=4134-4140&amp;publication_year=2014"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR65" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Sotillo
 E, Barrett DM, Black KL, Bagashev A, Oldridge D, Wu G, Sussman R, 
Lanauze C, Ruella M, Gazzara MR, et al. Convergence of acquired 
mutations and alternative splicing of CD19 enables resistance to CART-19
 immunotherapy. Cancer Discov. 2015;5(12):1282–95.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1158/2159-8290.CD-15-1020"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4670800"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670800"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Convergence%20of%20acquired%20mutations%20and%20alternative%20splicing%20of%20CD19%20enables%20resistance%20to%20CART-19%20immunotherapy&amp;author=E.%20Sotillo&amp;author=DM.%20Barrett&amp;author=KL.%20Black&amp;author=A.%20Bagashev&amp;author=D.%20Oldridge&amp;author=G.%20Wu&amp;author=R.%20Sussman&amp;author=C.%20Lanauze&amp;author=M.%20Ruella&amp;author=MR.%20Gazzara&amp;journal=Cancer%20Discov&amp;volume=5&amp;issue=12&amp;pages=1282-1295&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR66" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Locatelli
 F, Schrappe M, Bernardo ME, Rutella S. How I treat relapsed childhood 
acute lymphoblastic leukemia. Blood. 2012;120(14):2807–16.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1182/blood-2012-02-265884"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=How%20I%20treat%20relapsed%20childhood%20acute%20lymphoblastic%20leukemia&amp;author=F.%20Locatelli&amp;author=M.%20Schrappe&amp;author=ME.%20Bernardo&amp;author=S.%20Rutella&amp;journal=Blood&amp;volume=120&amp;issue=14&amp;pages=2807-2816&amp;publication_year=2012"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR67" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Curran E, Stock W. How I treat acute lymphoblastic leukemia in older adolescents and young adults. Blood. 2015;125(24):3702–10.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1182/blood-2014-11-551481"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4463735"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463735"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=How%20I%20treat%20acute%20lymphoblastic%20leukemia%20in%20older%20adolescents%20and%20young%20adults&amp;author=E.%20Curran&amp;author=W.%20Stock&amp;journal=Blood&amp;volume=125&amp;issue=24&amp;pages=3702-3710&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR68" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Mukherjee
 K, Chava AK, Mandal C, Dey SN, Kniep B, Chandra S, Mandal C. 
O-acetylation of GD3 prevents its apoptotic effect and promotes survival
 of lymphoblasts in childhood acute lymphoblastic leukaemia. J Cell 
Biochem. 2008;105(3):724–34.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1002/jcb.21867"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=O-acetylation%20of%20GD3%20prevents%20its%20apoptotic%20effect%20and%20promotes%20survival%20of%20lymphoblasts%20in%20childhood%20acute%20lymphoblastic%20leukaemia&amp;author=K.%20Mukherjee&amp;author=AK.%20Chava&amp;author=C.%20Mandal&amp;author=SN.%20Dey&amp;author=B.%20Kniep&amp;author=S.%20Chandra&amp;author=C.%20Mandal&amp;journal=J%20Cell%20Biochem&amp;volume=105&amp;issue=3&amp;pages=724-734&amp;publication_year=2008"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR69" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Parameswaran
 R, Lim M, Arutyunyan A, Abdel-Azim H, Hurtz C, Lau K, Muschen M, Yu RK,
 von Itzstein M, Heisterkamp N, et al. O-acetylated N-acetylneuraminic 
acid as a novel target for therapy in human pre-B acute lymphoblastic 
leukemia. J Exp Med. 2013;210(4):805–19.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1084/jem.20121482"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3620349"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620349"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=O-acetylated%20N-acetylneuraminic%20acid%20as%20a%20novel%20target%20for%20therapy%20in%20human%20pre-B%20acute%20lymphoblastic%20leukemia&amp;author=R.%20Parameswaran&amp;author=M.%20Lim&amp;author=A.%20Arutyunyan&amp;author=H.%20Abdel-Azim&amp;author=C.%20Hurtz&amp;author=K.%20Lau&amp;author=M.%20Muschen&amp;author=RK.%20Yu&amp;author=M.%20von%20Itzstein&amp;author=N.%20Heisterkamp&amp;journal=J%20Exp%20Med&amp;volume=210&amp;issue=4&amp;pages=805-819&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR70" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Baumann
 AM, Bakkers MJ, Buettner FF, Hartmann M, Grove M, Langereis MA, de 
Groot RJ, Muhlenhoff M. 9-O-acetylation of sialic acids is catalysed by 
CASD1 via a covalent acetyl-enzyme intermediate. Nat Commun. 
2015;6:7673.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/ncomms8673"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4510713"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510713"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=9-O-acetylation%20of%20sialic%20acids%20is%20catalysed%20by%20CASD1%20via%20a%20covalent%20acetyl-enzyme%20intermediate&amp;author=AM.%20Baumann&amp;author=MJ.%20Bakkers&amp;author=FF.%20Buettner&amp;author=M.%20Hartmann&amp;author=M.%20Grove&amp;author=MA.%20Langereis&amp;author=RJ.%20de%20Groot&amp;author=M.%20Muhlenhoff&amp;journal=Nat%20Commun&amp;volume=6&amp;pages=7673&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR71" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">LaCasse
 EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S, Korneluk RG. 
IAP-targeted therapies for cancer. Oncogene. 2008;27(48):6252–75.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/onc.2008.302"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=IAP-targeted%20therapies%20for%20cancer&amp;author=EC.%20LaCasse&amp;author=DJ.%20Mahoney&amp;author=HH.%20Cheung&amp;author=S.%20Plenchette&amp;author=S.%20Baird&amp;author=RG.%20Korneluk&amp;journal=Oncogene&amp;volume=27&amp;issue=48&amp;pages=6252-6275&amp;publication_year=2008"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR72" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Holohan
 C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance:
 an evolving paradigm. Nat Rev Cancer. 2013;13(10):714–26.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nrc3599"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Cancer%20drug%20resistance%3A%20an%20evolving%20paradigm&amp;author=C.%20Holohan&amp;author=S.%20Van%20Schaeybroeck&amp;author=DB.%20Longley&amp;author=PG.%20Johnston&amp;journal=Nat%20Rev%20Cancer&amp;volume=13&amp;issue=10&amp;pages=714-726&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR73" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Suzuki
 Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R. A serine 
protease, HtrA2, is released from the mitochondria and interacts with 
XIAP, inducing cell death. Mol Cell. 2001;8(3):613–21.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/S1097-2765%2801%2900341-0"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=A%20serine%20protease%2C%20HtrA2%2C%20is%20released%20from%20the%20mitochondria%20and%20interacts%20with%20XIAP%2C%20inducing%20cell%20death&amp;author=Y.%20Suzuki&amp;author=Y.%20Imai&amp;author=H.%20Nakayama&amp;author=K.%20Takahashi&amp;author=K.%20Takio&amp;author=R.%20Takahashi&amp;journal=Mol%20Cell&amp;volume=8&amp;issue=3&amp;pages=613-621&amp;publication_year=2001"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR74" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Bertrand
 MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, Gillard 
JW, Jaquith JB, Morris SJ, Barker PA. cIAP1 and cIAP2 facilitate cancer 
cell survival by functioning as E3 ligases that promote RIP1 
ubiquitination. Mol Cell. 2008;30(6):689–700.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.molcel.2008.05.014"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=cIAP1%20and%20cIAP2%20facilitate%20cancer%20cell%20survival%20by%20functioning%20as%20E3%20ligases%20that%20promote%20RIP1%20ubiquitination&amp;author=MJ.%20Bertrand&amp;author=S.%20Milutinovic&amp;author=KM.%20Dickson&amp;author=WC.%20Ho&amp;author=A.%20Boudreault&amp;author=J.%20Durkin&amp;author=JW.%20Gillard&amp;author=JB.%20Jaquith&amp;author=SJ.%20Morris&amp;author=PA.%20Barker&amp;journal=Mol%20Cell&amp;volume=30&amp;issue=6&amp;pages=689-700&amp;publication_year=2008"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR75" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">McComb
 S, Aguade-Gorgorio J, Harder L, Marovca B, Cario G, Eckert C, Schrappe 
M, Stanulla M, von Stackelberg A, Bourquin JP, et al. Activation of 
concurrent apoptosis and necroptosis by SMAC mimetics for the treatment 
of refractory and relapsed ALL. Sci Transl Med. 2016;8(339):339ra370.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1126/scitranslmed.aad2986"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Activation%20of%20concurrent%20apoptosis%20and%20necroptosis%20by%20SMAC%20mimetics%20for%20the%20treatment%20of%20refractory%20and%20relapsed%20ALL&amp;author=S.%20McComb&amp;author=J.%20Aguade-Gorgorio&amp;author=L.%20Harder&amp;author=B.%20Marovca&amp;author=G.%20Cario&amp;author=C.%20Eckert&amp;author=M.%20Schrappe&amp;author=M.%20Stanulla&amp;author=A.%20von%20Stackelberg&amp;author=JP.%20Bourquin&amp;journal=Sci%20Transl%20Med&amp;volume=8&amp;issue=339&amp;pages=339ra370&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR76" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Manabe
 A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D. Bone 
marrow-derived stromal cells prevent apoptotic cell death in B-lineage 
acute lymphoblastic leukemia. Blood. 1992;79(9):2370–7.</span><span class="Occurrences"><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1373973"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373973"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Bone%20marrow-derived%20stromal%20cells%20prevent%20apoptotic%20cell%20death%20in%20B-lineage%20acute%20lymphoblastic%20leukemia&amp;author=A.%20Manabe&amp;author=E.%20Coustan-Smith&amp;author=FG.%20Behm&amp;author=SC.%20Raimondi&amp;author=D.%20Campana&amp;journal=Blood&amp;volume=79&amp;issue=9&amp;pages=2370-2377&amp;publication_year=1992"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR77" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Bruggemann M, Raff T, Kneba M. Has MRD monitoring superseded other prognostic factors in adult ALL? Blood. 2012;120(23):4470–81.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1182/blood-2012-06-379040"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Has%20MRD%20monitoring%20superseded%20other%20prognostic%20factors%20in%20adult%20ALL%3F&amp;author=M.%20Bruggemann&amp;author=T.%20Raff&amp;author=M.%20Kneba&amp;journal=Blood&amp;volume=120&amp;issue=23&amp;pages=4470-4481&amp;publication_year=2012"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR78" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Konoplev
 S, Jorgensen JL, Thomas DA, Lin E, Burger J, Kantarjian HM, Andreeff M,
 Medeiros LJ, Konopleva M. Phosphorylated CXCR4 is associated with poor 
survival in adults with B-acute lymphoblastic leukemia. Cancer. 
2011;117(20):4689–95.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1002/cncr.26113"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Phosphorylated%20CXCR4%20is%20associated%20with%20poor%20survival%20in%20adults%20with%20B-acute%20lymphoblastic%20leukemia&amp;author=S.%20Konoplev&amp;author=JL.%20Jorgensen&amp;author=DA.%20Thomas&amp;author=E.%20Lin&amp;author=J.%20Burger&amp;author=HM.%20Kantarjian&amp;author=M.%20Andreeff&amp;author=LJ.%20Medeiros&amp;author=M.%20Konopleva&amp;journal=Cancer&amp;volume=117&amp;issue=20&amp;pages=4689-4695&amp;publication_year=2011"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR79" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Juarez
 J, Bradstock KF, Gottlieb DJ, Bendall LJ. Effects of inhibitors of the 
chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro.
 Leukemia. 2003;17(7):1294–300.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/sj.leu.2402998"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Effects%20of%20inhibitors%20of%20the%20chemokine%20receptor%20CXCR4%20on%20acute%20lymphoblastic%20leukemia%20cells%20in%20vitro&amp;author=J.%20Juarez&amp;author=KF.%20Bradstock&amp;author=DJ.%20Gottlieb&amp;author=LJ.%20Bendall&amp;journal=Leukemia&amp;volume=17&amp;issue=7&amp;pages=1294-1300&amp;publication_year=2003"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR80" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Juarez
 J, Dela Pena A, Baraz R, Hewson J, Khoo M, Cisterne A, Fricker S, Fujii
 N, Bradstock KF, Bendall LJ. CXCR4 antagonists mobilize childhood acute
 lymphoblastic leukemia cells into the peripheral blood and inhibit 
engraftment. Leukemia. 2007;21(6):1249–57.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/sj.leu.2404684"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=CXCR4%20antagonists%20mobilize%20childhood%20acute%20lymphoblastic%20leukemia%20cells%20into%20the%20peripheral%20blood%20and%20inhibit%20engraftment&amp;author=J.%20Juarez&amp;author=A.%20Dela%20Pena&amp;author=R.%20Baraz&amp;author=J.%20Hewson&amp;author=M.%20Khoo&amp;author=A.%20Cisterne&amp;author=S.%20Fricker&amp;author=N.%20Fujii&amp;author=KF.%20Bradstock&amp;author=LJ.%20Bendall&amp;journal=Leukemia&amp;volume=21&amp;issue=6&amp;pages=1249-1257&amp;publication_year=2007"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR81" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Jasin
 M, Haber JE. The democratization of gene editing: insights from 
site-specific cleavage and double-strand break repair. DNA repair. 
2016;44:6–16.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.dnarep.2016.05.001"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5529214"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529214"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=The%20democratization%20of%20gene%20editing%3A%20insights%20from%20site-specific%20cleavage%20and%20double-strand%20break%20repair&amp;author=M.%20Jasin&amp;author=JE.%20Haber&amp;journal=DNA%20repair&amp;volume=44&amp;pages=6-16&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR82" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Chiruvella
 KK, Liang Z, Wilson TE. Repair of double-strand breaks by end joining. 
Cold Spring Harb Perspect Biol. 2013;5(5):a012757.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1101/cshperspect.a012757"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3632057"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632057"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Repair%20of%20double-strand%20breaks%20by%20end%20joining&amp;author=KK.%20Chiruvella&amp;author=Z.%20Liang&amp;author=TE.%20Wilson&amp;journal=Cold%20Spring%20Harb%20Perspect%20Biol&amp;volume=5&amp;issue=5&amp;pages=a012757&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR83" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Jacoby
 E, Nguyen SM, Fountaine TJ, Welp K, Gryder B, Qin H, Yang Y, Chien CD, 
Seif AE, Lei H, et al. CD19 CAR immune pressure induces B-precursor 
acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic
 plasticity. Nat Commun. 2016;7:12320.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/ncomms12320"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4974466"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974466"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=CD19%20CAR%20immune%20pressure%20induces%20B-precursor%20acute%20lymphoblastic%20leukaemia%20lineage%20switch%20exposing%20inherent%20leukaemic%20plasticity&amp;author=E.%20Jacoby&amp;author=SM.%20Nguyen&amp;author=TJ.%20Fountaine&amp;author=K.%20Welp&amp;author=B.%20Gryder&amp;author=H.%20Qin&amp;author=Y.%20Yang&amp;author=CD.%20Chien&amp;author=AE.%20Seif&amp;author=H.%20Lei&amp;journal=Nat%20Commun&amp;volume=7&amp;pages=12320&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR84" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Legut
 M, Dolton G, Mian AA, Ottmann OG, Sewell AK. CRISPR-mediated TCR 
replacement generates superior anticancer transgenic T cells. Blood. 
2018;131(3):311–22.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1182/blood-2017-05-787598"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5774207"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774207"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=CRISPR-mediated%20TCR%20replacement%20generates%20superior%20anticancer%20transgenic%20T%20cells&amp;author=M.%20Legut&amp;author=G.%20Dolton&amp;author=AA.%20Mian&amp;author=OG.%20Ottmann&amp;author=AK.%20Sewell&amp;journal=Blood&amp;volume=131&amp;issue=3&amp;pages=311-322&amp;publication_year=2018"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR85" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Cooper
 ML, Choi J, Staser K, Ritchey JK, Devenport JM, Eckardt K, Rettig MP, 
Wang B, Eissenberg LG, Ghobadi A, et al. An “off-the-shelf” 
fratricide-resistant CAR-T for the treatment of T cell hematologic 
malignancies. Leukemia. 2018; <span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="ExternalRef"><a href="https://doi.org/10.1038/s41375-018-0065-5" target="_blank" class="ext-link"><span class="RefSource">https://doi.org/10.1038/s41375-018-0065-5</span></a></span>.</span><span class="Occurrences"></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR86" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Wang
 J, Li T, Zhou M, Hu Z, Zhou X, Zhou S, Wang N, Huang L, Zhao L, Cao Y, 
et al. TALENs-mediated gene disruption of FLT3 in leukemia cells: using 
genome-editing approach for exploring the molecular basis of gene 
abnormality. Sci Rep. 2015;5:18454.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/srep18454"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=4680874"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680874"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=TALENs-mediated%20gene%20disruption%20of%20FLT3%20in%20leukemia%20cells%3A%20using%20genome-editing%20approach%20for%20exploring%20the%20molecular%20basis%20of%20gene%20abnormality&amp;author=J.%20Wang&amp;author=T.%20Li&amp;author=M.%20Zhou&amp;author=Z.%20Hu&amp;author=X.%20Zhou&amp;author=S.%20Zhou&amp;author=N.%20Wang&amp;author=L.%20Huang&amp;author=L.%20Zhao&amp;author=Y.%20Cao&amp;journal=Sci%20Rep&amp;volume=5&amp;pages=18454&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR87" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Van
 Der Meer LT, Yu J, Butler M, Van der Meer JMR, Kuiper RP, van Leeuwen 
F. Crispr/Cas9 based Kinome screen identifies novel targets that 
determine sensitivity for Asparaginase therapy in acute lymphoblastic 
leukemia. Blood. 2015;126(23):2629.</span><span class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Crispr%2FCas9%20based%20Kinome%20screen%20identifies%20novel%20targets%20that%20determine%20sensitivity%20for%20Asparaginase%20therapy%20in%20acute%20lymphoblastic%20leukemia&amp;author=LT.%20Van%20Der%20Meer&amp;author=J.%20Yu&amp;author=M.%20Butler&amp;author=JMR.%20Van%20der%20Meer&amp;author=RP.%20Kuiper&amp;author=F.%20van%20Leeuwen&amp;journal=Blood&amp;volume=126&amp;issue=23&amp;pages=2629&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR88" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Erb
 MA, Scott TG, Li BE, Xie H, Paulk J, Seo HS, Souza A, Roberts JM, 
Dastjerdi S, Buckley DL, et al. Transcription control by the ENL YEATS 
domain in acute leukaemia. Nature. 2017;543(7644):270–4.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nature21688"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5497220"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497220"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Transcription%20control%20by%20the%20ENL%20YEATS%20domain%20in%20acute%20leukaemia&amp;author=MA.%20Erb&amp;author=TG.%20Scott&amp;author=BE.%20Li&amp;author=H.%20Xie&amp;author=J.%20Paulk&amp;author=HS.%20Seo&amp;author=A.%20Souza&amp;author=JM.%20Roberts&amp;author=S.%20Dastjerdi&amp;author=DL.%20Buckley&amp;journal=Nature&amp;volume=543&amp;issue=7644&amp;pages=270-274&amp;publication_year=2017"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR89" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Nishii
 R, Moriyama T, Janke LJ, Yang W, Suiter C, Lin TN, Li L, Kihira K, 
Toyoda H, Hofmann U, et al. Preclinical evaluation of NUDT15-guided 
thiopurine therapy and its effects on toxicity and anti-leukemic 
efficacy. Blood. 2018;131(22):2466–74.<span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="https://scholar.google.com/scholar?hl=en&amp;q=Nishii%20R%2C%20Moriyama%20T%2C%20Janke%20LJ%2C%20Yang%20W%2C%20Suiter%20C%2C%20Lin%20TN%2C%20Li%20L%2C%20Kihira%20K%2C%20Toyoda%20H%2C%20Hofmann%20U%2C%20et%20al.%20Preclinical%20evaluation%20of%20NUDT15-guided%20thiopurine%20therapy%20and%20its%20effects%20on%20toxicity%20and%20anti-leukemic%20efficacy.%20Blood.%202018%3B131%2822%29%3A2466%E2%80%9374."><span><span>Google Scholar</span></span></a></span></span></span><span class="Occurrences"></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR90" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Huang
 M, Inukai T, Miyake K, Tanaka Y, Kagami K, Abe M, Goto H, Minegishi M, 
Iwamoto S, Sugihara E, et al. Clofarabine exerts antileukemic activity 
against cytarabine-resistant B-cell precursor acute lymphoblastic 
leukemia with low deoxycytidine kinase expression. Cancer Med. 
2018;7(4):1297–316.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1002/cam4.1323"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=5911575"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911575"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Clofarabine%20exerts%20antileukemic%20activity%20against%20cytarabine-resistant%20B-cell%20precursor%20acute%20lymphoblastic%20leukemia%20with%20low%20deoxycytidine%20kinase%20expression&amp;author=M.%20Huang&amp;author=T.%20Inukai&amp;author=K.%20Miyake&amp;author=Y.%20Tanaka&amp;author=K.%20Kagami&amp;author=M.%20Abe&amp;author=H.%20Goto&amp;author=M.%20Minegishi&amp;author=S.%20Iwamoto&amp;author=E.%20Sugihara&amp;journal=Cancer%20Med&amp;volume=7&amp;issue=4&amp;pages=1297-1316&amp;publication_year=2018"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR91" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Burns
 MA, Liao ZW, Yamagata N, Pouliot GP, Stevenson KE, Neuberg DS, Thorner 
AR, Ducar M, Silverman EA, Hunger SP, et al. Hedgehog pathway mutations 
drive oncogenic transformation in high-risk T-cell acute lymphoblastic 
leukemia. Leukemia. 2018; <span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="ExternalRef"><a href="https://doi.org/10.1038/s41375-018-0097-x" target="_blank" class="ext-link"><span class="RefSource">https://doi.org/10.1038/s41375-018-0097-x</span></a></span>.</span><span class="Occurrences"></span></cite></li></ol></div></section><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Section1 RenderAsSection1 c-section" id="CopyrightMessage"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#TheAuthors" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="TheAuthors">Copyright</a></h2><div class="js-CollapseSection CollapseSection c-section__content" data-test="collapse-section" id="TheAuthors"><div xmlns="http://www.w3.org/1999/xhtml" class="ArticleCopyright">©&nbsp;The Author(s).&nbsp;2018</div></div></section></div>
                        


                    </article>
                </main>

                <div class="c-page-layout__side u-text-sm">
                    <aside>
                        <div class="c-separator">
                            
        <p class="u-margin-bottom-sm">
            <a id="articlePdf" data-test="download-pdf" class="c-button c-button--primary c-button--full-width" target="_blank" rel="noopener" href="https://bmcbiotechnol.biomedcentral.com/track/pdf/10.1186/s12896-018-0455-9" data-track="click" data-track-category="PDF Download" data-track-action="Click download article PDF" data-track-label="10.1186/s12896-018-0455-9">Download PDF</a>
        </p>
    
                            
                            
    <button type="button" class="c-button c-button--expandable" data-toggle="collapse" data-target="export-citations" data-test="export-citations-button" data-sticky-update="true" aria-controls="export-citations" aria-expanded="false">
        <span class="c-dropdown__toggle">Export citations</span>
    </button>
    <div id="export-citations" class="c-export-citations" data-test="export-citations-content">
        <div class="c-export-citations__section">
            <h4 class="c-export-citations__title">Papers, Zotero, Reference Manager, RefWorks (<strong>.RIS</strong>)</h4>
            <ul class="c-export-citations__list" id="articleReferences">
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download Papers, Zotero, Reference Manager, RefWorks article citations" data-track-label="10.1186/s12896-018-0455-9" href="http://citation-needed.springer.com/v2/references/10.1186/s12896-018-0455-9?format=refman&amp;flavour=citation">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>Citations
                </a></li>
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download Papers, Zotero, Reference Manager, RefWorks references" data-track-label="10.1186/s12896-018-0455-9" href="http://citation-needed.springer.com/v2/references/10.1186/s12896-018-0455-9?format=refman&amp;flavour=references">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>References
                </a></li>
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download Papers, Zotero, Reference Manager, RefWorks citations and references" data-track-label="10.1186/s12896-018-0455-9" href="http://citation-needed.springer.com/v2/references/10.1186/s12896-018-0455-9?format=refman&amp;flavour=full">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>Both
                </a></li>
            </ul>
        </div>
        <div class="c-export-citations__section">
            <h4 class="c-export-citations__title">EndNote (<strong>.ENW</strong>)</h4>
            <ul class="c-export-citations__list">
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download EndNote article citations" data-track-label="10.1186/s12896-018-0455-9" href="http://citation-needed.springer.com/v2/references/10.1186/s12896-018-0455-9?format=endnote&amp;flavour=citation">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>Citations
                </a></li>
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download EndNote references" data-track-label="10.1186/s12896-018-0455-9" href="http://citation-needed.springer.com/v2/references/10.1186/s12896-018-0455-9?format=endnote&amp;flavour=references">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>References
                </a></li>
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download EndNote citations and references" data-track-label="10.1186/s12896-018-0455-9" href="http://citation-needed.springer.com/v2/references/10.1186/s12896-018-0455-9?format=endnote&amp;flavour=full">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>Both
                </a></li>
            </ul>
        </div>
        <div class="c-export-citations__section">
            <h4 class="c-export-citations__title">Mendeley, JabRef (<strong>.BIB</strong>)</h4>
            <ul class="c-export-citations__list">
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download Mendeley, JabRef article citations" data-track-label="10.1186/s12896-018-0455-9" href="http://citation-needed.springer.com/v2/references/10.1186/s12896-018-0455-9?format=bibtex&amp;flavour=citation">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>Citations
                </a></li>
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download Mendeley, JabRef references" data-track-label="10.1186/s12896-018-0455-9" href="http://citation-needed.springer.com/v2/references/10.1186/s12896-018-0455-9?format=bibtex&amp;flavour=references">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>References
                </a></li>
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download Mendeley, JabRef citations and references" data-track-label="10.1186/s12896-018-0455-9" href="http://citation-needed.springer.com/v2/references/10.1186/s12896-018-0455-9?format=bibtex&amp;flavour=full">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>Both
                </a></li>
            </ul>
        </div>
    </div>

                        </div>
                        
    
    <div id="articleSections" class="c-separator">
        <h3 class="p-section-title">Section</h3>
        <ul class="c-list-group c-list-group--bordered c-list-group c-list-group--md">
            
                <li class="c-list-group__item">
                    <a href="https://bmcbiotechnol.biomedcentral.com/articles/sections/genetic-engineering-in-animals-and-animal-cell-systems" data-track="click" data-track-category="Article Page" data-track-action="Click section link" data-track-label="10.1186/s12896-018-0455-9">Genetic engineering in animals and animal cell systems</a>
                </li>
            
        </ul>
    </div>
    
 
                        
    
 
                        <div class="c-separator">
                            <h3 class="p-section-title">Metrics</h3>
                            <ul class="c-list-group c-list-group--md">
                                
            <li class="c-list-group__item">
                Article accesses:
                
                    2048
                
            </li>
        
                                
            <li class="c-list-group__item">
                Citations: 0 <a href="http://citations.springer.com/item?doi=10.1186/s12896-018-0455-9" rel="noopener" target="_blank">more information</a>
            </li>
        
                                
    <li class="c-list-group__item">
        <p>Altmetric Attention Score: 1</p>
        <div class="altmetric">
            <a class="altmetric__link" href="http://www.altmetric.com/details.php?citation_id=45416552&amp;domain=www.biomedcentral.com" target="_blank" rel="noopener" data-track="click" data-track-category="Article Page" data-track-action="Click Altmetric" data-track-label="10.1186/s12896-018-0455-9">
                <img class="altmetric__img" src="a.png" alt="Altmetric Attention Score">
            </a>
        </div>
    </li>

                            </ul>
                        </div>
                        
    <div class="c-separator">
        <div class="js-shown">
            <h3 class="p-section-title">Share this article</h3>
            <ul data-test="social-media-share-buttons" class="c-social-links">
                <li class="c-social-links__item">
                    <button id="shareOnTwitter" class="js-btnShareOnTwitter" data-track="click" data-track-category="Article Page" data-track-action="Share Twitter" data-track-label="10.1186/s12896-018-0455-9">
                        <span class="u-visually-hidden" data-track="click" data-track-category="Article Page" data-track-action="Share Twitter" data-track-label="10.1186/s12896-018-0455-9">Share on Twitter</span>
                        <svg class="c-icon c-social-links__icon" width="24" height="24" aria-hidden="true" data-track="click" data-track-category="Article Page" data-track-action="Share Twitter" data-track-label="10.1186/s12896-018-0455-9">
                            <use xlink:href="#icon-twitter"></use>
                        </svg>
                    </button>
                </li>
                <li class="c-social-links__item">
                    <button id="shareOnFacebook" class="js-btnShareOnFacebook" data-track="click" data-track-category="Article Page" data-track-action="Share Facebook" data-track-label="10.1186/s12896-018-0455-9">
                        <span class="u-visually-hidden" data-track="click" data-track-category="Article Page" data-track-action="Share Facebook" data-track-label="10.1186/s12896-018-0455-9">Share on Facebook</span>
                        <svg class="c-icon c-social-links__icon" width="24" height="24" aria-hidden="true" data-track="click" data-track-category="Article Page" data-track-action="Share Facebook" data-track-label="10.1186/s12896-018-0455-9">
                            <use xlink:href="#icon-facebook"></use>
                        </svg>
                    </button>
                </li>
                <li class="c-social-links__item">
                    <button id="shareOnLinkedIn" class="js-btnShareOnLinkedIn" data-track="click" data-track-category="Article Page" data-track-action="Share LinkedIn" data-track-label="10.1186/s12896-018-0455-9">
                        <span class="u-visually-hidden" data-track="click" data-track-category="Article Page" data-track-action="Share LinkedIn" data-track-label="10.1186/s12896-018-0455-9">Share on LinkedIn</span>
                        <svg class="c-icon c-social-links__icon" width="24" height="24" aria-hidden="true" data-track="click" data-track-category="Article Page" data-track-action="Share LinkedIn" data-track-label="10.1186/s12896-018-0455-9">
                            <use xlink:href="#icon-linkedin"></use>
                        </svg>
                    </button>
                </li>
                <li class="c-social-links__item">
                    <button id="shareOnWeibo" class="js-btnShareOnWeibo" data-track="click" data-track-category="Article Page" data-track-action="Share Weibo" data-track-label="10.1186/s12896-018-0455-9">
                        <span class="u-visually-hidden" data-track="click" data-track-category="Article Page" data-track-action="Share Weibo" data-track-label="10.1186/s12896-018-0455-9">Share on Weibo</span>
                        <svg class="c-icon c-social-links__icon" width="24" height="24" aria-hidden="true" data-track="click" data-track-category="Article Page" data-track-action="Share Weibo" data-track-label="10.1186/s12896-018-0455-9">
                            <use xlink:href="#icon-weibo"></use>
                        </svg>
                    </button>
                </li>
                <li class="c-social-links__item">
                    <button id="shareOnReddit" class="js-btnShareOnReddit" data-track="click" data-track-category="Article Page" data-track-action="Share Reddit" data-track-label="10.1186/s12896-018-0455-9">
                        <span class="u-visually-hidden" data-track="click" data-track-category="Article Page" data-track-action="Share Reddit" data-track-label="10.1186/s12896-018-0455-9">Share on Reddit</span>
                        <svg class="c-icon c-social-links__icon" width="24" height="24" aria-hidden="true" data-track="click" data-track-category="Article Page" data-track-action="Share Reddit" data-track-label="10.1186/s12896-018-0455-9">
                            <use xlink:href="#icon-reddit"></use>
                        </svg>
                    </button>
                </li>
            </ul>
        </div>
        
            <div data-sharedit="container">
                <a class="c-button u-margin-top-sm" href="https://bmcbiotechnol.biomedcentral.com/articles/10.1186/s12896-018-0455-9/sharedit" rel="nofollow" data-sharedit="button" data-track="click" data-track-category="sharedit" data-track-action="click article sharedit button" data-track-label="10.1186/s12896-018-0455-9">Get shareable link</a>
            </div>
        
    </div>
 
                        
    
        <div class="c-separator u-js-shown">
            <h3 class="p-section-title">See updates</h3>
            <button class="c-crossmark-button" data-target="crossmark" data-test="crossmark" data-track="click" data-track-category="Article Page" data-track-action="Click CrossMark" data-track-label="10.1186/s12896-018-0455-9">
                <img id="crossmark-icon" src="CROSSMARK_Color_horizontal.svg" alt="Crossmark logo">
            </button>
        </div>
    
 
                        <div class="c-separator">
                            <h3 class="p-section-title">Other Actions</h3>
                            <ul class="c-list-group c-list-group--bordered c-list-group c-list-group--md">
                                <li class="c-list-group__item">
                                    
    <a data-track="click" data-track-category="Article Page" data-track-action="Order article reprints" data-track-label="10.1186/s12896-018-0455-9" href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&amp;page=0&amp;journal=738&amp;doi=10.1186%2Fs12896-018-0455-9&amp;volume=18&amp;issue=1&amp;title=Targeted+genome+editing+in+acute+lymphoblastic+leukemia%3A+a+review&amp;author_name=Adri%C3%A1n+Monta%C3%B1o&amp;start_page=1&amp;end_page=10">Order reprint</a>

                                </li>
                            </ul>
                        </div>
                    </aside>
                    
    <div id="FulltextAd" class="adsbox c-ad c-ad--skyscraper">
        <div class="c-ad__inner" data-component="sticky" data-test="fulltext-ad">
            <p class="c-ad__label">Advertisement</p>
            <div class="c-ad__content">
                <span id="pbgrd-43415139"></span>
            </div>
        </div>
    </div>

                </div>
            </div>
        </div>


        
            <div class="c-journal-footer">
                <div class="c-journal-footer__inner">
                    <div class="c-journal-footer__summary">
                        <h4 class="c-journal-title c-journal-title--footer">
                            
                            <span class="c-journal-title__text">BMC Biotechnology</span>
                        </h4>
                         <p class="c-journal-footer__issn">ISSN: 1472-6750</p>
                    </div>
                    
                        <div class="c-journal-footer__contact">
                            <h4 class="c-journal-footer__contact-title ">Contact us</h4>
                            <ul class="c-journal-footer__contact-list">
                                
                                    <li class="c-journal-footer__contact-item">Submission enquiries: <a href="mailto:bmcbiotechnol@biomedcentral.com">bmcbiotechnol@biomedcentral.com</a></li>
                                
                                
                                    <li class="c-journal-footer__contact-item">General enquiries: <a href="mailto:info@biomedcentral.com">info@biomedcentral.com</a></li>
                                
                            </ul>
                        </div>
                    
                </div>
            </div>
        
        
    <img rel="nofollow" class="tracker" style="display:none" src="s12896-018-0455-9.png" alt="">

         
    <footer>
        
            <div class="c-publisher-footer" data-test="publisher-footer">
    <div class="u-container">
        
        <div class="c-flex c-flex--wrap c-flex--space-between" data-test="publisher-footer-menu">
            <div class="c-flex">
                
                    
                        <ul class="c-list-group c-list-group--sm u-margin-right-lg u-margin-bottom-md">
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="http://blogs.biomedcentral.com/">Read more on our blogs</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://www.biomedcentral.com/login">Receive BMC newsletters</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://www.biomedcentral.com/account">Manage article alerts</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://authorservices.springernature.com/go/10BMC">Language editing for authors</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="http://authorservices.springernature.com/scientific-editing/">Scientific editing for authors</a>
                                </li>
                            
                        </ul>
                    
                        <ul class="c-list-group c-list-group--sm u-margin-right-lg u-margin-bottom-md">
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://www.biomedcentral.com/about/policies">Policies</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://www.biomedcentral.com/accessibility">Accessibility</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://www.biomedcentral.com/about/press-centre">Press center</a>
                                </li>
                            
                        </ul>
                    
                        <ul class="c-list-group c-list-group--sm u-margin-right-lg u-margin-bottom-md">
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://www.biomedcentral.com/about/contact-us">Support and Contact</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://biomedcentral.typeform.com/to/VLXboo">Leave feedback</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://www.biomedcentral.com/about/jobs">Careers</a>
                                </li>
                            
                        </ul>
                    
                
            </div>
            <div class="u-margin-bottom-lg">
                <h3 id="social-menu" class="u-text-sm u-reset-margin u-text-normal">Follow BMC</h3>
                <ul class="c-flex u-reset-list" data-test="footer-social-links">
                    
                        <li class="u-margin-top-xs u-margin-right-xs">
                            <a href="https://twitter.com/biomedcentral" class="u-gray-link">
                                <span class="u-visually-hidden">BMC Twitter page</span>
                                <svg class="c-icon" width="24" height="24" aria-hidden="true">
                                    <use xlink:href="#icon-twitter-bordered"></use>
                                </svg>
                            </a>
                        </li>
                    
                        <li class="u-margin-top-xs u-margin-right-xs">
                            <a href="https://www.facebook.com/BioMedCentral" class="u-gray-link">
                                <span class="u-visually-hidden">BMC Facebook page</span>
                                <svg class="c-icon" width="24" height="24" aria-hidden="true">
                                    <use xlink:href="#icon-facebook-bordered"></use>
                                </svg>
                            </a>
                        </li>
                    
                        <li class="u-margin-top-xs u-margin-right-xs">
                            <a href="http://www.weibo.com/biomedcentral" class="u-gray-link">
                                <span class="u-visually-hidden">BMC Weibo page</span>
                                <svg class="c-icon" width="24" height="24" aria-hidden="true">
                                    <use xlink:href="#icon-weibo-bordered"></use>
                                </svg>
                            </a>
                        </li>
                    
                </ul>
            </div>
        </div>
        <p class="u-reset-margin">
            By using this website, you agree to our
            <a class="u-gray-link" href="https://www.biomedcentral.com/terms-and-conditions">Terms and Conditions</a>,
            <a class="u-gray-link" href="https://www.biomedcentral.com/privacy-statement">Privacy
                statement</a> and
            <a class="u-gray-link" href="https://www.biomedcentral.com/cookies" data-test="cookie-link">Cookies</a> policy.
            
                <a class="optanon-toggle-display u-gray-link" href="javascript:void(0);">Manage the cookies</a> we use in the preference centre.
            
        </p>
    </div>
</div>

        
        <div class="c-sn-footer">
    <div class="u-container">
        <img src="logo-springernature-8bd4e8d82f.svg" class="c-sn-footer__logo" alt="Springer Nature" itemprop="logo">
        <p data-test="copyright"> © 2019 BioMed Central Ltd unless otherwise stated. Part of
            <a href="https://www.springernature.com/" itemscope="" itemtype="http://schema.org/Organization" itemid="#parentOrganization">Springer Nature</a>.
        </p>
    </div>
</div>

        
    </footer>

    </div>

    
    <script type="text/javascript" src="bmc.js" async="async"></script>
    <noscript>
	<img hidden src="https://verify.nature.com/verify/nature.png" border="0" width="0" height="0" style="display: none">
</noscript>

        
<script>
    (function() {
        if (window.config && window.config.mustardcut) {
            var appScript = document.createElement('script');
            
            appScript.src = '/static/js/app-bundle-f26c570b6a.js';
            
            appScript.async = false;
            document.body.appendChild(appScript);
        }
    })();
</script><script src="app-bundle-f26c570b6a.js"></script>

    


<iframe src="https://event-tracker.springernature.com" title="EventTracker" id="event-tracker" style="display:none; visibility:hidden" aria-hidden="true" tabindex="-1" width="0" height="0"></iframe><script type="text/javascript" id="polyfill-matches">Element.prototype.matches||(Element.prototype.matches=Element.prototype.matchesSelector||Element.prototype.mozMatchesSelector||Element.prototype.msMatchesSelector||Element.prototype.oMatchesSelector||Element.prototype.webkitMatchesSelector||function(a){a=(this.document||this.ownerDocument).querySelectorAll(a);for(var b=a.length;0<=--b&&a.item(b)!==this;);return-1<b});</script><script type="text/javascript" id="gpt-control" src="https://www.googletagservices.com/tag/js/gpt.js"></script><script type="text/javascript" id="krux-control-bmc">window.Krux||((Krux=function(){Krux.q.push(arguments)}).q=[]);(function(){var a=document.createElement("script");a.type="text/javascript";a.async=!0;a.src=("https:"===location.protocol?"https:":"http:")+"//cdn.krxd.net/controltag/KDqylSLE.js";var b=document.getElementsByTagName("script")[0];b.parentNode.insertBefore(a,b)})();</script><script type="text/javascript" id="krux-interchange-bmc">window.Krux||((Krux=function(){Krux.q.push(arguments)}).q=[]);(function(){function c(a){a="kxmacmillan_"+a;try{var b=window.localStorage}catch(e){b=null}return b?b[a]||"":navigator.cookieEnabled?(b=document.cookie.match(a+"\x3d([^;]*)"))&&unescape(b[1])||"":""}Krux.user=c("user");Krux.segments=c("segs")?c("segs").split(","):[];var a=[];Krux.user&&a.push("kuid\x3d"+Krux.user);for(var d=0;d<Krux.segments.length;d++)a.push("ksg\x3d"+Krux.segments[d]);Krux.dfppKeyValues=a.length?a.join(";")+";":""})();</script><script type="text/javascript" id="krux-consent">var allowed=google_tag_manager["GTM-TDGJHK"].macro(27);allowed=!0===allowed?1:0;Krux("consent:set",{dc:allowed,al:allowed,tg:allowed,cd:!1,sh:!1,re:!1},function(a,b){});</script><script type="text/javascript" id="gpt-retrieve-ads">function splitKeys(a){var d=[],e="",g=[],h=a.split(";");for(a=0;a<h.length;++a){void 0!==k&&(e=k);var b=h[a].split("\x3d");var k=b[0];k!==e&&(0<e.length&&0<d.length&&g.push([e,d]),d=[]);if(2===b.length&&""!==b[0]&&""!==b[1]){var c=b[1].split(",");for(b=0;b<c.length;++b)d.push(c[b])}}0<k.length&&0<d.length&&g.push([k,d]);return g}
function splitSizes(a){var d=[];if(null!==a){var e=0<=a.indexOf("|")?a.split("|"):a.split(",");for(a=0;a<e.length;++a){var g=e[a].split("x");var h=parseInt(g[0],10);var b=parseInt(g[1],10);2===g.length&&!isNaN(h)&&!isNaN(b)&&0<=h&&0<=b&&d.push([h,b])}}return d}function debounce(a,d){var e=null,g=null;return function(){var h=this,b=Number(new Date),k=arguments;e&&b<e+d?(clearTimeout(g),g=setTimeout(function(){e=b;a.apply(h,k)},d)):(e=b,a.apply(h,k))}}
function addScrollEvent(a){window.addEventListener?window.addEventListener("scroll",a,!1):window.attachEvent("onscroll",a)}function removeScrollEvent(a){window.removeEventListener?window.removeEventListener("scroll",a,!1):window.detachEvent("scroll",a)}function getAdContainers(){return document.querySelectorAll("div[data-gpt-unitpath]")}function isLoggedIn(){return 0<=document.cookie.indexOf("OSCAR_SESSION_COOKIE")?"logged\x3dy;":"logged\x3dn;"}
(function(a,d){function e(f){var a="test";a=a.replace(/[\[\]]/g,"\\$\x26");a=new RegExp("[?\x26]"+a+"(\x3d([^\x26#]*)|\x26|#|$)");a=(a=a.exec(window.location.href))?a[2]?decodeURIComponent(a[2].replace(/\+/g," ")):"":null;a=a&&"ads"===a?"adtype\x3dtest;":"";f=f.getAttribute("data-gpt-targeting");var c=document.querySelector("[data-ad-targeting-search-terms]")?"search\x3d"+document.querySelector("[data-ad-targeting-search-terms]").innerText+";":!1;var d=isLoggedIn();a&&-1===f.indexOf(a)&&(f+=a);c&&
(f+=c);return f+d+b}function g(a,c){for(var f=a.length,b=[];f--;)c(a[f],f)&&(b.push(a[f].slot),a.splice(f,1));b.length&&googletag.pubads().refresh(b);return a}function h(f){var c=Math.max(document.documentElement.clientHeight,a.innerHeight||0);return g(f,function(a){a=document.getElementById(a.divId);a=a.getBoundingClientRect();a=a.top-300;return c>a})}var b,k=getAdContainers(),c=[];d&&(b=d.dfppKeyValues?d.dfppKeyValues:"");a.googletag=a.googletag||{};a.googletag.cmd=a.googletag.cmd||[];for(var m=
0;k[m];++m){var l=k[m];splitKeys(e(l));c.push({divId:l.getAttribute("id"),adUnitPath:l.getAttribute("data-gpt-unitpath"),sizeArray:splitSizes(l.getAttribute("data-gpt-sizes")),targeting:splitKeys(e(l))})}googletag.cmd.push(function(){googletag.pubads().setRequestNonPersonalizedAds(google_tag_manager["GTM-TDGJHK"].macro(31)?0:1);googletag.pubads().disableInitialLoad();googletag.enableServices()});googletag.cmd.push(function(){for(var a=0;c[a];++a)try{c[a].slot=googletag.defineSlot(c[a].adUnitPath,c[a].sizeArray,c[a].divId).addService(googletag.pubads());
for(var b=0,d=c[a].targeting.length;b<d;++b)2===c[a].targeting[b].length&&""!==c[a].targeting[b][0]&&""!==c[a].targeting[b][1]&&c[a].slot.setTargeting(c[a].targeting[b][0],c[a].targeting[b][1])}catch(p){console.log("failed to create slot for",c[a])}});googletag.cmd.push(function(){for(var a=0;c[a];++a)googletag.display(c[a].divId)});googletag.cmd.push(function(){c=h(c)});var n=debounce(function(){googletag.cmd.push(function(){c=h(c);c.length||removeScrollEvent(n)})},250);addScrollEvent(n)})(window,
window.Krux);</script><script type="text/javascript" id="ga-data-track-event-listeners">var setupHandler=google_tag_manager["GTM-TDGJHK"].macro(39);setupHandler("click");setupHandler("submit");</script><script type="text/javascript" id="crossmark-script" src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script><script type="text/javascript" id="recommended-script" src="https://recommended.springernature.com/latest/entry-point.js"></script></body></html>